100-01-6	REACT:R-HSA-168256|Immune System
100-02-7	REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1430728|Metabolism;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa00830|Retinol metabolism;KEGG:hsa00983|Drug metabolism - other enzymes;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
100-33-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
100-41-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins
100-42-5	REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05164|Influenza A;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05162|Measles;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05144|Malaria;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology
100-63-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism
1002-53-5	REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
10025-82-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins
10028-15-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05164|Influenza A;KEGG:hsa05133|Pertussis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05162|Measles;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-451927|Interleukin-2 signaling
10035-10-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04360|Axon guidance;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-446728|Cell junction organization;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-421270|Cell-cell junction organization;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04216|Ferroptosis;KEGG:hsa04978|Mineral absorption;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04514|Cell adhesion molecules (CAMs);REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05146|Amoebiasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04916|Melanogenesis
10043-01-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
10043-52-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05164|Influenza A;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-70326|Glucose metabolism;KEGG:hsa05132|Salmonella infection;KEGG:hsa04510|Focal adhesion;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04145|Phagosome;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR)
10048-13-2	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway
10049-05-5	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway
100929-53-1	REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-388396|GPCR downstream signaling
10097-84-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-68886|M Phase;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules
100986-85-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease
10099-58-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
101-14-4	REACT:R-HSA-1430728|Metabolism
101-20-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins
101-26-8	KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1430728|Metabolism;KEGG:hsa05016|Huntington's disease;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05152|Tuberculosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01100|Metabolic pathways;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa00480|Glutathione metabolism;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05133|Pertussis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-422475|Axon guidance
101-77-9	REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa03010|Ribosome;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-72766|Translation;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168254|Influenza Infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-109581|Apoptosis
101-86-0	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways
10102-06-4	REACT:R-HSA-1430728|Metabolism
10102-18-8	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-72766|Translation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-72613|Eukaryotic Translation Initiation;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);KEGG:hsa03010|Ribosome;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-192823|Viral mRNA Translation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-168254|Influenza Infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04510|Focal adhesion;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109582|Hemostasis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05164|Influenza A;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
10102-43-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1643685|Disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05134|Legionellosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05162|Measles;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05146|Amoebiasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05160|Hepatitis C;KEGG:hsa04510|Focal adhesion;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05132|Salmonella infection
10102-44-0	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05144|Malaria;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05161|Hepatitis B;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-372790|Signaling by GPCR
10102-45-1	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression
10103-47-6	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
10108-64-2	REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04210|Apoptosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05164|Influenza A;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-68886|M Phase;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-72766|Translation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05168|Herpes simplex infection
10118-90-8	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05134|Legionellosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05144|Malaria;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05146|Amoebiasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05162|Measles;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression
10121-91-2	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System
10124-36-4	REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05133|Pertussis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-3371556|Cellular response to heat stress;KEGG:hsa05020|Prion diseases;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;KEGG:hsa04978|Mineral absorption;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5689880|Ub-specific processing proteases;KEGG:hsa04014|Ras signaling pathway
10124-43-3	KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
10138-52-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05164|Influenza A;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05146|Amoebiasis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05133|Pertussis;KEGG:hsa05132|Salmonella infection;KEGG:hsa05162|Measles;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05144|Malaria;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05215|Prostate cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins
10159-53-2	REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins
10182-84-0	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
101932-71-2	KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05224|Breast cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System
102-32-9	REACT:R-HSA-1430728|Metabolism
102-37-4	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
102-61-4	REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04110|Cell cycle;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69242|S Phase;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways
102052-95-9	KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05200|Pathways in cancer
10206-21-0	REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
102121-60-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease
10236-47-2	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05224|Breast cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05160|Hepatitis C;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04510|Focal adhesion;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04930|Type II diabetes mellitus;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05218|Melanoma;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05214|Glioma;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05132|Salmonella infection;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05219|Bladder cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1280218|Adaptive Immune System
10236-58-5	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins
10238-21-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04976|Bile secretion;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa02010|ABC transporters;KEGG:hsa05133|Pertussis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction
102396-24-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
1024-57-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
10265-92-6	KEGG:hsa05206|MicroRNAs in cancer
103-85-5	REACT:R-HSA-1430728|Metabolism
103-90-2	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-68886|M Phase;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04144|Endocytosis;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04210|Apoptosis;KEGG:hsa05016|Huntington's disease;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04510|Focal adhesion;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+
10309-37-2	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System
10309-95-2	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
10325-94-7	KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05134|Legionellosis;KEGG:hsa05133|Pertussis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
103628-46-2	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05144|Malaria;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05162|Measles;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04210|Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1643685|Disease
103745-39-7	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR
103882-84-4	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05224|Breast cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05162|Measles;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05144|Malaria;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05134|Legionellosis;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05132|Salmonella infection;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05218|Melanoma;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation
104-40-5	KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05164|Influenza A;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa05214|Glioma;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R
104-46-1	KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology
104-54-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01100|Metabolic pathways
104-55-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05132|Salmonella infection;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05133|Pertussis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05162|Measles;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05215|Prostate cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05144|Malaria;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;KEGG:hsa05131|Shigellosis;KEGG:hsa04931|Insulin resistance;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1280218|Adaptive Immune System
104-87-0	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System
104594-70-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05134|Legionellosis;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05162|Measles;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04020|Calcium signaling pathway
10463-84-0	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
10465-78-8	REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System
104713-70-4	REACT:R-HSA-168256|Immune System
104807-46-7	REACT:R-HSA-162582|Signal Transduction
10540-29-1	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05162|Measles;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-199991|Membrane Trafficking
105637-50-1	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
105650-23-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72766|Translation;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;KEGG:hsa03010|Ribosome;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05214|Glioma;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05164|Influenza A;KEGG:hsa05218|Melanoma;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05152|Tuberculosis
105827-78-9	KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways
10588-01-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-69242|S Phase;KEGG:hsa04110|Cell cycle;KEGG:hsa05152|Tuberculosis;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-72312|rRNA processing;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-69306|DNA Replication;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-69190|DNA strand elongation;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6790901|rRNA modification in the nucleus and cytosol;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05020|Prion diseases;REACT:R-HSA-73894|DNA Repair;KEGG:hsa03030|DNA replication;KEGG:hsa05133|Pertussis;REACT:R-HSA-73933|Resolution of Abasic Sites (AP sites);REACT:R-HSA-73884|Base Excision Repair;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04510|Focal adhesion;KEGG:hsa05132|Salmonella infection;KEGG:hsa00240|Pyrimidine metabolism;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa03008|Ribosome biogenesis in eukaryotes;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05210|Colorectal cancer
10596-23-3	REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-379716|Cytosolic tRNA aminoacylation;KEGG:hsa01100|Metabolic pathways;KEGG:hsa_M00359|Aminoacyl-tRNA biosynthesis, eukaryotes;REACT:R-HSA-379724|tRNA Aminoacylation;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa00970|Aminoacyl-tRNA biosynthesis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport
10597-60-1	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System
105979-17-7	REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
106-44-5	KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
106-46-7	KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168256|Immune System
106-49-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-2262752|Cellular responses to stress
106-50-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05134|Legionellosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05162|Measles;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System
106-51-4	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease
106-60-5	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
106-89-8	KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-168256|Immune System
106-93-4	REACT:R-HSA-1430728|Metabolism
106-94-5	KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-372790|Signaling by GPCR
106-99-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6788656|Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-3769402|Deactivation of the beta-catenin transactivating complex;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-2871809|FCERI mediated Ca+2 mobilization;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-194840|Rho GTPase cycle;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04911|Insulin secretion;REACT:R-HSA-983695|Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04976|Bile secretion;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05210|Colorectal cancer
10605-21-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways
106266-06-2	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-375280|Amine ligand-binding receptors;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05034|Alcoholism;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168256|Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
106344-20-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System
1066-45-1	KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05134|Legionellosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF
1066-51-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-72766|Translation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa03010|Ribosome;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
1068-57-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
107-02-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05162|Measles;KEGG:hsa05152|Tuberculosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05132|Salmonella infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1643685|Disease;KEGG:hsa05133|Pertussis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05160|Hepatitis C;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05144|Malaria;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis
107-06-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa04210|Apoptosis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation
107-07-3	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
107-11-9	KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways
107-13-1	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
107-18-6	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
107-20-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-379716|Cytosolic tRNA aminoacylation;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;KEGG:hsa_M00359|Aminoacyl-tRNA biosynthesis, eukaryotes;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa04216|Ferroptosis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-379724|tRNA Aminoacylation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa00970|Aminoacyl-tRNA biosynthesis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-168256|Immune System;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-109582|Hemostasis
107-21-1	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
107-22-2	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05146|Amoebiasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05132|Salmonella infection;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05144|Malaria;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa05160|Hepatitis C;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-382551|Transmembrane transport of small molecules
107-35-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04931|Insulin resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa01522|Endocrine resistance;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1643685|Disease;KEGG:hsa04976|Bile secretion;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05133|Pertussis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05162|Measles;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04930|Type II diabetes mellitus;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04137|Mitophagy - animal;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade
107-43-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05016|Huntington's disease;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules
107-44-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-70326|Glucose metabolism;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05016|Huntington's disease;KEGG:hsa04210|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa00010|Glycolysis / Gluconeogenesis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04145|Phagosome;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-8856825|Cargo recognition for clathrin-mediated endocytosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-8856828|Clathrin-mediated endocytosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05034|Alcoholism;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes
107-73-3	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
107-92-6	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05152|Tuberculosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05134|Legionellosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa05224|Breast cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05020|Prion diseases;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05133|Pertussis;REACT:R-HSA-1643685|Disease;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05132|Salmonella infection;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05218|Melanoma;KEGG:hsa05144|Malaria;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05162|Measles;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04371|Apelin signaling pathway
107-95-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa00564|Glycerophospholipid metabolism;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04530|Tight junction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5683057|MAPK family signaling cascades
107-96-0	REACT:R-HSA-168256|Immune System
1071-83-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72766|Translation;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa03010|Ribosome;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-72312|rRNA processing;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05020|Prion diseases;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05012|Parkinson's disease;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04110|Cell cycle;KEGG:hsa05224|Breast cancer;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05164|Influenza A;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05215|Prostate cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05016|Huntington's disease;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04360|Axon guidance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling
107254-86-4	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168256|Immune System
107753-78-6	REACT:R-HSA-1430728|Metabolism
108-03-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
108-38-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
108-46-3	REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System
108-73-6	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05164|Influenza A;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04110|Cell cycle;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05134|Legionellosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05224|Breast cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System
108-78-1	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-162582|Signal Transduction
108-86-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-350562|Regulation of ornithine decarboxylase (ODC);REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5619115|Disorders of transmembrane transporters;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5358346|Hedgehog ligand biogenesis;REACT:R-HSA-5619084|ABC transporter disorders;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-2871837|FCERI mediated NF-kB activation;REACT:R-HSA-1236974|ER-Phagosome pathway;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-4086400|PCP/CE pathway;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-202424|Downstream TCR signaling;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-5689603|UCH proteinases;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-72766|Translation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-202403|TCR signaling;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-5358351|Signaling by Hedgehog;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-74752|Signaling by Insulin receptor
108-88-3	REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04210|Apoptosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05016|Huntington's disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04110|Cell cycle;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05164|Influenza A;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04510|Focal adhesion;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05133|Pertussis;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450
108-90-7	REACT:R-HSA-168256|Immune System
108-95-2	KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1643685|Disease
108068-98-0	KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1266738|Developmental Biology
108605-62-5	KEGG:hsa05161|Hepatitis B;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
109-86-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04611|Platelet activation;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04510|Focal adhesion;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04144|Endocytosis;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04110|Cell cycle;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-68886|M Phase;REACT:R-HSA-5663205|Infectious disease
109376-83-2	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04510|Focal adhesion;KEGG:hsa05161|Hepatitis B;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-212436|Generic Transcription Pathway
109581-93-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-109582|Hemostasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;KEGG:hsa05162|Measles;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05144|Malaria;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-381042|PERK regulates gene expression;KEGG:hsa04940|Type I diabetes mellitus;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;KEGG:hsa05020|Prion diseases;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04917|Prolactin signaling pathway
110-00-9	REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04110|Cell cycle;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-69242|S Phase;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04210|Apoptosis;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-69306|DNA Replication;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-2871796|FCERI mediated MAPK activation
110-54-3	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules
110-60-1	KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-390522|Striated Muscle Contraction;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04931|Insulin resistance;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease
110-62-3	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04210|Apoptosis;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-194840|Rho GTPase cycle;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05166|HTLV-I infection;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-216083|Integrin cell surface interactions;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04611|Platelet activation;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa05134|Legionellosis;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05164|Influenza A;KEGG:hsa04360|Axon guidance
110-80-5	REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins
11000-17-2	REACT:R-HSA-162582|Signal Transduction
110044-82-1	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
11016-15-2	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
11032-49-8	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction
11050-21-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1643685|Disease;KEGG:hsa04146|Peroxisome;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04210|Apoptosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa00270|Cysteine and methionine metabolism;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05218|Melanoma;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa00561|Glycerolipid metabolism;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-70326|Glucose metabolism;KEGG:hsa05224|Breast cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05214|Glioma;KEGG:hsa05230|Central carbon metabolism in cancer
11056-06-7	KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1643685|Disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05133|Pertussis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05144|Malaria;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05164|Influenza A;KEGG:hsa05132|Salmonella infection;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04510|Focal adhesion;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01100|Metabolic pathways;KEGG:hsa05134|Legionellosis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05219|Bladder cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-445355|Smooth Muscle Contraction;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05202|Transcriptional misregulation in cancer
11062-77-4	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
1107-26-2	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
110703-94-1	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System
11077-03-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
11079-53-1	REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
11089-65-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa04210|Apoptosis;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1643685|Disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04110|Cell cycle;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-948021|Transport to the Golgi and subsequent modification;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-68886|M Phase;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-199977|ER to Golgi Anterograde Transport;REACT:R-HSA-381070|IRE1alpha activates chaperones;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6799198|Complex I biogenesis;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;REACT:R-HSA-6811442|Intra-Golgi and retrograde Golgi-to-ER traffic;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-381038|XBP1(S) activates chaperone genes;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05152|Tuberculosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04068|FoxO signaling pathway
11096-82-5	KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways
11097-69-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-68886|M Phase;REACT:R-HSA-72766|Translation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04210|Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases
111-02-4	REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
111-30-8	REACT:R-HSA-168256|Immune System
111-71-7	REACT:R-HSA-1430728|Metabolism
111-76-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-69242|S Phase;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04931|Insulin resistance;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04210|Apoptosis;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05144|Malaria;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04611|Platelet activation;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05215|Prostate cancer;KEGG:hsa04216|Ferroptosis;REACT:R-HSA-1650814|Collagen biosynthesis and modifying enzymes;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1474290|Collagen formation;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-68886|M Phase;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-983695|Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation
111025-46-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04931|Insulin resistance;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05215|Prostate cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-174824|Lipoprotein metabolism;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-390522|Striated Muscle Contraction;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05133|Pertussis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-174800|Chylomicron-mediated lipid transport;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-5576891|Cardiac conduction;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04976|Bile secretion;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05219|Bladder cancer;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-2980736|Peptide hormone metabolism;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04923|Regulation of lipolysis in adipocytes;REACT:R-HSA-112316|Neuronal System
11103-57-4	REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04210|Apoptosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05161|Hepatitis B;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-112316|Neuronal System;KEGG:hsa04360|Axon guidance;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05164|Influenza A;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-500792|GPCR ligand binding
11103-72-3	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
11104-28-2	REACT:R-HSA-162582|Signal Transduction
11104-61-3	REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
11113-50-1	KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05146|Amoebiasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease
11116-32-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression
11119-70-3	REACT:R-HSA-162582|Signal Transduction
1113-59-3	KEGG:hsa04066|HIF-1 signaling pathway
11130-73-7	REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05162|Measles;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins
11141-17-6	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
1116-54-7	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-6799198|Complex I biogenesis;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05012|Parkinson's disease;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-913709|O-linked glycosylation of mucins;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-5173105|O-linked glycosylation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa00512|Mucin type O-glycan biosynthesis;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa_M00056|O-glycan biosynthesis, mucin type core;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-1630316|Glycosaminoglycan metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
111911-87-6	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology
112-05-0	REACT:R-HSA-168256|Immune System;KEGG:hsa05162|Measles;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology
112-24-3	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05016|Huntington's disease;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05012|Parkinson's disease;KEGG:hsa00020|Citrate cycle (TCA cycle);KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-71406|Pyruvate metabolism and Citric Acid (TCA) cycle;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168256|Immune System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins
112-53-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1643685|Disease;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6805567|Keratinization;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05162|Measles;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04210|Apoptosis;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04664|Fc epsilon RI signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6809371|Formation of the cornified envelope;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-68886|M Phase;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-2871796|FCERI mediated MAPK activation
112-80-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-75109|Triglyceride Biosynthesis;KEGG:hsa00071|Fatty acid degradation;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-75105|Fatty Acyl-CoA Biosynthesis;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa_M00087|beta-Oxidation;REACT:R-HSA-174824|Lipoprotein metabolism;KEGG:hsa04146|Peroxisome;KEGG:hsa04975|Fat digestion and absorption;KEGG:hsa01040|Biosynthesis of unsaturated fatty acids;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa00062|Fatty acid elongation;REACT:R-HSA-174800|Chylomicron-mediated lipid transport;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-77289|Mitochondrial Fatty Acid Beta-Oxidation;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-163685|Integration of energy metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa00561|Glycerolipid metabolism;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa00280|Valine, leucine and isoleucine degradation;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04930|Type II diabetes mellitus;KEGG:hsa01200|Carbon metabolism;KEGG:hsa05161|Hepatitis B;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1483257|Phospholipid metabolism;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2187338|Visual phototransduction;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-199991|Membrane Trafficking
1120-21-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-500792|GPCR ligand binding
1121-30-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
1122-90-3	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;KEGG:hsa01200|Carbon metabolism;KEGG:hsa00010|Glycolysis / Gluconeogenesis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168256|Immune System;KEGG:hsa00520|Amino sugar and nucleotide sugar metabolism;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-70326|Glucose metabolism;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation
1124-11-4	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05132|Salmonella infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05160|Hepatitis C;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression
112648-68-7	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05133|Pertussis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05132|Salmonella infection;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04916|Melanogenesis;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05164|Influenza A;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1430728|Metabolism
112809-51-5	KEGG:hsa01522|Endocrine resistance;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05219|Bladder cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05214|Glioma;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression
112953-11-4	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05214|Glioma;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa05218|Melanoma;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05224|Breast cancer;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04110|Cell cycle;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
113-45-1	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease
113-79-1	REACT:R-HSA-162582|Signal Transduction
1134-47-0	REACT:R-HSA-162582|Signal Transduction
1135-24-6	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05164|Influenza A;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology
113558-15-9	KEGG:hsa05200|Pathways in cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System
113669-21-9	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction
113775-47-6	KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
113852-37-2	KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-379716|Cytosolic tRNA aminoacylation;KEGG:hsa_M00359|Aminoacyl-tRNA biosynthesis, eukaryotes;REACT:R-HSA-379724|tRNA Aminoacylation;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa00970|Aminoacyl-tRNA biosynthesis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04210|Apoptosis;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1280218|Adaptive Immune System
114-07-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1236974|ER-Phagosome pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-422475|Axon guidance;KEGG:hsa03050|Proteasome;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5387390|Hh mutants abrogate ligand secretion;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-68886|M Phase;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-5619115|Disorders of transmembrane transporters;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-5358346|Hedgehog ligand biogenesis;REACT:R-HSA-5362768|Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;KEGG:hsa04142|Lysosome;REACT:R-HSA-350562|Regulation of ornithine decarboxylase (ODC);REACT:R-HSA-5678895|Defective CFTR causes cystic fibrosis;REACT:R-HSA-174184|Cdc20:Phospho-APC/C mediated degradation of Cyclin A;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-179419|APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162906|HIV Infection;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-69541|Stabilization of p53;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-5619084|ABC transporter disorders;REACT:R-HSA-68867|Assembly of the pre-replicative complex;REACT:R-HSA-202403|TCR signaling;REACT:R-HSA-68827|CDT1 association with the CDC6:ORC:origin complex;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-5607761|Dectin-1 mediated noncanonical NF-kB signaling;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-1236978|Cross-presentation of soluble exogenous antigens (endosomes);REACT:R-HSA-211733|Regulation of activated PAK-2p34 by proteasome mediated degradation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2871837|FCERI mediated NF-kB activation;REACT:R-HSA-174178|APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-69017|CDK-mediated phosphorylation and removal of Cdc6;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-180534|Vpu mediated degradation of CD4;REACT:R-HSA-174084|Autodegradation of Cdh1 by Cdh1:APC/C;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-69610|p53-Independent DNA Damage Response;REACT:R-HSA-69613|p53-Independent G1/S DNA damage checkpoint;REACT:R-HSA-69601|Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;REACT:R-HSA-169911|Regulation of Apoptosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-5689603|UCH proteinases;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-174113|SCF-beta-TrCP mediated degradation of Emi1;REACT:R-HSA-8854050|FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;REACT:R-HSA-4641257|Degradation of AXIN;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-174154|APC/C:Cdc20 mediated degradation of Securin
114-86-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-400253|Circadian Clock;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04110|Cell cycle;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-68886|M Phase;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa04931|Insulin resistance;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04976|Bile secretion;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-75109|Triglyceride Biosynthesis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-69242|S Phase;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-166520|Signalling by NGF
114719-57-2	REACT:R-HSA-162582|Signal Transduction
114798-26-4	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05164|Influenza A;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05210|Colorectal cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05144|Malaria;KEGG:hsa05215|Prostate cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-216083|Integrin cell surface interactions;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1643685|Disease;KEGG:hsa05160|Hepatitis C;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05162|Measles;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05214|Glioma;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05218|Melanoma;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade
115-09-3	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04360|Axon guidance;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;KEGG:hsa04144|Endocytosis;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04150|mTOR signaling pathway
115-29-7	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1483257|Phospholipid metabolism;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05161|Hepatitis B;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04210|Apoptosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1474290|Collagen formation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-216083|Integrin cell surface interactions;REACT:R-HSA-1630316|Glycosaminoglycan metabolism;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05164|Influenza A
115-86-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168256|Immune System;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-72766|Translation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-2408557|Selenocysteine synthesis;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa03010|Ribosome;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-174824|Lipoprotein metabolism;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-72172|mRNA Splicing;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-68886|M Phase;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-69242|S Phase;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa03040|Spliceosome;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-69206|G1/S Transition
1154-25-2	REACT:R-HSA-168256|Immune System
115939-25-8	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
116-31-4	KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-2187338|Visual phototransduction;REACT:R-HSA-5362517|Signaling by Retinoic Acid;REACT:R-HSA-5365859|RA biosynthesis pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations
1162-65-8	REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-68886|M Phase;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;KEGG:hsa04144|Endocytosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04360|Axon guidance;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway
1163-19-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-68886|M Phase;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05224|Breast cancer
116314-67-1	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
116355-83-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05160|Hepatitis C;KEGG:hsa05132|Salmonella infection;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05164|Influenza A;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05020|Prion diseases;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04931|Insulin resistance;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05162|Measles;KEGG:hsa05131|Shigellosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04530|Tight junction;REACT:R-HSA-73887|Death Receptor Signalling;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05214|Glioma
1165-39-5	REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
117-10-2	KEGG:hsa04210|Apoptosis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
117-39-5	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05164|Influenza A;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05162|Measles;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05152|Tuberculosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05224|Breast cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-5653656|Vesicle-mediated transport
117-81-7	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-195721|Signaling by Wnt
117-89-5	KEGG:hsa05152|Tuberculosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-168256|Immune System;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins
117-96-4	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
118-00-3	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
118-42-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05164|Influenza A;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05133|Pertussis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05160|Hepatitis C;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05134|Legionellosis;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins
118-74-1	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05133|Pertussis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1643685|Disease;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04931|Insulin resistance;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05214|Glioma;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04930|Type II diabetes mellitus;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04672|Intestinal immune network for IgA production;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05144|Malaria;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa04722|Neurotrophin signaling pathway
118-75-2	REACT:R-HSA-168256|Immune System
118-79-6	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
118-96-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168256|Immune System;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa03010|Ribosome;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5419276|Mitochondrial translation termination;REACT:R-HSA-5368287|Mitochondrial translation;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-5368286|Mitochondrial translation initiation;REACT:R-HSA-5389840|Mitochondrial translation elongation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-72766|Translation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK
118414-82-7	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
1185-57-5	KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-162582|Signal Transduction
119-13-1	KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System
119-36-8	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
119-61-9	REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
1191-85-1	REACT:R-HSA-168256|Immune System
119139-23-0	KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74160|Gene Expression
119212-33-8	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-72172|mRNA Splicing;KEGG:hsa03040|Spliceosome;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-68886|M Phase;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5419276|Mitochondrial translation termination;REACT:R-HSA-5368286|Mitochondrial translation initiation;REACT:R-HSA-5389840|Mitochondrial translation elongation;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5368287|Mitochondrial translation;REACT:R-HSA-6802952|Signaling by BRAF and RAF fusions;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04520|Adherens junction;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-6802957|Oncogenic MAPK signaling;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-68882|Mitotic Anaphase;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa01200|Carbon metabolism;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa04530|Tight junction;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-72766|Translation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-72312|rRNA processing;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa03013|RNA transport;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-71291|Metabolism of amino acids and derivatives
1199-18-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05031|Amphetamine addiction;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05215|Prostate cancer;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05034|Alcoholism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-112316|Neuronal System;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05134|Legionellosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05020|Prion diseases;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05224|Breast cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05132|Salmonella infection
120-08-1	KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05133|Pertussis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168256|Immune System
120-46-7	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
120-80-9	KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
12001-28-4	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05164|Influenza A;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05215|Prostate cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-8853659|RET signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04740|Olfactory transduction;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05160|Hepatitis C;KEGG:hsa05132|Salmonella infection
12001-79-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-68886|M Phase;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04110|Cell cycle;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-977225|Amyloid fiber formation;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-212165|Epigenetic regulation of gene expression;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5334118|DNA methylation;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-73864|RNA Polymerase I Transcription;REACT:R-HSA-5625740|RHO GTPases activate PKNs;REACT:R-HSA-427389|ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-69242|S Phase;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-5250924|B-WICH complex positively regulates rRNA expression;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-912446|Meiotic recombination;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-1500620|Meiosis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05164|Influenza A
120011-70-3	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction
120068-37-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-168256|Immune System;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-975298|Ligand-gated ion channel transport;KEGG:hsa04210|Apoptosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04976|Bile secretion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-156590|Glutathione conjugation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04144|Endocytosis;REACT:R-HSA-977443|GABA receptor activation;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS
120223-04-3	REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology
120225-54-9	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
120287-85-6	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System
121-14-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa03013|RNA transport;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04210|Apoptosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-73857|RNA Polymerase II Transcription;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-162587|HIV Life Cycle;REACT:R-HSA-162599|Late Phase of HIV Life Cycle;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04120|Ubiquitin mediated proteolysis;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa03008|Ribosome biogenesis in eukaryotes;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-168254|Influenza Infection;KEGG:hsa00230|Purine metabolism;KEGG:hsa00240|Pyrimidine metabolism;REACT:R-HSA-5696398|Nucleotide Excision Repair;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa03040|Spliceosome;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-72306|tRNA processing;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04110|Cell cycle;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-68886|M Phase;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-72202|Transport of Mature Transcript to Cytoplasm;REACT:R-HSA-2990846|SUMOylation;REACT:R-HSA-3108232|SUMO E3 ligases SUMOylate target proteins;REACT:R-HSA-4839726|Chromatin organization
121-19-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways
121-33-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
121-54-0	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
121-75-5	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05224|Breast cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04110|Cell cycle;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa05162|Measles;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-6798695|Neutrophil degranulation
121-82-4	KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-6798695|Neutrophil degranulation
12122-67-7	KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1643685|Disease;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05160|Hepatitis C;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01100|Metabolic pathways
12125-02-9	REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-72764|Eukaryotic Translation Termination;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa05224|Breast cancer;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-71387|Metabolism of carbohydrates
121263-19-2	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04931|Insulin resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1643685|Disease;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1430728|Metabolism
12172-73-5	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74160|Gene Expression
12192-57-3	KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05162|Measles;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05134|Legionellosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
122-14-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways
122-32-7	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
122-34-9	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology
122-39-4	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05164|Influenza A;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression
122-48-5	KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
12244-57-4	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05164|Influenza A;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05146|Amoebiasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling
123-31-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05162|Measles;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-109581|Apoptosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05133|Pertussis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1643685|Disease;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05152|Tuberculosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05034|Alcoholism;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5334118|DNA methylation;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05134|Legionellosis;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-3214858|RMTs methylate histone arginines;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-69278|Cell Cycle, Mitotic
123-38-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-68886|M Phase;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-68882|Mitotic Anaphase;KEGG:hsa05034|Alcoholism;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;KEGG:hsa04110|Cell cycle;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-977225|Amyloid fiber formation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-3214815|HDACs deacetylate histones;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-3214847|HATs acetylate histones;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-3214858|RMTs methylate histone arginines;REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-427359|SIRT1 negatively regulates rRNA Expression;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2132295|MHC class II antigen presentation;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-5334118|DNA methylation;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-427389|ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;REACT:R-HSA-5625886|Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;REACT:R-HSA-983189|Kinesins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-5625740|RHO GTPases activate PKNs;KEGG:hsa00350|Tyrosine metabolism;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69473|G2/M DNA damage checkpoint;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-198933|Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-216083|Integrin cell surface interactions;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05145|Toxoplasmosis
123-39-7	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
123-72-8	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04514|Cell adhesion molecules (CAMs);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-194840|Rho GTPase cycle;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-216083|Integrin cell surface interactions;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-1630316|Glycosaminoglycan metabolism;KEGG:hsa05164|Influenza A;KEGG:hsa04360|Axon guidance;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-193648|NRAGE signals death through JNK;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa00230|Purine metabolism;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-416476|G alpha (q) signalling events
123-78-4	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04510|Focal adhesion;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05215|Prostate cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05219|Bladder cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-109582|Hemostasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05224|Breast cancer;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa05214|Glioma;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05218|Melanoma;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05133|Pertussis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1643685|Disease;KEGG:hsa05164|Influenza A;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04912|GnRH signaling pathway
123318-82-1	KEGG:hsa04110|Cell cycle;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-162582|Signal Transduction
123653-11-2	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05162|Measles;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05215|Prostate cancer;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05134|Legionellosis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1643685|Disease;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-372790|Signaling by GPCR
123948-87-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-68886|M Phase;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa04110|Cell cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-69242|S Phase;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-69190|DNA strand elongation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-3108232|SUMO E3 ligases SUMOylate target proteins;REACT:R-HSA-2990846|SUMOylation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa03030|DNA replication;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-68962|Activation of the pre-replicative complex;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04210|Apoptosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-73886|Chromosome Maintenance;KEGG:hsa04120|Ubiquitin mediated proteolysis;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-176187|Activation of ATR in response to replication stress;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-174417|Telomere C-strand (Lagging Strand) Synthesis;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-180786|Extension of Telomeres
124-13-0	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
124-20-9	REACT:R-HSA-390522|Striated Muscle Contraction;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04931|Insulin resistance;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05160|Hepatitis C;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease
124-38-9	REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction
124-58-3	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05224|Breast cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05218|Melanoma;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;KEGG:hsa04210|Apoptosis;KEGG:hsa05214|Glioma;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05160|Hepatitis C;KEGG:hsa05162|Measles;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-597592|Post-translational protein modification
124-68-5	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-68886|M Phase;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-446728|Cell junction organization;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04530|Tight junction;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa04110|Cell cycle;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04514|Cell adhesion molecules (CAMs);REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04151|PI3K-Akt signaling pathway
124-87-8	KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04727|GABAergic synapse;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-977443|GABA receptor activation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-975298|Ligand-gated ion channel transport;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05033|Nicotine addiction;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease
124-94-7	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System
12427-38-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05215|Prostate cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05134|Legionellosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05164|Influenza A;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05210|Colorectal cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05012|Parkinson's disease;KEGG:hsa05224|Breast cancer;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05214|Glioma;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05034|Alcoholism;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05016|Huntington's disease;KEGG:hsa05133|Pertussis;KEGG:hsa05162|Measles;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04510|Focal adhesion;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5683057|MAPK family signaling cascades
124489-20-9	KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa00983|Drug metabolism - other enzymes;KEGG:hsa00830|Retinol metabolism;KEGG:hsa01100|Metabolic pathways
125-46-2	KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05162|Measles;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05164|Influenza A;KEGG:hsa05215|Prostate cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa04110|Cell cycle;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-73894|DNA Repair;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology
125-71-3	REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways
125-84-8	REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways
125314-64-9	KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1643685|Disease
12542-36-8	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway
1258-84-0	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05224|Breast cancer;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05217|Basal cell carcinoma;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05215|Prostate cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System
126-07-8	KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-168249|Innate Immune System
126-73-8	KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
126-99-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-1643685|Disease;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05340|Primary immunodeficiency;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-198933|Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-194840|Rho GTPase cycle;KEGG:hsa04514|Cell adhesion molecules (CAMs);REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05162|Measles;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04144|Endocytosis;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05164|Influenza A;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-380108|Chemokine receptors bind chemokines;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa04520|Adherens junction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-382551|Transmembrane transport of small molecules
12629-02-6	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05164|Influenza A;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04110|Cell cycle;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05134|Legionellosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-69242|S Phase;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-3371556|Cellular response to heat stress;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1566948|Elastic fibre formation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-69306|DNA Replication;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP)
126643-37-6	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-168256|Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-388396|GPCR downstream signaling
12672-29-6	REACT:R-HSA-168256|Immune System
127-07-1	KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04110|Cell cycle;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05162|Measles;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05134|Legionellosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05219|Bladder cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-69231|Cyclin D associated events in G1;REACT:R-HSA-69236|G1 Phase;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05144|Malaria;KEGG:hsa05218|Melanoma;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05214|Glioma;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-3108232|SUMO E3 ligases SUMOylate target proteins;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2990846|SUMOylation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69242|S Phase;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04919|Thyroid hormone signaling pathway
127-17-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
127-18-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04146|Peroxisome;KEGG:hsa04210|Apoptosis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-75109|Triglyceride Biosynthesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-75105|Fatty Acyl-CoA Biosynthesis;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa02010|ABC transporters;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05016|Huntington's disease;KEGG:hsa01212|Fatty acid metabolism;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04931|Insulin resistance;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-15869|Metabolism of nucleotides;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04530|Tight junction;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-69275|G2/M Transition;KEGG:hsa04145|Phagosome;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
127-40-2	REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
127-47-9	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
127191-97-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74160|Gene Expression
127243-85-0	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1643685|Disease;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05133|Pertussis;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05219|Bladder cancer;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04210|Apoptosis;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04916|Melanogenesis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-8864260|Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
127779-20-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology
12789-03-6	REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-68886|M Phase;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification
12794-10-4	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-112316|Neuronal System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05133|Pertussis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05033|Nicotine addiction;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-375280|Amine ligand-binding receptors;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-1643685|Disease;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-977441|GABA A receptor activation;KEGG:hsa05215|Prostate cancer;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04727|GABAergic synapse;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05140|Leishmaniasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05020|Prion diseases;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-975298|Ligand-gated ion channel transport;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05146|Amoebiasis;KEGG:hsa05224|Breast cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05162|Measles
128-13-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04976|Bile secretion;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05215|Prostate cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05218|Melanoma;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05219|Bladder cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05162|Measles;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05210|Colorectal cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05140|Leishmaniasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-159418|Recycling of bile acids and salts;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa04110|Cell cycle;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05132|Salmonella infection;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05224|Breast cancer;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-192105|Synthesis of bile acids and bile salts;REACT:R-HSA-193368|Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05144|Malaria;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05168|Herpes simplex infection
128-20-1	KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa05033|Nicotine addiction;KEGG:hsa04727|GABAergic synapse;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
128-37-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04210|Apoptosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05216|Thyroid cancer;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04370|VEGF signaling pathway;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs
128-53-0	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism
128-62-1	REACT:R-HSA-162582|Signal Transduction
129-00-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins
129-03-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
129453-61-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05215|Prostate cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05224|Breast cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04110|Cell cycle;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05218|Melanoma;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05162|Measles;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05214|Glioma;KEGG:hsa05134|Legionellosis;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-112399|IRS-mediated signalling
129497-78-5	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
129618-40-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System
130-01-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04976|Bile secretion;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-194068|Bile acid and bile salt metabolism;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-382551|Transmembrane transport of small molecules
130-15-4	REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00830|Retinol metabolism;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System
130-26-7	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05219|Bladder cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins
130-95-0	REACT:R-HSA-1430728|Metabolism
13020-19-4	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
1303-00-0	REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-449147|Signaling by Interleukins
130495-35-1	REACT:R-HSA-162582|Signal Transduction
13058-04-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
1306-23-6	KEGG:hsa04210|Apoptosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways
1306-24-7	REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease
1306-25-8	KEGG:hsa05161|Hepatitis B;KEGG:hsa05134|Legionellosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-168256|Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins
1306-38-3	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05162|Measles;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress
130663-39-7	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168256|Immune System
13071-79-9	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa04972|Pancreatic secretion;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04360|Axon guidance;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa04510|Focal adhesion;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04611|Platelet activation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04210|Apoptosis;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04144|Endocytosis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-375165|NCAM signaling for neurite out-growth
13073-35-3	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-72766|Translation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-1643685|Disease;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa03010|Ribosome;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04146|Peroxisome;REACT:R-HSA-2871837|FCERI mediated NF-kB activation;REACT:R-HSA-1236974|ER-Phagosome pathway;REACT:R-HSA-4086400|PCP/CE pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-202424|Downstream TCR signaling;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-202403|TCR signaling;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation
1308-38-9	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway
1309-37-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04210|Apoptosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;KEGG:hsa05134|Legionellosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-68875|Mitotic Prophase;KEGG:hsa05133|Pertussis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-912446|Meiotic recombination;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05034|Alcoholism;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-977225|Amyloid fiber formation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-73864|RNA Polymerase I Transcription;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1500620|Meiosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05322|Systemic lupus erythematosus;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-68886|M Phase;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes
1309-48-4	KEGG:hsa04210|Apoptosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
131-11-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04976|Bile secretion;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-400253|Circadian Clock;KEGG:hsa04210|Apoptosis;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa01522|Endocrine resistance;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05224|Breast cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-157118|Signaling by NOTCH;KEGG:hsa04914|Progesterone-mediated oocyte maturation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-170984|ARMS-mediated activation
131-18-0	REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
131-57-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05016|Huntington's disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05012|Parkinson's disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04210|Apoptosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-74160|Gene Expression;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-166520|Signalling by NGF
131-70-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05224|Breast cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05164|Influenza A;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-5663202|Diseases of signal transduction
13117-60-7	REACT:R-HSA-162582|Signal Transduction
131258-00-9	REACT:R-HSA-1430728|Metabolism
1313-99-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-193704|p75 NTR receptor-mediated signalling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-416482|G alpha (12/13) signalling events;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-194840|Rho GTPase cycle;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04210|Apoptosis;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04142|Lysosome;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-204998|Cell death signalling via NRAGE, NRIF and NADE;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-2029480|Fcgamma receptor (FCGR) dependent phagocytosis;KEGG:hsa04611|Platelet activation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-193648|NRAGE signals death through JNK;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04144|Endocytosis;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04666|Fc gamma R-mediated phagocytosis;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-163685|Integration of energy metabolism;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74751|Insulin receptor signalling cascade
131341-86-1	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
1314-13-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05134|Legionellosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05144|Malaria;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05162|Measles;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05215|Prostate cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-5260271|Diseases of Immune System;REACT:R-HSA-5602358|Diseases associated with the TLR signaling cascade;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05020|Prion diseases;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04216|Ferroptosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane
1314-62-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04540|Gap junction;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-877300|Interferon gamma signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04611|Platelet activation;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
1314-98-3	REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05164|Influenza A;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05132|Salmonella infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-446652|Interleukin-1 signaling;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5260271|Diseases of Immune System;REACT:R-HSA-5602358|Diseases associated with the TLR signaling cascade;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05134|Legionellosis;KEGG:hsa05162|Measles;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System
1317-38-0	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04110|Cell cycle;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04210|Apoptosis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-68886|M Phase;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04978|Mineral absorption;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-72766|Translation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05133|Pertussis;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;KEGG:hsa04213|Longevity regulating pathway - multiple species;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-73857|RNA Polymerase II Transcription;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa03040|Spliceosome;REACT:R-HSA-6811434|COPI-dependent Golgi-to-ER retrograde traffic;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04530|Tight junction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5663220|RHO GTPases Activate Formins
131733-92-1	REACT:R-HSA-1430728|Metabolism
132-64-9	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
132-65-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins
1321-48-8	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
13217-66-8	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
1327-53-3	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05164|Influenza A;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04110|Cell cycle;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-73894|DNA Repair
13270-61-6	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
132880-11-6	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05133|Pertussis;KEGG:hsa05144|Malaria;KEGG:hsa05134|Legionellosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
13292-46-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04976|Bile secretion;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa02010|ABC transporters;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-211999|CYP2E1 reactions;KEGG:hsa05164|Influenza A;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa04931|Insulin resistance;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-382556|ABC-family proteins mediated transport;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-400253|Circadian Clock;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-1368082|RORA activates gene expression;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04940|Type I diabetes mellitus;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05134|Legionellosis;KEGG:hsa05332|Graft-versus-host disease;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-2151201|Transcriptional activation of mitochondrial biogenesis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1592230|Mitochondrial biogenesis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-157118|Signaling by NOTCH;REACT:R-HSA-73894|DNA Repair
1330-78-5	REACT:R-HSA-1430728|Metabolism
13311-84-7	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa03013|RNA transport;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-68886|M Phase;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-72766|Translation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa03040|Spliceosome;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-195253|Degradation of beta-catenin by the destruction complex;REACT:R-HSA-5368287|Mitochondrial translation;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD)
1332-21-4	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04510|Focal adhesion;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05164|Influenza A;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway
1333-38-6	KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1430728|Metabolism
1333-74-0	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
133343-34-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05146|Amoebiasis;KEGG:hsa05162|Measles;KEGG:hsa05133|Pertussis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05215|Prostate cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-74160|Gene Expression
13345-25-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
1338-24-5	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System
1339-63-5	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05133|Pertussis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05164|Influenza A;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1643685|Disease;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05016|Huntington's disease;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05012|Parkinson's disease;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01100|Metabolic pathways
13392-18-2	REACT:R-HSA-162582|Signal Transduction
134-32-7	KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05134|Legionellosis;KEGG:hsa05164|Influenza A;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05133|Pertussis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05030|Cocaine addiction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05160|Hepatitis C;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05162|Measles;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04062|Chemokine signaling pathway
134-62-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-211981|Xenobiotics;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa00830|Retinol metabolism;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa00590|Arachidonic acid metabolism;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling
1343-98-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04510|Focal adhesion;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05164|Influenza A;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway
134308-13-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa03010|Ribosome;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05016|Huntington's disease;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-72766|Translation;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa_M00177|Ribosome, eukaryotes;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-5419276|Mitochondrial translation termination;REACT:R-HSA-5368286|Mitochondrial translation initiation;REACT:R-HSA-5389840|Mitochondrial translation elongation;REACT:R-HSA-5368287|Mitochondrial translation;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-1268020|Mitochondrial protein import;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-72172|mRNA Splicing;KEGG:hsa03040|Spliceosome;REACT:R-HSA-6799198|Complex I biogenesis;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-199977|ER to Golgi Anterograde Transport;REACT:R-HSA-73857|RNA Polymerase II Transcription;REACT:R-HSA-948021|Transport to the Golgi and subsequent modification;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168256|Immune System
1344-28-1	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05133|Pertussis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05144|Malaria;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-216083|Integrin cell surface interactions;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa05134|Legionellosis;KEGG:hsa05164|Influenza A;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04210|Apoptosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1474228|Degradation of the extracellular matrix;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress
1344-95-2	KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
134404-52-7	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1474228|Degradation of the extracellular matrix;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation
13463-67-7	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1643685|Disease;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05164|Influenza A;KEGG:hsa05133|Pertussis;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04210|Apoptosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-112316|Neuronal System;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-216083|Integrin cell surface interactions;KEGG:hsa05161|Hepatitis B;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04145|Phagosome;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05145|Toxoplasmosis
134678-17-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04260|Cardiac muscle contraction;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04110|Cell cycle;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer
13494-80-9	KEGG:hsa05161|Hepatitis B;KEGG:hsa05134|Legionellosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-168256|Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression
13494-90-1	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
134959-51-6	KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins
135-19-3	REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
13510-49-1	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05132|Salmonella infection;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins
135467-92-4	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05133|Pertussis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05134|Legionellosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05160|Hepatitis C;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-372790|Signaling by GPCR
136087-85-9	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
136194-77-9	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04210|Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04540|Gap junction;KEGG:hsa05152|Tuberculosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-1643685|Disease;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa05133|Pertussis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05160|Hepatitis C;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04666|Fc gamma R-mediated phagocytosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System
13647-35-3	REACT:R-HSA-162582|Signal Transduction
13655-52-2	REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction
136587-13-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
13674-84-5	REACT:R-HSA-1430728|Metabolism
13674-87-8	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-68886|M Phase;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-69242|S Phase;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-68882|Mitotic Anaphase;KEGG:hsa05034|Alcoholism;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-3214847|HATs acetylate histones;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-5250941|Negative epigenetic regulation of rRNA expression;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-427413|NoRC negatively regulates rRNA expression;REACT:R-HSA-73864|RNA Polymerase I Transcription;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04110|Cell cycle;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04210|Apoptosis;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds
137-26-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05144|Malaria;KEGG:hsa05164|Influenza A;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04144|Endocytosis;KEGG:hsa05214|Glioma;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1474290|Collagen formation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2022090|Assembly of collagen fibrils and other multimeric structures;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04666|Fc gamma R-mediated phagocytosis;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-2029480|Fcgamma receptor (FCGR) dependent phagocytosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction
137-30-4	KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05164|Influenza A;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR
137-58-6	KEGG:hsa05161|Hepatitis B;KEGG:hsa04110|Cell cycle;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-69231|Cyclin D associated events in G1;REACT:R-HSA-69236|G1 Phase;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05214|Glioma;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05215|Prostate cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05224|Breast cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism
13768-07-5	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-68886|M Phase;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-69275|G2/M Transition;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-69242|S Phase;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-2559583|Cellular Senescence
138381-45-0	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04510|Focal adhesion;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04210|Apoptosis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05152|Tuberculosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05133|Pertussis;KEGG:hsa05162|Measles;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05164|Influenza A;KEGG:hsa05132|Salmonella infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2022090|Assembly of collagen fibrils and other multimeric structures;KEGG:hsa05219|Bladder cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04611|Platelet activation;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05218|Melanoma;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05214|Glioma;KEGG:hsa05131|Shigellosis;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04530|Tight junction;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1643685|Disease;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2424491|DAP12 signaling
138402-11-6	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism
138605-00-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa04931|Insulin resistance;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04923|Regulation of lipolysis in adipocytes;KEGG:hsa04925|Aldosterone synthesis and secretion;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-196071|Metabolism of steroid hormones;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05218|Melanoma;REACT:R-HSA-1643685|Disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05164|Influenza A;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05161|Hepatitis B;KEGG:hsa04611|Platelet activation;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-422475|Axon guidance;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5663202|Diseases of signal transduction
13877-93-5	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
138908-40-4	KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
139-13-9	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-162582|Signal Transduction
1391-73-7	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05162|Measles;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04931|Insulin resistance;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1643685|Disease;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280218|Adaptive Immune System
139298-40-1	KEGG:hsa05161|Hepatitis B;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology
1393-48-2	KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05162|Measles;KEGG:hsa04210|Apoptosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System
139481-59-7	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa05144|Malaria;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-388396|GPCR downstream signaling
13956-29-1	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05162|Measles;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05164|Influenza A;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05034|Alcoholism;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade
1397-89-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa04110|Cell cycle;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-69242|S Phase;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa03030|DNA replication;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-68886|M Phase;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-176187|Activation of ATR in response to replication stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05134|Legionellosis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-5693579|Homologous DNA Pairing and Strand Exchange;KEGG:hsa05144|Malaria;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5693616|Presynaptic phase of homologous DNA pairing and strand exchange;KEGG:hsa05133|Pertussis;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-1643685|Disease;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05132|Salmonella infection;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05164|Influenza A;REACT:R-HSA-69473|G2/M DNA damage checkpoint;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04145|Phagosome;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-73886|Chromosome Maintenance;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-453274|Mitotic G2-G2/M phases
1398-61-4	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins
139890-68-9	KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05132|Salmonella infection;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05215|Prostate cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05146|Amoebiasis;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05160|Hepatitis C;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-109581|Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05020|Prion diseases;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05134|Legionellosis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05214|Glioma;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade
140-66-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05161|Hepatitis B;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05160|Hepatitis C;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR
140-67-0	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression
1400-48-2	KEGG:hsa04727|GABAergic synapse;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism
1400-61-9	KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05164|Influenza A;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology
140111-52-0	REACT:R-HSA-622327|Postsynaptic nicotinic acetylcholine receptors;REACT:R-HSA-181431|Acetylcholine Binding And Downstream Events;REACT:R-HSA-629602|Activation of Nicotinic Acetylcholine Receptors;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-112316|Neuronal System
1404-04-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01100|Metabolic pathways;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04931|Insulin resistance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05016|Huntington's disease;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-392499|Metabolism of proteins
1404-26-8	REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05144|Malaria;KEGG:hsa05132|Salmonella infection;KEGG:hsa05146|Amoebiasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
1404-90-6	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa00280|Valine, leucine and isoleucine degradation;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1643685|Disease;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05133|Pertussis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa00380|Tryptophan metabolism;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-6788656|Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa00260|Glycine, serine and threonine metabolism;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;KEGG:hsa04210|Apoptosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-70895|Branched-chain amino acid catabolism;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa00330|Arginine and proline metabolism;REACT:R-HSA-2022090|Assembly of collagen fibrils and other multimeric structures;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa00010|Glycolysis / Gluconeogenesis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa04611|Platelet activation;KEGG:hsa00410|beta-Alanine metabolism;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN
1405-86-3	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System
1405-87-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism
1406-16-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04110|Cell cycle;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-68886|M Phase;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05224|Breast cancer;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05133|Pertussis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-69242|S Phase;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05162|Measles;REACT:R-HSA-2559583|Cellular Senescence
1406-18-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05164|Influenza A;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05162|Measles;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-8853659|RET signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05152|Tuberculosis
1406-65-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05162|Measles;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-909733|Interferon alpha/beta signaling;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa05164|Influenza A;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-422475|Axon guidance
141-05-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa05161|Hepatitis B;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04210|Apoptosis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-156590|Glutathione conjugation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05160|Hepatitis C;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04216|Ferroptosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05162|Measles;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa01200|Carbon metabolism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05215|Prostate cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04110|Cell cycle;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-76002|Platelet activation, signaling and aggregation
141-90-2	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04360|Axon guidance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-1296071|Potassium Channels;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa05224|Breast cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-195258|RHO GTPase Effectors
14152-28-4	REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System
141732-76-5	KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System
142-47-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04146|Peroxisome;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05016|Huntington's disease;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05218|Melanoma;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05164|Influenza A;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05214|Glioma;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-422475|Axon guidance;KEGG:hsa05160|Hepatitis C;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6799198|Complex I biogenesis;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-112316|Neuronal System
142340-99-6	KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins
14277-97-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System
143-07-7	REACT:R-HSA-1430728|Metabolism
143-50-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;KEGG:hsa04510|Focal adhesion;KEGG:hsa04210|Apoptosis;KEGG:hsa05224|Breast cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-194138|Signaling by VEGF
143-74-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
14325-03-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05133|Pertussis;KEGG:hsa05144|Malaria;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05134|Legionellosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05162|Measles;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04931|Insulin resistance;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05160|Hepatitis C;KEGG:hsa04210|Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04510|Focal adhesion;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05219|Bladder cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05211|Renal cell carcinoma;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05218|Melanoma;KEGG:hsa04622|RIG-I-like receptor signaling pathway;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04660|T cell receptor signaling pathway
14325-05-4	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05144|Malaria;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05132|Salmonella infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-372790|Signaling by GPCR
143313-51-3	REACT:R-HSA-168256|Immune System
1434-54-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1643685|Disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-68886|M Phase;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-69242|S Phase;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04976|Bile secretion;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69304|Regulation of DNA replication;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-68867|Assembly of the pre-replicative complex;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation
143545-90-8	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72764|Eukaryotic Translation Termination;KEGG:hsa03010|Ribosome;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-72766|Translation;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168256|Immune System;KEGG:hsa00830|Retinol metabolism;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04110|Cell cycle;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa00983|Drug metabolism - other enzymes;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05134|Legionellosis;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5419276|Mitochondrial translation termination;REACT:R-HSA-5368286|Mitochondrial translation initiation;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-5389840|Mitochondrial translation elongation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5368287|Mitochondrial translation;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-73887|Death Receptor Signalling;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-72306|tRNA processing;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling
144-54-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05133|Pertussis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05162|Measles;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05144|Malaria;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology
144092-31-9	KEGG:hsa05162|Measles;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
1449-05-4	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways
145-13-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1643685|Disease;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-68886|M Phase;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-69242|S Phase;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04976|Bile secretion;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-68867|Assembly of the pre-replicative complex;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-112399|IRS-mediated signalling
145-63-1	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-168256|Immune System;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology
145040-37-5	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins
146-48-5	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05034|Alcoholism;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04923|Regulation of lipolysis in adipocytes;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa05133|Pertussis;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-112316|Neuronal System;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04976|Bile secretion;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05012|Parkinson's disease;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04540|Gap junction;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-74160|Gene Expression
146-77-0	KEGG:hsa04210|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression
14605-22-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04931|Insulin resistance;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa05164|Influenza A;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05162|Measles;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1280218|Adaptive Immune System
1464-42-2	KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa05133|Pertussis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05164|Influenza A;KEGG:hsa05215|Prostate cancer;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology
146836-84-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05219|Bladder cancer;KEGG:hsa05133|Pertussis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-68886|M Phase;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01200|Carbon metabolism;KEGG:hsa05152|Tuberculosis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04110|Cell cycle;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05162|Measles;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa03013|RNA transport;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-162909|Host Interactions of HIV factors;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-186763|Downstream signal transduction
14691-52-2	KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04931|Insulin resistance;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR
147-84-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05164|Influenza A;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05134|Legionellosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05162|Measles;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05020|Prion diseases;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05132|Salmonella infection;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04360|Axon guidance;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade
147-85-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa05133|Pertussis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05144|Malaria;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05134|Legionellosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05162|Measles;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK
147-94-4	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-168256|Immune System;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1650814|Collagen biosynthesis and modifying enzymes;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2022090|Assembly of collagen fibrils and other multimeric structures;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-8948216|Collagen chain trimerization;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;KEGG:hsa05161|Hepatitis B;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05162|Measles;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05152|Tuberculosis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1630316|Glycosaminoglycan metabolism;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04360|Axon guidance;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1643685|Disease;KEGG:hsa04145|Phagosome;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04611|Platelet activation;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05164|Influenza A;KEGG:hsa04144|Endocytosis;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-983712|Ion channel transport
147465-43-8	REACT:R-HSA-168256|Immune System
147511-69-1	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
147536-97-8	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04976|Bile secretion;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa00830|Retinol metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System
14769-73-4	KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168249|Innate Immune System
147819-32-7	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System
148-24-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05133|Pertussis;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway
148-79-8	REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
148-82-3	KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04360|Axon guidance;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-109582|Hemostasis
14808-60-7	KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05134|Legionellosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05146|Amoebiasis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism
14838-15-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
14875-96-8	REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05132|Salmonella infection;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05164|Influenza A;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-189445|Metabolism of porphyrins;KEGG:hsa05215|Prostate cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05134|Legionellosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05214|Glioma;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05220|Chronic myeloid leukemia
149-29-1	KEGG:hsa04210|Apoptosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System
149-30-4	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System
149-45-1	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05146|Amoebiasis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05134|Legionellosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05164|Influenza A;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR
149-91-7	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05133|Pertussis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04510|Focal adhesion;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05134|Legionellosis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05132|Salmonella infection;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05144|Malaria
1490-04-6	KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-73887|Death Receptor Signalling;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-5669034|TNFs bind their physiological receptors;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168643|Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;KEGG:hsa05164|Influenza A;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5213460|RIPK1-mediated regulated necrosis;REACT:R-HSA-5218859|Regulated Necrosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5357769|Caspase activation via extrinsic apoptotic signalling pathway;REACT:R-HSA-5675482|Regulation of necroptotic cell death;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1643685|Disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-114452|Activation of BH3-only proteins;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-5218900|CASP8 activity is inhibited;REACT:R-HSA-69416|Dimerization of procaspase-8;REACT:R-HSA-3371378|Regulation by c-FLIP;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-168638|NOD1/2 Signaling Pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-75893|TNF signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-140534|Ligand-dependent caspase activation;REACT:R-HSA-75153|Apoptotic execution  phase;KEGG:hsa05218|Melanoma;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05160|Hepatitis C;KEGG:hsa05133|Pertussis;KEGG:hsa05162|Measles;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05214|Glioma;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05223|Non-small cell lung cancer
14901-07-6	KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
14930-96-2	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
14937-32-7	KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05164|Influenza A;REACT:R-HSA-168256|Immune System
14992-62-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins
150-86-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-68886|M Phase;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04110|Cell cycle;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-977225|Amyloid fiber formation;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-212165|Epigenetic regulation of gene expression;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5334118|DNA methylation;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-73864|RNA Polymerase I Transcription;REACT:R-HSA-5625740|RHO GTPases activate PKNs;REACT:R-HSA-427389|ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-69242|S Phase;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-5250924|B-WICH complex positively regulates rRNA expression;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-912446|Meiotic recombination;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-1500620|Meiosis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05164|Influenza A
150-97-0	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05162|Measles;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05134|Legionellosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05144|Malaria;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05146|Amoebiasis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04931|Insulin resistance;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05131|Shigellosis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04611|Platelet activation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-5663202|Diseases of signal transduction
150314-39-9	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR
150378-17-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168256|Immune System
15078-28-1	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05215|Prostate cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04931|Insulin resistance;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05160|Hepatitis C;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04730|Long-term depression;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04611|Platelet activation;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1643685|Disease;KEGG:hsa05224|Breast cancer;KEGG:hsa05203|Viral carcinogenesis
150863-82-4	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
151-21-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1643685|Disease;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6805567|Keratinization;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05162|Measles;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04210|Apoptosis;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04664|Fc epsilon RI signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6809371|Formation of the cornified envelope;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-68886|M Phase;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-2871796|FCERI mediated MAPK activation
151-67-7	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
152-72-7	REACT:R-HSA-1430728|Metabolism
152918-18-8	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
153-18-4	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05164|Influenza A;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05133|Pertussis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05134|Legionellosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05160|Hepatitis C;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa01522|Endocrine resistance;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05162|Measles;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS
15307-86-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04210|Apoptosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05164|Influenza A;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05162|Measles;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01100|Metabolic pathways;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05224|Breast cancer;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05133|Pertussis;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05140|Leishmaniasis
154-17-6	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04931|Insulin resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05160|Hepatitis C;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1643685|Disease;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR
154-23-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05164|Influenza A;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04931|Insulin resistance;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05162|Measles;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04144|Endocytosis;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-68886|M Phase;KEGG:hsa05224|Breast cancer;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-168254|Influenza Infection
154-42-7	REACT:R-HSA-1430728|Metabolism
154-93-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04510|Focal adhesion;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04210|Apoptosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05218|Melanoma;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05214|Glioma;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05146|Amoebiasis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5576891|Cardiac conduction;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04931|Insulin resistance;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05162|Measles;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04915|Estrogen signaling pathway
15442-64-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05133|Pertussis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05162|Measles;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05132|Salmonella infection;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05144|Malaria;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05146|Amoebiasis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization
154447-36-6	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05164|Influenza A;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04510|Focal adhesion;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05162|Measles;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05218|Melanoma;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05224|Breast cancer;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;KEGG:hsa05221|Acute myeloid leukemia
154453-18-6	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System
154635-17-3	KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
155-09-9	REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
15502-74-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04210|Apoptosis;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04510|Focal adhesion;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05224|Breast cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05162|Measles;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa04931|Insulin resistance;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05146|Amoebiasis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05214|Glioma;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-375276|Peptide ligand-binding receptors
1553-41-9	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04931|Insulin resistance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05152|Tuberculosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR
15532-75-9	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
15611-43-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05162|Measles;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-909733|Interferon alpha/beta signaling;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression
156177-65-0	REACT:R-HSA-168256|Immune System
1563-66-2	REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-156902|Peptide chain elongation;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-72766|Translation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa03010|Ribosome;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis
15646-46-5	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04110|Cell cycle;REACT:R-HSA-69242|S Phase;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa03030|DNA replication;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-176187|Activation of ATR in response to replication stress;REACT:R-HSA-380108|Chemokine receptors bind chemokines;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-69190|DNA strand elongation;KEGG:hsa00240|Pyrimidine metabolism;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05162|Measles;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-69205|G1/S-Specific Transcription;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-69304|Regulation of DNA replication;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-180786|Extension of Telomeres;REACT:R-HSA-174417|Telomere C-strand (Lagging Strand) Synthesis;KEGG:hsa05164|Influenza A;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-68867|Assembly of the pre-replicative complex;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05132|Salmonella infection;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05133|Pertussis;REACT:R-HSA-15869|Metabolism of nucleotides;KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05134|Legionellosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-157579|Telomere Maintenance;KEGG:hsa04623|Cytosolic DNA-sensing pathway;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05144|Malaria;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05330|Allograft rejection;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-73886|Chromosome Maintenance;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04672|Intestinal immune network for IgA production;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-68886|M Phase;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa04914|Progesterone-mediated oocyte maturation
15663-27-1	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05161|Hepatitis B;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04360|Axon guidance;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-8853659|RET signaling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-68886|M Phase;KEGG:hsa05164|Influenza A;KEGG:hsa04110|Cell cycle;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-71291|Metabolism of amino acids and derivatives
15676-16-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
15687-27-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05161|Hepatitis B;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05133|Pertussis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04976|Bile secretion;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa_M00014|Glucuronate pathway (uronate pathway);KEGG:hsa00053|Ascorbate and aldarate metabolism;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05160|Hepatitis C;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05219|Bladder cancer;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa00040|Pentose and glucuronate interconversions;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04931|Insulin resistance;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04210|Apoptosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-194068|Bile acid and bile salt metabolism;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa00983|Drug metabolism - other enzymes;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade
15805-73-9	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression
15826-37-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
158681-13-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04510|Focal adhesion;KEGG:hsa04210|Apoptosis;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04720|Long-term potentiation;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05034|Alcoholism;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05133|Pertussis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04360|Axon guidance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-166054|Activated TLR4 signalling
158966-92-8	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
15972-60-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05164|Influenza A;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05162|Measles;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
159989-64-7	KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04210|Apoptosis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System
16009-13-5	KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-212436|Generic Transcription Pathway
1614-12-6	REACT:R-HSA-1430728|Metabolism
1617-53-4	KEGG:hsa_M00014|Glucuronate pathway (uronate pathway);KEGG:hsa00053|Ascorbate and aldarate metabolism;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa00040|Pentose and glucuronate interconversions;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;KEGG:hsa00983|Drug metabolism - other enzymes;KEGG:hsa00830|Retinol metabolism;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
1617-55-6	KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
1622-62-4	REACT:R-HSA-1430728|Metabolism
162760-96-5	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System
1631-73-8	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05164|Influenza A;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04510|Focal adhesion;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-1643685|Disease;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05323|Rheumatoid arthritis
16330-92-0	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05218|Melanoma;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05214|Glioma;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04510|Focal adhesion;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-212436|Generic Transcription Pathway
1634-04-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1643685|Disease;REACT:R-HSA-199991|Membrane Trafficking
16423-68-0	REACT:R-HSA-1430728|Metabolism
16448-54-7	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
16561-29-8	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-68886|M Phase;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05152|Tuberculosis;KEGG:hsa04110|Cell cycle;KEGG:hsa04210|Apoptosis;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-69275|G2/M Transition;KEGG:hsa05164|Influenza A;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-69242|S Phase;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04668|TNF signaling pathway
16590-41-3	REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins
16721-80-5	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05132|Salmonella infection;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01100|Metabolic pathways
1675-54-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04931|Insulin resistance;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa05164|Influenza A;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04510|Focal adhesion;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05132|Salmonella infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1430728|Metabolism;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05215|Prostate cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05162|Measles;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins
16837-52-8	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System
16846-24-5	REACT:R-HSA-74160|Gene Expression
16858-02-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05164|Influenza A;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05133|Pertussis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-435354|Zinc transporters;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-425410|Metal ion SLC transporters;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-68875|Mitotic Prophase;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;KEGG:hsa05224|Breast cancer;KEGG:hsa04978|Mineral absorption;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence
16919-58-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
16960-16-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System
170449-18-0	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05219|Bladder cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05215|Prostate cancer;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05224|Breast cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04510|Focal adhesion;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1643685|Disease;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-450282|MAPK targets/ Nuclear events mediated by MAP kinases;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05218|Melanoma;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04540|Gap junction;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade
17181-54-3	KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism
17230-88-5	REACT:R-HSA-162582|Signal Transduction
17303-67-2	KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04110|Cell cycle;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168256|Immune System;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression
17395-31-2	REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-382551|Transmembrane transport of small molecules
1744-22-5	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
1746-01-6	REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-68886|M Phase;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa04144|Endocytosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-162906|HIV Infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-72312|rRNA processing;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-5357801|Programmed Cell Death
17617-45-7	KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-112316|Neuronal System
17619-97-5	REACT:R-HSA-1430728|Metabolism
1763-23-1	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1643685|Disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-382556|ABC-family proteins mediated transport;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;KEGG:hsa03050|Proteasome;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-350562|Regulation of ornithine decarboxylase (ODC);REACT:R-HSA-69242|S Phase;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-69610|p53-Independent DNA Damage Response;REACT:R-HSA-69613|p53-Independent G1/S DNA damage checkpoint;REACT:R-HSA-69601|Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-351202|Metabolism of polyamines;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211733|Regulation of activated PAK-2p34 by proteasome mediated degradation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69017|CDK-mediated phosphorylation and removal of Cdc6;REACT:R-HSA-69541|Stabilization of p53;REACT:R-HSA-4641257|Degradation of AXIN;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint
17711-16-9	REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
17780-72-2	REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
17804-35-2	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction
17902-23-7	REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-162582|Signal Transduction
17912-87-7	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
17924-92-4	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05162|Measles;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-196071|Metabolism of steroid hormones;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05214|Glioma;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05144|Malaria;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05218|Melanoma;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-194138|Signaling by VEGF
1806-26-4	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
1806-98-0	KEGG:hsa04976|Bile secretion;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism
1821-12-1	KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa05134|Legionellosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04930|Type II diabetes mellitus;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04931|Insulin resistance;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05132|Salmonella infection;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-3371556|Cellular response to heat stress;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05162|Measles;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04510|Focal adhesion;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis
18256-98-9	REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05133|Pertussis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05162|Measles;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1640170|Cell Cycle
18263-25-7	REACT:R-HSA-1430728|Metabolism
18378-89-7	REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System
18540-29-9	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72766|Translation;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa03010|Ribosome;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04210|Apoptosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05162|Measles;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04660|T cell receptor signaling pathway
18559-94-9	REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05146|Amoebiasis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05162|Measles;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109582|Hemostasis
18642-44-9	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
18654-18-7	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins
18883-66-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04510|Focal adhesion;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05164|Influenza A;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa01200|Carbon metabolism;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-70326|Glucose metabolism;KEGG:hsa04930|Type II diabetes mellitus;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04976|Bile secretion;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade
19044-88-3	REACT:R-HSA-1475029|Reversible hydration of carbon dioxide;KEGG:hsa00910|Nitrogen metabolism;REACT:R-HSA-1430728|Metabolism
19057-60-4	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05210|Colorectal cancer;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05164|Influenza A;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04931|Insulin resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-73887|Death Receptor Signalling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05133|Pertussis;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1266738|Developmental Biology
191-24-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-382551|Transmembrane transport of small molecules
191-30-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05161|Hepatitis B;KEGG:hsa04530|Tight junction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05218|Melanoma;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-446728|Cell junction organization;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-421270|Cell-cell junction organization;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa00040|Pentose and glucuronate interconversions;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa05214|Glioma
1912-24-9	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-73894|DNA Repair;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-68886|M Phase;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa05016|Huntington's disease;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04360|Axon guidance;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa04210|Apoptosis;KEGG:hsa03010|Ribosome;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04144|Endocytosis;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-2586552|Signaling by Leptin
19122-79-3	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;REACT:R-HSA-168256|Immune System
19130-96-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
191732-72-6	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
192-97-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04360|Axon guidance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-194840|Rho GTPase cycle;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa05032|Morphine addiction;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-1474290|Collagen formation;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-1650814|Collagen biosynthesis and modifying enzymes;REACT:R-HSA-3781865|Diseases of glycosylation;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2672351|Stimuli-sensing channels;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-3906995|Diseases associated with O-glycosylation of proteins;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-157118|Signaling by NOTCH;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-416482|G alpha (12/13) signalling events;KEGG:hsa05414|Dilated cardiomyopathy
19202-36-9	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System
19216-56-9	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-168256|Immune System;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05146|Amoebiasis;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05224|Breast cancer;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway
193-39-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa01100|Metabolic pathways
19356-17-3	REACT:R-HSA-168256|Immune System;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-372790|Signaling by GPCR
19406-51-0	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa03008|Ribosome biogenesis in eukaryotes;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa03013|RNA transport;REACT:R-HSA-162906|HIV Infection;KEGG:hsa05164|Influenza A;REACT:R-HSA-15869|Metabolism of nucleotides;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-68886|M Phase;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-72306|tRNA processing;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-162587|HIV Life Cycle;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5617833|Cilium Assembly;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04530|Tight junction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa00230|Purine metabolism;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase
1948-33-0	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1430728|Metabolism;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05162|Measles;KEGG:hsa05164|Influenza A;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05020|Prion diseases;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05330|Allograft rejection;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04216|Ferroptosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04940|Type I diabetes mellitus;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05146|Amoebiasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05132|Salmonella infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation
1951-25-3	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168256|Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04146|Peroxisome;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04931|Insulin resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04976|Bile secretion;KEGG:hsa04210|Apoptosis;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa00830|Retinol metabolism;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-70326|Glucose metabolism;REACT:R-HSA-75109|Triglyceride Biosynthesis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01212|Fatty acid metabolism;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-174824|Lipoprotein metabolism;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-382556|ABC-family proteins mediated transport;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-390918|Peroxisomal lipid metabolism;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa02010|ABC transporters;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-72766|Translation;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-174800|Chylomicron-mediated lipid transport;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes
19545-26-7	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1643685|Disease;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05162|Measles;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05218|Melanoma;KEGG:hsa05224|Breast cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05134|Legionellosis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05133|Pertussis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74160|Gene Expression;KEGG:hsa04110|Cell cycle;REACT:R-HSA-3700989|Transcriptional Regulation by TP53
1968-05-4	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-192823|Viral mRNA Translation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-72766|Translation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05162|Measles;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-72764|Eukaryotic Translation Termination;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05218|Melanoma;KEGG:hsa05224|Breast cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa03010|Ribosome;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-71291|Metabolism of amino acids and derivatives
19685-10-0	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression
1977-33-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa00564|Glycerophospholipid metabolism;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04530|Tight junction;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04514|Cell adhesion molecules (CAMs);REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2262752|Cellular responses to stress
198-55-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-500792|GPCR ligand binding
1982-67-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05162|Measles;KEGG:hsa05132|Salmonella infection;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05134|Legionellosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05215|Prostate cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05146|Amoebiasis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-72766|Translation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;KEGG:hsa05144|Malaria;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168254|Influenza Infection
19982-08-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
20048-27-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
20086-06-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01200|Carbon metabolism;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology
2010-15-3	REACT:R-HSA-157118|Signaling by NOTCH;REACT:R-HSA-1980143|Signaling by NOTCH1;REACT:R-HSA-2644602|Signaling by NOTCH1 PEST Domain Mutants in Cancer;REACT:R-HSA-2894858|Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;REACT:R-HSA-2644603|Signaling by NOTCH1 in Cancer;REACT:R-HSA-2894862|Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;REACT:R-HSA-2644606|Constitutive Signaling by NOTCH1 PEST Domain Mutants;REACT:R-HSA-1980145|Signaling by NOTCH2;KEGG:hsa04330|Notch signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2122948|Activated NOTCH1 Transmits Signal to the Nucleus;REACT:R-HSA-2979096|NOTCH2 Activation and Transmission of Signal to the Nucleus;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2691232|Constitutive Signaling by NOTCH1 HD Domain Mutants;REACT:R-HSA-2691230|Signaling by NOTCH1 HD Domain Mutants in Cancer;REACT:R-HSA-2122947|NOTCH1 Intracellular Domain Regulates Transcription;KEGG:hsa_M00682|Notch signaling;REACT:R-HSA-1912422|Pre-NOTCH Expression and Processing;REACT:R-HSA-1236394|Signaling by ERBB4;REACT:R-HSA-1912408|Pre-NOTCH Transcription and Translation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-193704|p75 NTR receptor-mediated signalling;REACT:R-HSA-204998|Cell death signalling via NRAGE, NRIF and NADE;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules
20256-56-8	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
2032-65-7	REACT:R-HSA-1430728|Metabolism
20350-15-6	KEGG:hsa04210|Apoptosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
20449-79-0	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05215|Prostate cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05162|Measles;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05133|Pertussis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05219|Bladder cancer;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04510|Focal adhesion;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;KEGG:hsa05214|Glioma;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation
205-99-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-68886|M Phase;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04110|Cell cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04510|Focal adhesion;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-5625740|RHO GTPases activate PKNs;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-68882|Mitotic Anaphase;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-1221632|Meiotic synapsis;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5334118|DNA methylation;KEGG:hsa05034|Alcoholism;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-380108|Chemokine receptors bind chemokines;REACT:R-HSA-977225|Amyloid fiber formation
2050-87-5	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04510|Focal adhesion;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1643685|Disease;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05133|Pertussis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-74160|Gene Expression;KEGG:hsa05219|Bladder cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05162|Measles;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05134|Legionellosis;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05214|Glioma;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04110|Cell cycle;KEGG:hsa05218|Melanoma;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04370|VEGF signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling
2051-62-9	REACT:R-HSA-1430728|Metabolism
20535-83-5	REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
20537-88-6	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
20562-02-1	KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System
20562-03-2	REACT:R-HSA-168256|Immune System
2058-94-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5653656|Vesicle-mediated transport
206-44-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05224|Breast cancer;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-112409|RAF-independent MAPK1/3 activation;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic
207-08-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05146|Amoebiasis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-6805567|Keratinization;KEGG:hsa04611|Platelet activation;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04145|Phagosome;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04210|Apoptosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04360|Axon guidance;KEGG:hsa05224|Breast cancer;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04144|Endocytosis;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04530|Tight junction;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-597592|Post-translational protein modification
2078-54-8	KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05033|Nicotine addiction;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05224|Breast cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05162|Measles;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System
20830-75-5	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
20830-81-3	REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-68886|M Phase;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05016|Huntington's disease;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa05164|Influenza A;KEGG:hsa04144|Endocytosis;KEGG:hsa04110|Cell cycle;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa04068|FoxO signaling pathway
20831-76-9	KEGG:hsa04210|Apoptosis
2086-83-1	REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05034|Alcoholism;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-5334118|DNA methylation;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-5625886|Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-427359|SIRT1 negatively regulates rRNA Expression;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-427389|ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;REACT:R-HSA-5250941|Negative epigenetic regulation of rRNA expression;REACT:R-HSA-3214847|HATs acetylate histones;REACT:R-HSA-5250924|B-WICH complex positively regulates rRNA expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-427413|NoRC negatively regulates rRNA expression;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-977225|Amyloid fiber formation;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5625740|RHO GTPases activate PKNs;REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;REACT:R-HSA-73864|RNA Polymerase I Transcription;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-73777|RNA Polymerase I Chain Elongation;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-3214858|RMTs methylate histone arginines;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-68886|M Phase;REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-171306|Packaging Of Telomere Ends;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04210|Apoptosis;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1221632|Meiotic synapsis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;REACT:R-HSA-3214841|PKMTs methylate histone lysines;REACT:R-HSA-5693565|Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;REACT:R-HSA-5693606|DNA Double Strand Break Response;REACT:R-HSA-73886|Chromosome Maintenance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-69473|G2/M DNA damage checkpoint;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;REACT:R-HSA-5693571|Nonhomologous End-Joining (NHEJ);KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-5689880|Ub-specific processing proteases;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-3214842|HDMs demethylate histones;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1643685|Disease;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-212436|Generic Transcription Pathway
20874-52-6	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05146|Amoebiasis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05162|Measles;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05224|Breast cancer;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-372790|Signaling by GPCR
2098-66-0	REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins
21019-30-7	KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology
2104-86-1	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
21145-77-7	REACT:R-HSA-1430728|Metabolism
21187-98-4	KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
21259-20-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04510|Focal adhesion;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa04360|Axon guidance;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04530|Tight junction;KEGG:hsa04210|Apoptosis;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-3781865|Diseases of glycosylation;KEGG:hsa04931|Insulin resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-1650814|Collagen biosynthesis and modifying enzymes;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR)
213-46-7	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
21392-57-4	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
2140-46-7	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
21416-87-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-6799198|Complex I biogenesis;KEGG:hsa04210|Apoptosis;KEGG:hsa04260|Cardiac muscle contraction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa00280|Valine, leucine and isoleucine degradation;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa01200|Carbon metabolism;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05161|Hepatitis B;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa05164|Influenza A;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF
21593-77-1	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism
21637-25-2	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05164|Influenza A;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05215|Prostate cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-372790|Signaling by GPCR
21645-51-2	REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa05164|Influenza A;KEGG:hsa05132|Salmonella infection;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-162582|Signal Transduction
21679-14-1	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-69242|S Phase;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05224|Breast cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05162|Measles;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1500620|Meiosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1643685|Disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification
2179-57-9	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05160|Hepatitis C;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04510|Focal adhesion;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05224|Breast cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways
218-01-9	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04510|Focal adhesion;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-216083|Integrin cell surface interactions;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-3000178|ECM proteoglycans;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1643685|Disease;KEGG:hsa04360|Axon guidance;KEGG:hsa04611|Platelet activation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04210|Apoptosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04530|Tight junction;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa03013|RNA transport;REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-5625740|RHO GTPases activate PKNs;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa05164|Influenza A;KEGG:hsa05224|Breast cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1433557|Signaling by SCF-KIT
21829-25-4	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04510|Focal adhesion;KEGG:hsa05215|Prostate cancer;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05166|HTLV-I infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05164|Influenza A;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05224|Breast cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1643685|Disease;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-500792|GPCR ligand binding
21967-41-9	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
2197-37-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05140|Leishmaniasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05144|Malaria;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05152|Tuberculosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1643685|Disease
22040-96-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04360|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04611|Platelet activation;REACT:R-HSA-1650814|Collagen biosynthesis and modifying enzymes;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-1474290|Collagen formation;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-194840|Rho GTPase cycle;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04144|Endocytosis;KEGG:hsa04530|Tight junction;KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-8948216|Collagen chain trimerization;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-416482|G alpha (12/13) signalling events;REACT:R-HSA-6794362|Protein-protein interactions at synapses;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04911|Insulin secretion;REACT:R-HSA-3781865|Diseases of glycosylation;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04972|Pancreatic secretion;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5173105|O-linked glycosylation;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-179812|GRB2 events in EGFR signaling
22071-15-4	KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
22144-77-0	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins
22204-53-1	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05162|Measles;KEGG:hsa05146|Amoebiasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05330|Allograft rejection;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05332|Graft-versus-host disease;KEGG:hsa05132|Salmonella infection;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways
2222-07-3	REACT:R-HSA-162582|Signal Transduction
2226-96-2	REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05133|Pertussis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways
22427-39-0	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04976|Bile secretion;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins
2257-09-2	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04110|Cell cycle;REACT:R-HSA-68886|M Phase;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69242|S Phase;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-68962|Activation of the pre-replicative complex;KEGG:hsa05134|Legionellosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;KEGG:hsa05215|Prostate cancer;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-68875|Mitotic Prophase;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05132|Salmonella infection;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;KEGG:hsa05130|Pathogenic Escherichia coli infection;KEGG:hsa05162|Measles;REACT:R-HSA-69190|DNA strand elongation;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-5689880|Ub-specific processing proteases;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa03030|DNA replication;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa04540|Gap junction;REACT:R-HSA-68877|Mitotic Prometaphase
22584-04-9	REACT:R-HSA-168256|Immune System
22839-47-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa04146|Peroxisome;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-168256|Immune System;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa01522|Endocrine resistance;KEGG:hsa04210|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-109582|Hemostasis
22862-76-6	REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-450282|MAPK targets/ Nuclear events mediated by MAP kinases;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05132|Salmonella infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
22888-70-6	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04110|Cell cycle;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05218|Melanoma;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05162|Measles;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins
22916-47-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-72766|Translation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-168256|Immune System;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;KEGG:hsa03010|Ribosome;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-68886|M Phase;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-69242|S Phase;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa03410|Base excision repair;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-73933|Resolution of Abasic Sites (AP sites);REACT:R-HSA-73884|Base Excision Repair;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-6782210|Gap-filling DNA repair synthesis and ligation in TC-NER;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-6781827|Transcription-Coupled Nucleotide Excision Repair (TC-NER);REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-170984|ARMS-mediated activation
2292-16-2	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05164|Influenza A;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism
2295-31-0	KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05200|Pathways in cancer
22967-92-6	KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04360|Axon guidance;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04611|Platelet activation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1280218|Adaptive Immune System
23031-25-6	KEGG:hsa05133|Pertussis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-168256|Immune System;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins
23058-19-7	KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
2318-18-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
23180-57-6	KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-162582|Signal Transduction
23210-56-2	KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112316|Neuronal System
23214-92-8	REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-68886|M Phase;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;KEGG:hsa05016|Huntington's disease;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04144|Endocytosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04110|Cell cycle
23246-96-0	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
23255-69-8	KEGG:hsa04210|Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System
23282-20-4	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction
23288-49-5	KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05144|Malaria;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
23313-12-4	REACT:R-HSA-162582|Signal Transduction
23402-09-7	KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-380108|Chemokine receptors bind chemokines;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-168256|Immune System;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04668|TNF signaling pathway
2353-33-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04110|Cell cycle;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05217|Basal cell carcinoma;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04510|Focal adhesion;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05164|Influenza A;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05162|Measles;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05160|Hepatitis C;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-157118|Signaling by NOTCH;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance
23583-48-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-196071|Metabolism of steroid hormones;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-211976|Endogenous sterols;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04931|Insulin resistance;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04925|Aldosterone synthesis and secretion;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa00100|Steroid biosynthesis;KEGG:hsa05020|Prion diseases;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04916|Melanogenesis;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-1257604|PIP3 activates AKT signaling
23593-75-1	REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
2363-88-4	KEGG:hsa01100|Metabolic pathways
2385-85-5	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-1430728|Metabolism
241-55-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
24211-30-1	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
24219-97-4	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR
24280-93-1	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa05133|Pertussis;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04210|Apoptosis;KEGG:hsa05134|Legionellosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04672|Intestinal immune network for IgA production;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05162|Measles;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05160|Hepatitis C;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
243-17-4	REACT:R-HSA-1430728|Metabolism
24365-47-7	REACT:R-HSA-168256|Immune System
244-54-2	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05164|Influenza A;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05144|Malaria;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05134|Legionellosis;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection
244-63-3	REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
2440-22-4	REACT:R-HSA-6802948|Signaling by high-kinase activity BRAF mutants;REACT:R-HSA-6802955|Paradoxical activation of RAF signaling by kinase inactive BRAF;REACT:R-HSA-6802946|Signaling by moderate kinase activity BRAF mutants;REACT:R-HSA-5674135|MAP2K and MAPK activation;REACT:R-HSA-6802949|Signaling by RAS mutants;REACT:R-HSA-6802952|Signaling by BRAF and RAF fusions;REACT:R-HSA-6802957|Oncogenic MAPK signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
24425-52-3	REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-168256|Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism
2447-54-3	KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism
24579-73-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways
2465-27-2	REACT:R-HSA-168256|Immune System
2465-59-0	REACT:R-HSA-168256|Immune System
24730-31-2	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System
24909-09-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System
24938-91-8	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
24939-17-1	REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
24967-94-0	REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System
2498-66-0	REACT:R-HSA-1430728|Metabolism
25013-16-5	KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04110|Cell cycle;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05133|Pertussis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa05164|Influenza A;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05160|Hepatitis C;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis
25067-58-7	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
2508-19-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05133|Pertussis;KEGG:hsa05146|Amoebiasis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05134|Legionellosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05164|Influenza A;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05132|Salmonella infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05144|Malaria;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-1430728|Metabolism;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-1643685|Disease;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04510|Focal adhesion;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-216083|Integrin cell surface interactions;KEGG:hsa04622|RIG-I-like receptor signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-1474228|Degradation of the extracellular matrix;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04972|Pancreatic secretion;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05150|Staphylococcus aureus infection
25122-41-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-72766|Translation;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05016|Huntington's disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa03010|Ribosome;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-391251|Protein folding;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-68886|M Phase;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling
25126-76-5	KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
25154-52-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05162|Measles;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05215|Prostate cancer;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05133|Pertussis;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04210|Apoptosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05160|Hepatitis C;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade
25167-62-8	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05164|Influenza A;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05162|Measles;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05215|Prostate cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05132|Salmonella infection;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05144|Malaria;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05219|Bladder cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04664|Fc epsilon RI signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-2559583|Cellular Senescence
25249-22-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05160|Hepatitis C;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05133|Pertussis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05144|Malaria;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa05330|Allograft rejection;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5260271|Diseases of Immune System;REACT:R-HSA-5602358|Diseases associated with the TLR signaling cascade;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04940|Type I diabetes mellitus;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-388396|GPCR downstream signaling
2528-16-7	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04110|Cell cycle;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-69231|Cyclin D associated events in G1;REACT:R-HSA-69236|G1 Phase;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168256|Immune System
25451-15-4	KEGG:hsa05033|Nicotine addiction;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-112316|Neuronal System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-382551|Transmembrane transport of small molecules
25612-59-3	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-168249|Innate Immune System
25614-03-3	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism
25637-99-4	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-68886|M Phase;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-69242|S Phase;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04110|Cell cycle;KEGG:hsa03040|Spliceosome;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa03013|RNA transport;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa05161|Hepatitis B;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK
2564-83-2	KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System
25644-25-1	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-380108|Chemokine receptors bind chemokines;REACT:R-HSA-168256|Immune System;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction
25717-80-0	KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling
2574-71-2	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins
25769-03-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05131|Shigellosis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1643685|Disease;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05144|Malaria;KEGG:hsa05020|Prion diseases;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-109581|Apoptosis
25812-30-0	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa01212|Fatty acid metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-174824|Lipoprotein metabolism;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa04146|Peroxisome;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04931|Insulin resistance;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05164|Influenza A;REACT:R-HSA-168256|Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System
25843-45-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04510|Focal adhesion;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;KEGG:hsa04978|Mineral absorption;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04972|Pancreatic secretion;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;REACT:R-HSA-373080|Class B/2 (Secretin family receptors);KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04976|Bile secretion;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04916|Melanogenesis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04068|FoxO signaling pathway
25990-37-8	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05152|Tuberculosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05160|Hepatitis C;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1640170|Cell Cycle
26048-05-5	KEGG:hsa04210|Apoptosis;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
2607-52-5	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System
2609-46-3	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa05134|Legionellosis;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05146|Amoebiasis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05160|Hepatitis C;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2672351|Stimuli-sensing channels;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
26129-32-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
26171-23-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
26172-55-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression
26538-44-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism
26566-61-0	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05164|Influenza A;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05016|Huntington's disease;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System
26628-22-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
26652-09-5	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
26675-46-7	KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05133|Pertussis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-5669034|TNFs bind their physiological receptors;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-73887|Death Receptor Signalling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05016|Huntington's disease;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology
26761-40-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways
2682-20-4	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;REACT:R-HSA-5334118|DNA methylation;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-5625886|Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;REACT:R-HSA-427389|ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;REACT:R-HSA-427359|SIRT1 negatively regulates rRNA Expression;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-977225|Amyloid fiber formation;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-3214847|HATs acetylate histones;KEGG:hsa05034|Alcoholism;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-5250924|B-WICH complex positively regulates rRNA expression;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-3214858|RMTs methylate histone arginines;REACT:R-HSA-73777|RNA Polymerase I Chain Elongation;REACT:R-HSA-5625740|RHO GTPases activate PKNs;REACT:R-HSA-427413|NoRC negatively regulates rRNA expression;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;REACT:R-HSA-5250941|Negative epigenetic regulation of rRNA expression;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;REACT:R-HSA-73864|RNA Polymerase I Transcription;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;KEGG:hsa05134|Legionellosis;REACT:R-HSA-68875|Mitotic Prophase;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05164|Influenza A;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-171306|Packaging Of Telomere Ends;KEGG:hsa05161|Hepatitis B;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1221632|Meiotic synapsis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-68886|M Phase;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-3214842|HDMs demethylate histones;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266695|Interleukin-7 signaling;REACT:R-HSA-3214841|PKMTs methylate histone lysines;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway
26833-87-4	KEGG:hsa05161|Hepatitis B;KEGG:hsa05215|Prostate cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression
26993-30-6	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-168249|Innate Immune System
27025-41-8	REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction
271-80-7	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa04110|Cell cycle;KEGG:hsa04210|Apoptosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05214|Glioma;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05218|Melanoma;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-74160|Gene Expression;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-372790|Signaling by GPCR
271-89-6	REACT:R-HSA-1430728|Metabolism
27203-92-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
27208-38-4	KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-372790|Signaling by GPCR
2752-65-0	KEGG:hsa04210|Apoptosis
2753-30-2	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways
27556-51-0	REACT:R-HSA-1430728|Metabolism
2763-96-4	KEGG:hsa04080|Neuroactive ligand-receptor interaction
2764-72-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04216|Ferroptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05200|Pathways in cancer;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05016|Huntington's disease;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04530|Tight junction;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-109582|Hemostasis
27774-13-6	REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05020|Prion diseases;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04210|Apoptosis;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05162|Measles;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05152|Tuberculosis
281-23-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05164|Influenza A;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05160|Hepatitis C;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-72766|Translation;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;KEGG:hsa05162|Measles;KEGG:hsa05016|Huntington's disease;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-73887|Death Receptor Signalling;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168254|Influenza Infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-156902|Peptide chain elongation;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5675482|Regulation of necroptotic cell death;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-112399|IRS-mediated signalling
28289-54-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05133|Pertussis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112316|Neuronal System;KEGG:hsa05016|Huntington's disease;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05020|Prion diseases;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05034|Alcoholism;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05134|Legionellosis;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6783783|Interleukin-10 signaling
28300-74-5	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-597592|Post-translational protein modification
28322-02-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
28395-03-1	REACT:R-HSA-382551|Transmembrane transport of small molecules
28553-12-0	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-382551|Transmembrane transport of small molecules
28721-07-5	REACT:R-HSA-1430728|Metabolism
288-13-1	REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-5678895|Defective CFTR causes cystic fibrosis;REACT:R-HSA-5619115|Disorders of transmembrane transporters;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-5619084|ABC transporter disorders;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-350562|Regulation of ornithine decarboxylase (ODC);REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa03050|Proteasome;REACT:R-HSA-5362768|Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;REACT:R-HSA-5387390|Hh mutants abrogate ligand secretion;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-1236978|Cross-presentation of soluble exogenous antigens (endosomes);REACT:R-HSA-211733|Regulation of activated PAK-2p34 by proteasome mediated degradation;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-69017|CDK-mediated phosphorylation and removal of Cdc6;REACT:R-HSA-180534|Vpu mediated degradation of CD4;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-69610|p53-Independent DNA Damage Response;REACT:R-HSA-69613|p53-Independent G1/S DNA damage checkpoint;REACT:R-HSA-69601|Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;REACT:R-HSA-169911|Regulation of Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-69541|Stabilization of p53;REACT:R-HSA-174113|SCF-beta-TrCP mediated degradation of Emi1;REACT:R-HSA-8854050|FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;REACT:R-HSA-4641257|Degradation of AXIN;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-5358346|Hedgehog ligand biogenesis;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;REACT:R-HSA-4641258|Degradation of DVL;REACT:R-HSA-5676590|NIK-->noncanonical NF-kB signaling;REACT:R-HSA-68827|CDT1 association with the CDC6:ORC:origin complex;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-5610780|Degradation of GLI1 by the proteasome;REACT:R-HSA-5610785|GLI3 is processed to GLI3R by the proteasome;REACT:R-HSA-5610783|Degradation of GLI2 by the proteasome;REACT:R-HSA-5607761|Dectin-1 mediated noncanonical NF-kB signaling;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-174084|Autodegradation of Cdh1 by Cdh1:APC/C;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-4608870|Asymmetric localization of PCP proteins;REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-174154|APC/C:Cdc20 mediated degradation of Securin;REACT:R-HSA-68867|Assembly of the pre-replicative complex;REACT:R-HSA-5658442|Regulation of RAS by GAPs;REACT:R-HSA-2871837|FCERI mediated NF-kB activation;REACT:R-HSA-1236974|ER-Phagosome pathway;REACT:R-HSA-202424|Downstream TCR signaling;REACT:R-HSA-174184|Cdc20:Phospho-APC/C mediated degradation of Cyclin A;REACT:R-HSA-174178|APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-179419|APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;REACT:R-HSA-195253|Degradation of beta-catenin by the destruction complex;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-5632684|Hedgehog 'on' state;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-202403|TCR signaling;REACT:R-HSA-5689603|UCH proteinases;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-69242|S Phase;REACT:R-HSA-4086400|PCP/CE pathway;REACT:R-HSA-5610787|Hedgehog 'off' state;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-5358351|Signaling by Hedgehog;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-69620|Cell Cycle Checkpoints
28808-62-0	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
28822-58-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04931|Insulin resistance;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04210|Apoptosis;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05224|Breast cancer;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04916|Melanogenesis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04923|Regulation of lipolysis in adipocytes;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05215|Prostate cancer;KEGG:hsa05161|Hepatitis B
289499-45-2	KEGG:hsa05219|Bladder cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
28957-04-2	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05152|Tuberculosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease
29106-49-8	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
29122-68-7	KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR
2921-88-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05224|Breast cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04210|Apoptosis;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04360|Axon guidance;KEGG:hsa04916|Melanogenesis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa01522|Endocrine resistance;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-375280|Amine ligand-binding receptors;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-451927|Interleukin-2 signaling
29232-93-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
29342-05-0	REACT:R-HSA-162582|Signal Transduction
29343-52-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;KEGG:hsa05162|Measles;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05133|Pertussis;KEGG:hsa04510|Focal adhesion;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05218|Melanoma;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05219|Bladder cancer
29552-41-8	KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05164|Influenza A;KEGG:hsa05133|Pertussis;KEGG:hsa05134|Legionellosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04622|RIG-I-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05160|Hepatitis C;KEGG:hsa05162|Measles;KEGG:hsa05146|Amoebiasis;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease
297-83-6	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism
2971-36-0	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05224|Breast cancer;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05166|HTLV-I infection;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-68886|M Phase;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-194315|Signaling by Rho GTPases
29767-20-2	REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism
298-00-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
298-46-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04510|Focal adhesion;KEGG:hsa04210|Apoptosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04360|Axon guidance;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05164|Influenza A;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05214|Glioma;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04916|Melanogenesis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74751|Insulin receptor signalling cascade
298-81-7	REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04976|Bile secretion;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways
29838-67-3	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
299-42-3	REACT:R-HSA-162582|Signal Transduction
29908-03-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology
300-62-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05152|Tuberculosis;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04925|Aldosterone synthesis and secretion;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04611|Platelet activation;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05030|Cocaine addiction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04145|Phagosome;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04360|Axon guidance;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05162|Measles;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-2871796|FCERI mediated MAPK activation
301-04-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05164|Influenza A;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04974|Protein digestion and absorption
302-01-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-174824|Lipoprotein metabolism;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-168256|Immune System;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis
302-27-2	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05160|Hepatitis C;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05164|Influenza A;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR
302-33-0	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
302-79-4	REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05224|Breast cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04360|Axon guidance;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05146|Amoebiasis;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05215|Prostate cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04110|Cell cycle;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-167044|Signalling to RAS
30237-26-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04931|Insulin resistance;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05133|Pertussis;KEGG:hsa04930|Type II diabetes mellitus;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05160|Hepatitis C;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05152|Tuberculosis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-163685|Integration of energy metabolism;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-174824|Lipoprotein metabolism;KEGG:hsa05144|Malaria;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-1643685|Disease;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade
303-34-4	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-73894|DNA Repair;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
303-45-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System
303-47-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04110|Cell cycle;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05214|Glioma;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05162|Measles;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05224|Breast cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05160|Hepatitis C;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05218|Melanoma;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-8853659|RET signaling
303-49-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
3031-94-5	KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-165159|mTOR signalling;REACT:R-HSA-109703|PKB-mediated events;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa04930|Type II diabetes mellitus;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05133|Pertussis;REACT:R-HSA-109704|PI3K Cascade;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05214|Glioma;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05224|Breast cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05168|Herpes simplex infection
304-55-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05162|Measles;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-909733|Interferon alpha/beta signaling;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-877300|Interferon gamma signaling;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa04510|Focal adhesion;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05219|Bladder cancer;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade
305-01-1	KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05133|Pertussis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05134|Legionellosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology
305-03-3	KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System
305-84-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05134|Legionellosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05133|Pertussis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology
30516-87-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05016|Huntington's disease;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;KEGG:hsa05162|Measles;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-909733|Interferon alpha/beta signaling;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05161|Hepatitis B;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6799198|Complex I biogenesis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05164|Influenza A;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04260|Cardiac muscle contraction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa_M00154|Cytochrome c oxidase;REACT:R-HSA-352230|Amino acid transport across the plasma membrane;KEGG:hsa02010|ABC transporters;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-877300|Interferon gamma signaling;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa04931|Insulin resistance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-69231|Cyclin D associated events in G1;REACT:R-HSA-69236|G1 Phase;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-425397|Transport of vitamins, nucleosides, and related molecules;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01523|Antifolate resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05215|Prostate cancer;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04976|Bile secretion;KEGG:hsa05332|Graft-versus-host disease;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04940|Type I diabetes mellitus;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1643685|Disease
3056-17-5	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology
30562-34-6	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05218|Melanoma;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04510|Focal adhesion;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05214|Glioma;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05224|Breast cancer;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05211|Renal cell carcinoma;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04370|VEGF signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1227986|Signaling by ERBB2;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05162|Measles;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05145|Toxoplasmosis
3067-13-8	REACT:R-HSA-1430728|Metabolism
3073-59-4	REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69242|S Phase;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-176187|Activation of ATR in response to replication stress;KEGG:hsa03030|DNA replication;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04110|Cell cycle;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
30811-80-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05160|Hepatitis C;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05133|Pertussis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05144|Malaria;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa05330|Allograft rejection;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5260271|Diseases of Immune System;REACT:R-HSA-5602358|Diseases associated with the TLR signaling cascade;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04940|Type I diabetes mellitus;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors)
309-00-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-212436|Generic Transcription Pathway
3094-09-5	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
311-45-5	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1640170|Cell Cycle
3116-76-5	REACT:R-HSA-168256|Immune System
313-67-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05215|Prostate cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04140|Autophagy - animal;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05164|Influenza A;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04360|Axon guidance;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663205|Infectious disease
3131-23-5	KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis
31356-94-2	REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
31430-18-9	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-68886|M Phase;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology
31431-39-7	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology
315-22-0	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05134|Legionellosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04510|Focal adhesion;KEGG:hsa05132|Salmonella infection;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04110|Cell cycle;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-6798695|Neutrophil degranulation
315-30-0	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05164|Influenza A;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa05132|Salmonella infection;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05134|Legionellosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01100|Metabolic pathways
31879-05-7	REACT:R-HSA-1430728|Metabolism
319-84-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05224|Breast cancer;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-392499|Metabolism of proteins
31961-54-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05133|Pertussis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05162|Measles;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05164|Influenza A;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;KEGG:hsa05020|Prion diseases;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05224|Breast cancer;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05218|Melanoma;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04510|Focal adhesion;KEGG:hsa05144|Malaria;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1280218|Adaptive Immune System
320-67-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05224|Breast cancer;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04110|Cell cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05217|Basal cell carcinoma;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade
32004-67-4	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05218|Melanoma;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04659|Th17 cell differentiation
321-64-2	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
322-35-0	REACT:R-HSA-162582|Signal Transduction
32222-06-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04110|Cell cycle;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1643685|Disease;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04210|Apoptosis;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-68886|M Phase;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5663220|RHO GTPases Activate Formins;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-69242|S Phase;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa05152|Tuberculosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-68882|Mitotic Anaphase;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05162|Measles;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05224|Breast cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-5693538|Homology Directed Repair
32231-06-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
32358-83-1	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
32534-81-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa01200|Carbon metabolism;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04918|Thyroid hormone synthesis;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin
326-91-0	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
32619-42-4	REACT:R-HSA-168256|Immune System
327-97-9	KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04210|Apoptosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05160|Hepatitis C;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05224|Breast cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05146|Amoebiasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04931|Insulin resistance;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04064|NF-kappa B signaling pathway
32809-16-8	REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-168256|Immune System;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-6794362|Protein-protein interactions at synapses;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-5576892|Phase 0 - rapid depolarisation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6794361|Interactions of neurexins and neuroligins at synapses;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-8848021|Signaling by PTK6;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-5576891|Cardiac conduction;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2262752|Cellular responses to stress
329-98-6	REACT:R-HSA-1430728|Metabolism
3296-90-0	REACT:R-HSA-1430728|Metabolism
330-54-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1474228|Degradation of the extracellular matrix;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1474290|Collagen formation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-72766|Translation;REACT:R-HSA-2022090|Assembly of collagen fibrils and other multimeric structures;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-192823|Viral mRNA Translation;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-2408557|Selenocysteine synthesis;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-168254|Influenza Infection;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-445355|Smooth Muscle Contraction;REACT:R-HSA-1650814|Collagen biosynthesis and modifying enzymes;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04974|Protein digestion and absorption;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa03010|Ribosome;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa05146|Amoebiasis;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04530|Tight junction;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-2173782|Binding and Uptake of Ligands by Scavenger Receptors;REACT:R-HSA-3000157|Laminin interactions;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-1630316|Glycosaminoglycan metabolism;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-8948216|Collagen chain trimerization;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-1566948|Elastic fibre formation;KEGG:hsa04144|Endocytosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway
330-55-2	REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-6794362|Protein-protein interactions at synapses;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5576892|Phase 0 - rapid depolarisation;KEGG:hsa05224|Breast cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-6794361|Interactions of neurexins and neuroligins at synapses;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins
33089-61-1	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
331-39-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05133|Pertussis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway
3326-32-7	KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins
333-41-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05224|Breast cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04210|Apoptosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04110|Cell cycle;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04726|Serotonergic synapse
33419-42-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04210|Apoptosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04110|Cell cycle;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1643685|Disease;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05224|Breast cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109581|Apoptosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04931|Insulin resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05164|Influenza A;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-69206|G1/S Transition;KEGG:hsa00982|Drug metabolism - cytochrome P450
33458-93-4	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05215|Prostate cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05224|Breast cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1643685|Disease;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74160|Gene Expression
335-67-1	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa01200|Carbon metabolism;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69242|S Phase;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04146|Peroxisome;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-179812|GRB2 events in EGFR signaling
335-76-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04210|Apoptosis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1266738|Developmental Biology
3351-86-8	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
33515-09-2	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System
3376-24-7	REACT:R-HSA-168256|Immune System;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction
3380-34-5	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-72766|Translation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-70326|Glucose metabolism;KEGG:hsa04976|Bile secretion;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa00010|Glycolysis / Gluconeogenesis;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2408557|Selenocysteine synthesis;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-72764|Eukaryotic Translation Termination;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168254|Influenza Infection;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04260|Cardiac muscle contraction;REACT:R-HSA-70263|Gluconeogenesis;KEGG:hsa04360|Axon guidance
34031-32-8	KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168256|Immune System;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05164|Influenza A;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05134|Legionellosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04210|Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05133|Pertussis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction
34086-50-5	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction
34123-59-6	REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-156902|Peptide chain elongation;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-72766|Translation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa03010|Ribosome;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
34157-83-0	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05162|Measles;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05134|Legionellosis;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05133|Pertussis;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1643685|Disease;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa01100|Metabolic pathways
3416-24-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1643685|Disease;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05152|Tuberculosis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05133|Pertussis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04931|Insulin resistance;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05162|Measles;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-450294|MAP kinase activation in TLR cascade;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05020|Prion diseases
34184-77-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism
34240-05-6	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa01200|Carbon metabolism;KEGG:hsa04146|Peroxisome;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer
34256-82-1	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa04210|Apoptosis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-1643685|Disease;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-72766|Translation;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
34284-75-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
34316-15-9	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology
34368-04-2	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa05164|Influenza A;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1280218|Adaptive Immune System
34807-41-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
3483-12-3	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05162|Measles;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05134|Legionellosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05160|Hepatitis C;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04931|Insulin resistance;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1266738|Developmental Biology
34841-39-9	REACT:R-HSA-168256|Immune System
35065-27-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-68886|M Phase;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05224|Breast cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa05164|Influenza A;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05218|Melanoma;REACT:R-HSA-68882|Mitotic Anaphase;KEGG:hsa05214|Glioma;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-68962|Activation of the pre-replicative complex;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05162|Measles;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
35065-28-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-68886|M Phase;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5663220|RHO GTPases Activate Formins;KEGG:hsa04110|Cell cycle;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04144|Endocytosis;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-983189|Kinesins;REACT:R-HSA-6811434|COPI-dependent Golgi-to-ER retrograde traffic
35121-78-9	REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1266738|Developmental Biology
35189-28-7	KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-109582|Hemostasis
3521-62-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
3522-50-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
35354-74-6	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04210|Apoptosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05164|Influenza A;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-212436|Generic Transcription Pathway
355-46-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-174824|Lipoprotein metabolism;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa04976|Bile secretion;KEGG:hsa04975|Fat digestion and absorption;KEGG:hsa04146|Peroxisome;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-75109|Triglyceride Biosynthesis;REACT:R-HSA-174800|Chylomicron-mediated lipid transport;REACT:R-HSA-194068|Bile acid and bile salt metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules
35572-78-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04510|Focal adhesion;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
3562-84-3	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-72766|Translation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-382556|ABC-family proteins mediated transport;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa03010|Ribosome;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa01523|Antifolate resistance;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04146|Peroxisome;REACT:R-HSA-1236974|ER-Phagosome pathway;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2871837|FCERI mediated NF-kB activation;REACT:R-HSA-4086400|PCP/CE pathway;REACT:R-HSA-202424|Downstream TCR signaling;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-202403|TCR signaling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN
35693-99-3	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168256|Immune System;REACT:R-HSA-68886|M Phase;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04110|Cell cycle;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-416482|G alpha (12/13) signalling events;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-69242|S Phase;KEGG:hsa05224|Breast cancer;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa04914|Progesterone-mediated oocyte maturation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-73886|Chromosome Maintenance;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-983189|Kinesins;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-6811434|COPI-dependent Golgi-to-ER retrograde traffic;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R
35825-57-1	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
36-88-4	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05161|Hepatitis B;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04360|Axon guidance;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05224|Breast cancer;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05164|Influenza A;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis
360-65-6	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System
360-97-4	KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05160|Hepatitis C;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04930|Type II diabetes mellitus;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-165159|mTOR signalling;REACT:R-HSA-109703|PKB-mediated events;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05146|Amoebiasis;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05164|Influenza A;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-109704|PI3K Cascade;KEGG:hsa05134|Legionellosis;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05214|Glioma;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04670|Leukocyte transendothelial migration
36062-04-1	REACT:R-HSA-1430728|Metabolism
361-09-1	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism
362-05-0	KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
362-07-2	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;KEGG:hsa05162|Measles;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism
362-74-3	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1643685|Disease;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04510|Focal adhesion;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05215|Prostate cancer;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05133|Pertussis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05219|Bladder cancer;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04925|Aldosterone synthesis and secretion;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05162|Measles;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05214|Glioma;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR)
363-24-6	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05164|Influenza A;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04210|Apoptosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1643685|Disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-422475|Axon guidance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05144|Malaria;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05132|Salmonella infection;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04510|Focal adhesion;KEGG:hsa00590|Arachidonic acid metabolism;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation
36304-82-2	REACT:R-HSA-168256|Immune System
36322-90-4	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-68886|M Phase;REACT:R-HSA-69242|S Phase;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04110|Cell cycle;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-176187|Activation of ATR in response to replication stress;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-73893|DNA Damage Bypass;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1169408|ISG15 antiviral mechanism;REACT:R-HSA-1169410|Antiviral mechanism by IFN-stimulated genes;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa03030|DNA replication;REACT:R-HSA-110314|Recognition of DNA damage by PCNA-containing replication complex;KEGG:hsa03013|RNA transport;REACT:R-HSA-3371556|Cellular response to heat stress;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;KEGG:hsa03040|Spliceosome;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-72202|Transport of Mature Transcript to Cytoplasm;KEGG:hsa03420|Nucleotide excision repair;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-73933|Resolution of Abasic Sites (AP sites);REACT:R-HSA-73884|Base Excision Repair;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2980766|Nuclear Envelope Breakdown;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-5696400|Dual Incision in GG-NER;REACT:R-HSA-110313|Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5696399|Global Genome Nucleotide Excision Repair (GG-NER);REACT:R-HSA-3108232|SUMO E3 ligases SUMOylate target proteins;KEGG:hsa05134|Legionellosis;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition
36357-77-4	REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction
364-62-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
364-98-7	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
3648-21-3	REACT:R-HSA-1430728|Metabolism
3650-09-7	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression
36505-84-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa04145|Phagosome;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-75109|Triglyceride Biosynthesis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-75105|Fatty Acyl-CoA Biosynthesis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa00071|Fatty acid degradation;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05133|Pertussis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04530|Tight junction;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-1483257|Phospholipid metabolism;KEGG:hsa04146|Peroxisome;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05164|Influenza A;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-15869|Metabolism of nucleotides;REACT:R-HSA-1643685|Disease;KEGG:hsa04142|Lysosome;KEGG:hsa04110|Cell cycle;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2132295|MHC class II antigen presentation;REACT:R-HSA-69242|S Phase;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa00230|Purine metabolism;REACT:R-HSA-68886|M Phase;KEGG:hsa05161|Hepatitis B;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05146|Amoebiasis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-163685|Integration of energy metabolism;KEGG:hsa04919|Thyroid hormone signaling pathway
36507-31-0	REACT:R-HSA-168256|Immune System
366-18-7	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
366-93-8	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
3671-38-3	KEGG:hsa04210|Apoptosis
36791-04-5	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05162|Measles;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
3681-99-0	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04931|Insulin resistance;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05146|Amoebiasis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05224|Breast cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-1643685|Disease;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05162|Measles;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1474244|Extracellular matrix organization
370-81-0	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-112316|Neuronal System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04360|Axon guidance;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04713|Circadian entrainment;KEGG:hsa05224|Breast cancer;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05152|Tuberculosis
370-86-5	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05134|Legionellosis;KEGG:hsa05162|Measles;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction
37148-27-9	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
37300-21-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-212436|Generic Transcription Pathway
3734-49-4	KEGG:hsa05206|MicroRNAs in cancer
3735-78-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-68886|M Phase;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5617833|Cilium Assembly;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69242|S Phase;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-162587|HIV Life Cycle;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04110|Cell cycle;KEGG:hsa04120|Ubiquitin mediated proteolysis;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-162599|Late Phase of HIV Life Cycle;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-72766|Translation;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;KEGG:hsa03013|RNA transport;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-109581|Apoptosis
37350-58-6	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-392499|Metabolism of proteins
375-22-4	REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa01100|Metabolic pathways
375-85-9	KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
375-95-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04931|Insulin resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04210|Apoptosis;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05160|Hepatitis C;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05016|Huntington's disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules
37558-16-0	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR
37589-80-3	REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction
37680-73-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-68886|M Phase;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-5663220|RHO GTPases Activate Formins;KEGG:hsa04110|Cell cycle;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-68962|Activation of the pre-replicative complex;KEGG:hsa05161|Hepatitis B;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-69242|S Phase;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1643685|Disease;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05224|Breast cancer;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-6811434|COPI-dependent Golgi-to-ER retrograde traffic;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-73886|Chromosome Maintenance;KEGG:hsa04210|Apoptosis;REACT:R-HSA-983189|Kinesins
3771-19-5	REACT:R-HSA-1430728|Metabolism
3778-73-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05134|Legionellosis;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05162|Measles;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05164|Influenza A;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-109582|Hemostasis
378-44-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-72766|Translation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-72312|rRNA processing;KEGG:hsa05200|Pathways in cancer;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa03010|Ribosome;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69275|G2/M Transition
38030-57-8	REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6805567|Keratinization;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-422475|Axon guidance
38102-62-4	REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-6794362|Protein-protein interactions at synapses;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5576893|Phase 2 - plateau phase;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-6794361|Interactions of neurexins and neuroligins at synapses;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5576892|Phase 0 - rapid depolarisation;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04260|Cardiac muscle contraction;KEGG:hsa05033|Nicotine addiction;KEGG:hsa05224|Breast cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04360|Axon guidance;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-442755|Activation of NMDA receptor upon glutamate binding and postsynaptic events;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-112310|Neurotransmitter Release Cycle;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;KEGG:hsa04720|Long-term potentiation;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05206|MicroRNAs in cancer
38194-50-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1643685|Disease;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05162|Measles;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05219|Bladder cancer;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance
3820-67-5	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-72766|Translation;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1643685|Disease;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-156902|Peptide chain elongation;KEGG:hsa03010|Ribosome;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;KEGG:hsa04146|Peroxisome;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-948021|Transport to the Golgi and subsequent modification;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-199977|ER to Golgi Anterograde Transport;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa03060|Protein export;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-381070|IRE1alpha activates chaperones;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-381038|XBP1(S) activates chaperone genes;KEGG:hsa00280|Valine, leucine and isoleucine degradation;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-6807878|COPI-mediated anterograde transport;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-6811442|Intra-Golgi and retrograde Golgi-to-ER traffic;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;KEGG:hsa01200|Carbon metabolism;KEGG:hsa00380|Tryptophan metabolism;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-6788656|Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa00330|Arginine and proline metabolism;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-192105|Synthesis of bile acids and bile salts;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-532668|N-glycan trimming in the ER and Calnexin/Calreticulin cycle;REACT:R-HSA-390918|Peroxisomal lipid metabolism;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa00410|beta-Alanine metabolism;KEGG:hsa00510|N-Glycan biosynthesis;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-6811434|COPI-dependent Golgi-to-ER retrograde traffic;KEGG:hsa04216|Ferroptosis;REACT:R-HSA-193368|Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;REACT:R-HSA-15869|Metabolism of nucleotides;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation
38216-54-5	REACT:R-HSA-168256|Immune System
38379-99-6	REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction
3843-74-1	KEGG:hsa05200|Pathways in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
3846-71-7	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1430728|Metabolism
38748-32-2	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04110|Cell cycle;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04510|Focal adhesion;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05224|Breast cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05214|Glioma;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05134|Legionellosis;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05219|Bladder cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1445148|Translocation of GLUT4 to the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05131|Shigellosis;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction
3896-11-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05162|Measles;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05133|Pertussis;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;KEGG:hsa05164|Influenza A;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04931|Insulin resistance;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa04664|Fc epsilon RI signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-983695|Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-114604|GPVI-mediated activation cascade;KEGG:hsa05215|Prostate cancer;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04068|FoxO signaling pathway
38966-21-1	REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-73894|DNA Repair
39324-30-6	KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System
39424-53-8	KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05162|Measles;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-157118|Signaling by NOTCH;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer
39492-01-8	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications
39800-16-3	REACT:R-HSA-73894|DNA Repair;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System
402-71-1	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05134|Legionellosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05146|Amoebiasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05162|Measles;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism
40391-99-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
404-86-4	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05215|Prostate cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05162|Measles;KEGG:hsa05164|Influenza A;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04931|Insulin resistance;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1643685|Disease;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway
40596-69-8	REACT:R-HSA-1430728|Metabolism
40957-83-3	KEGG:hsa01522|Endocrine resistance;KEGG:hsa05224|Breast cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR
41198-08-7	REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways
41294-56-8	REACT:R-HSA-1430728|Metabolism
41340-25-4	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
41575-94-4	KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05166|HTLV-I infection;KEGG:hsa05164|Influenza A;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109582|Hemostasis
41598-07-6	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05162|Measles;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1430728|Metabolism;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05134|Legionellosis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05133|Pertussis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05144|Malaria;KEGG:hsa04510|Focal adhesion;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-2172127|DAP12 interactions
4170-30-3	KEGG:hsa05134|Legionellosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05162|Measles;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05146|Amoebiasis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-372790|Signaling by GPCR
41859-67-0	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-174824|Lipoprotein metabolism;KEGG:hsa04931|Insulin resistance;KEGG:hsa00071|Fatty acid degradation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04146|Peroxisome;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05144|Malaria;REACT:R-HSA-174800|Chylomicron-mediated lipid transport;REACT:R-HSA-1368082|RORA activates gene expression;REACT:R-HSA-400253|Circadian Clock;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04976|Bile secretion;KEGG:hsa05152|Tuberculosis;KEGG:hsa04975|Fat digestion and absorption;REACT:R-HSA-5362517|Signaling by Retinoic Acid;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05133|Pertussis;KEGG:hsa05134|Legionellosis;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-75109|Triglyceride Biosynthesis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05162|Measles;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1643685|Disease;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04510|Focal adhesion
420-04-2	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
4205-90-7	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism
423-55-2	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
42399-41-7	KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
42471-28-3	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
42542-10-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04360|Axon guidance;REACT:R-HSA-8856828|Clathrin-mediated endocytosis;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04210|Apoptosis;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04144|Endocytosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1483257|Phospholipid metabolism;KEGG:hsa05166|HTLV-I infection
42553-65-1	KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05133|Pertussis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05134|Legionellosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System
42583-46-0	KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
427-51-0	REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins
42835-25-6	REACT:R-HSA-168256|Immune System
4289-98-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04664|Fc epsilon RI signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04666|Fc gamma R-mediated phagocytosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2029480|Fcgamma receptor (FCGR) dependent phagocytosis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04611|Platelet activation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism
4291-63-8	KEGG:hsa04210|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
42935-17-1	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism
431-03-8	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology
43121-43-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-5362517|Signaling by Retinoic Acid;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04976|Bile secretion;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04144|Endocytosis;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1280218|Adaptive Immune System
43210-67-9	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
4339-71-3	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05219|Bladder cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05160|Hepatitis C;KEGG:hsa05164|Influenza A;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05133|Pertussis;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-1643685|Disease;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05131|Shigellosis;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1430728|Metabolism
4339-72-4	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
434-13-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04976|Bile secretion;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-194068|Bile acid and bile salt metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-159418|Recycling of bile acids and salts;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05133|Pertussis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-193368|Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-192105|Synthesis of bile acids and bile salts;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-193807|Synthesis of bile acids and bile salts via 27-hydroxycholesterol;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04210|Apoptosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa02010|ABC transporters;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05134|Legionellosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-211976|Endogenous sterols;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04931|Insulin resistance;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa00564|Glycerophospholipid metabolism;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa01523|Antifolate resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-174824|Lipoprotein metabolism;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-422475|Axon guidance;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway
434-22-0	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109582|Hemostasis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism
4342-03-4	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05134|Legionellosis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05215|Prostate cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04110|Cell cycle;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05146|Amoebiasis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05160|Hepatitis C;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-69473|G2/M DNA damage checkpoint;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1430728|Metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1643685|Disease;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1280218|Adaptive Immune System
4368-28-9	KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa05034|Alcoholism;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
437-38-7	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
4376-20-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05161|Hepatitis B;KEGG:hsa05215|Prostate cancer;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04210|Apoptosis;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling
4382-43-8	KEGG:hsa05206|MicroRNAs in cancer
439-14-5	REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04727|GABAergic synapse;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-977441|GABA A receptor activation;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05033|Nicotine addiction;REACT:R-HSA-975298|Ligand-gated ion channel transport;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-977443|GABA receptor activation;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05032|Morphine addiction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05133|Pertussis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05132|Salmonella infection;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology
4394-00-7	REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism
4419-39-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05310|Asthma;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05164|Influenza A;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-375165|NCAM signaling for neurite out-growth
442-51-3	KEGG:hsa04110|Cell cycle;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins
443-48-1	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules
4430-36-8	REACT:R-HSA-1430728|Metabolism
4431-01-0	KEGG:hsa05210|Colorectal cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05215|Prostate cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction
4449-51-8	KEGG:hsa04340|Hedgehog signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
446-72-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05215|Prostate cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04110|Cell cycle;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05224|Breast cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04810|Regulation of actin cytoskeleton
446-86-6	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-68886|M Phase;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa04110|Cell cycle;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69242|S Phase;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05164|Influenza A;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-176187|Activation of ATR in response to replication stress;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa03030|DNA replication;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1643685|Disease;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-68962|Activation of the pre-replicative complex;KEGG:hsa05162|Measles;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-73894|DNA Repair;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-69205|G1/S-Specific Transcription;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05144|Malaria;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-157579|Telomere Maintenance;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05132|Salmonella infection
4478-93-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05134|Legionellosis;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04145|Phagosome;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04931|Insulin resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05012|Parkinson's disease;KEGG:hsa04514|Cell adhesion molecules (CAMs);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-177929|Signaling by EGFR
452-06-2	KEGG:hsa05161|Hepatitis B;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05134|Legionellosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System
454-28-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05133|Pertussis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05160|Hepatitis C;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05219|Bladder cancer;KEGG:hsa05131|Shigellosis;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa04140|Autophagy - animal;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05162|Measles;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05016|Huntington's disease;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-212436|Generic Transcription Pathway
458-36-6	REACT:R-HSA-1430728|Metabolism
458-37-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1643685|Disease;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05164|Influenza A;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05224|Breast cancer;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05133|Pertussis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04015|Rap1 signaling pathway
4602-84-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa01100|Metabolic pathways;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-75109|Triglyceride Biosynthesis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-168256|Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa05218|Melanoma;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05160|Hepatitis C;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04931|Insulin resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05224|Breast cancer;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis
4618-18-2	REACT:R-HSA-168256|Immune System
462-20-4	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
462-94-2	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System
463-40-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology
463-58-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression
463-79-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05164|Influenza A;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04210|Apoptosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05133|Pertussis;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-70326|Glucose metabolism;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05162|Measles;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-71387|Metabolism of carbohydrates
464-92-6	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System
465-00-9	KEGG:hsa04210|Apoptosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction
465-21-4	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04510|Focal adhesion;KEGG:hsa05133|Pertussis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05132|Salmonella infection;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa05215|Prostate cancer;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1430728|Metabolism
465-65-6	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05020|Prion diseases;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05133|Pertussis;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05162|Measles;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05034|Alcoholism;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease
4670-05-7	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
4685-14-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1643685|Disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01100|Metabolic pathways;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05164|Influenza A;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05134|Legionellosis;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05162|Measles;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04110|Cell cycle;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05212|Pancreatic cancer
469-83-0	KEGG:hsa01524|Platinum drug resistance;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-1430728|Metabolism
470-37-1	KEGG:hsa05200|Pathways in cancer
470-82-6	REACT:R-HSA-168256|Immune System
471-05-6	KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5357956|TNFR1-induced NFkappaB signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-73887|Death Receptor Signalling;REACT:R-HSA-5357905|Regulation of TNFR1 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-75893|TNF signaling;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05164|Influenza A;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism
471-47-6	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
471-53-4	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05133|Pertussis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05132|Salmonella infection;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04611|Platelet activation;KEGG:hsa04360|Axon guidance;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-2682334|EPH-Ephrin signaling;KEGG:hsa05146|Amoebiasis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-212436|Generic Transcription Pathway
471-80-7	KEGG:hsa04931|Insulin resistance;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR
472-15-1	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05224|Breast cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification
472-61-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05016|Huntington's disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway
4721-07-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction
473-98-3	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
474-25-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04976|Bile secretion;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa05215|Prostate cancer;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04931|Insulin resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa00983|Drug metabolism - other enzymes;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa00830|Retinol metabolism;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-193368|Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-159418|Recycling of bile acids and salts;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-192105|Synthesis of bile acids and bile salts;KEGG:hsa01212|Fatty acid metabolism;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;REACT:R-HSA-174824|Lipoprotein metabolism;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05146|Amoebiasis;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-75109|Triglyceride Biosynthesis
474-73-7	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
475-31-0	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System
475-80-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease
4759-48-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-191273|Cholesterol biosynthesis;KEGG:hsa04146|Peroxisome;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01200|Carbon metabolism;KEGG:hsa01212|Fatty acid metabolism;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5362517|Signaling by Retinoic Acid;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05146|Amoebiasis;KEGG:hsa05016|Huntington's disease;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa00280|Valine, leucine and isoleucine degradation;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-75109|Triglyceride Biosynthesis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa00100|Steroid biosynthesis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-75105|Fatty Acyl-CoA Biosynthesis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05133|Pertussis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-912526|Interleukin receptor SHC signaling
476-66-4	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05133|Pertussis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05164|Influenza A;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1643685|Disease;KEGG:hsa05134|Legionellosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04622|RIG-I-like receptor signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05162|Measles;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05016|Huntington's disease;KEGG:hsa05224|Breast cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
477-30-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-1500620|Meiosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-68886|M Phase;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;KEGG:hsa04110|Cell cycle;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05322|Systemic lupus erythematosus;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-1221632|Meiotic synapsis;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-69242|S Phase;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;KEGG:hsa05164|Influenza A;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-427389|ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-69205|G1/S-Specific Transcription;REACT:R-HSA-877300|Interferon gamma signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-5334118|DNA methylation;REACT:R-HSA-1643685|Disease;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5625886|Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;REACT:R-HSA-427359|SIRT1 negatively regulates rRNA Expression;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;REACT:R-HSA-73777|RNA Polymerase I Chain Elongation;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-73864|RNA Polymerase I Transcription;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-171306|Packaging Of Telomere Ends;KEGG:hsa05162|Measles;KEGG:hsa05034|Alcoholism;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5693571|Nonhomologous End-Joining (NHEJ);KEGG:hsa05130|Pathogenic Escherichia coli infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis)
477-90-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System
4773-96-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05144|Malaria;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05134|Legionellosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05132|Salmonella infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1606322|ZBP1(DAI) mediated induction of type I IFNs;REACT:R-HSA-445989|TAK1 activates NFkB by phosphorylation and activation of IKKs complex;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05131|Shigellosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1834949|Cytosolic sensors of pathogen-associated DNA;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04140|Autophagy - animal;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04650|Natural killer cell mediated cytotoxicity
478-01-3	REACT:R-HSA-168256|Immune System
478-43-3	KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
479-13-0	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-68886|M Phase;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04110|Cell cycle;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-69242|S Phase;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-1643685|Disease;KEGG:hsa03030|DNA replication;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-176187|Activation of ATR in response to replication stress;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2565942|Regulation of PLK1 Activity at G2/M Transition;REACT:R-HSA-174417|Telomere C-strand (Lagging Strand) Synthesis;REACT:R-HSA-180786|Extension of Telomeres;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-5693579|Homologous DNA Pairing and Strand Exchange;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-8854518|AURKA Activation by TPX2;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-69186|Lagging Strand Synthesis;REACT:R-HSA-5693616|Presynaptic phase of homologous DNA pairing and strand exchange;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2990846|SUMOylation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-3108232|SUMO E3 ligases SUMOylate target proteins;REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-380270|Recruitment of mitotic centrosome proteins and complexes;REACT:R-HSA-380287|Centrosome maturation;REACT:R-HSA-110373|Resolution of AP sites via the multiple-nucleotide patch replacement pathway;REACT:R-HSA-69205|G1/S-Specific Transcription;REACT:R-HSA-162587|HIV Life Cycle;REACT:R-HSA-72172|mRNA Splicing;KEGG:hsa00240|Pyrimidine metabolism;REACT:R-HSA-380284|Loss of proteins required for interphase microtubule organization from the centrosome;REACT:R-HSA-380259|Loss of Nlp from mitotic centrosomes;REACT:R-HSA-166520|Signalling by NGF
479-41-4	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
479-50-5	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-68886|M Phase;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-68882|Mitotic Anaphase;KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;REACT:R-HSA-5334118|DNA methylation;REACT:R-HSA-5625886|Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;REACT:R-HSA-3214847|HATs acetylate histones;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-427359|SIRT1 negatively regulates rRNA Expression;KEGG:hsa05034|Alcoholism;REACT:R-HSA-5625740|RHO GTPases activate PKNs;REACT:R-HSA-427389|ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-73777|RNA Polymerase I Chain Elongation;REACT:R-HSA-5250924|B-WICH complex positively regulates rRNA expression;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-3214858|RMTs methylate histone arginines;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-977225|Amyloid fiber formation;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;REACT:R-HSA-427413|NoRC negatively regulates rRNA expression;REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;REACT:R-HSA-5250941|Negative epigenetic regulation of rRNA expression;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;REACT:R-HSA-73864|RNA Polymerase I Transcription;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-171306|Packaging Of Telomere Ends;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1221632|Meiotic synapsis;REACT:R-HSA-983189|Kinesins;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-3214842|HDMs demethylate histones;REACT:R-HSA-3214841|PKMTs methylate histone lysines;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-5693571|Nonhomologous End-Joining (NHEJ);REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5693565|Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;REACT:R-HSA-5693606|DNA Double Strand Break Response;REACT:R-HSA-6811434|COPI-dependent Golgi-to-ER retrograde traffic;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2132295|MHC class II antigen presentation;REACT:R-HSA-8856688|Golgi-to-ER retrograde transport;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-69242|S Phase;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-6811442|Intra-Golgi and retrograde Golgi-to-ER traffic;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168256|Immune System;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-212436|Generic Transcription Pathway
479-66-3	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction
479-91-4	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05162|Measles;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05134|Legionellosis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04110|Cell cycle;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05164|Influenza A;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05210|Colorectal cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04211|Longevity regulating pathway
479-98-1	REACT:R-HSA-162582|Signal Transduction
480-16-0	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05210|Colorectal cancer;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05152|Tuberculosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05224|Breast cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04140|Autophagy - animal;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05162|Measles;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04510|Focal adhesion;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease
480-18-2	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
480-19-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
480-22-8	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
480-26-2	KEGG:hsa04110|Cell cycle;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases
480-40-0	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05146|Amoebiasis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04510|Focal adhesion;KEGG:hsa05162|Measles;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05134|Legionellosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05219|Bladder cancer;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa01523|Antifolate resistance;KEGG:hsa05132|Salmonella infection;KEGG:hsa05224|Breast cancer;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05144|Malaria;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05214|Glioma;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway
480-41-1	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05160|Hepatitis C;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05164|Influenza A;KEGG:hsa04931|Insulin resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01100|Metabolic pathways;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04918|Thyroid hormone synthesis;KEGG:hsa05133|Pertussis;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa05134|Legionellosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa00590|Arachidonic acid metabolism;KEGG:hsa05214|Glioma;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04510|Focal adhesion;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05224|Breast cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane
480-49-9	KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
481-39-0	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
481-42-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways
481-53-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
481-74-3	KEGG:hsa04210|Apoptosis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
481-97-0	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-425407|SLC-mediated transmembrane transport
48134-75-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05016|Huntington's disease;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa05164|Influenza A;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-68886|M Phase;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05224|Breast cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05203|Viral carcinogenesis
482-20-2	KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
482-36-0	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
483-18-1	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System
484-11-7	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
484-12-8	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-168256|Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-392499|Metabolism of proteins
484-20-8	KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
484-29-7	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
485-49-4	KEGG:hsa05033|Nicotine addiction;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-162582|Signal Transduction
485-72-3	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
486-39-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
486-56-6	KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
486-66-8	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05133|Pertussis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05215|Prostate cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05224|Breast cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05162|Measles;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04925|Aldosterone synthesis and secretion;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05134|Legionellosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa05132|Salmonella infection;KEGG:hsa05214|Glioma;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa00830|Retinol metabolism;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04658|Th1 and Th2 cell differentiation
487-26-3	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
487-52-5	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
487-79-6	KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05033|Nicotine addiction;KEGG:hsa05133|Pertussis;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05034|Alcoholism;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05134|Legionellosis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-442755|Activation of NMDA receptor upon glutamate binding and postsynaptic events;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05164|Influenza A;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04720|Long-term potentiation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2682334|EPH-Ephrin signaling
487-94-5	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism
489-32-7	KEGG:hsa05140|Leishmaniasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
490-91-5	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;KEGG:hsa05134|Legionellosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05224|Breast cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05146|Amoebiasis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05218|Melanoma;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa05132|Salmonella infection;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05160|Hepatitis C;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05016|Huntington's disease
491-67-8	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05224|Breast cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05219|Bladder cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05214|Glioma;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05164|Influenza A;KEGG:hsa05160|Hepatitis C;KEGG:hsa05146|Amoebiasis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05162|Measles;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05218|Melanoma;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05133|Pertussis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-5663202|Diseases of signal transduction
491-70-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa05219|Bladder cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05134|Legionellosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05144|Malaria;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05218|Melanoma;KEGG:hsa05213|Endometrial cancer
491-78-1	REACT:R-HSA-1430728|Metabolism
491-80-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins
49562-28-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05200|Pathways in cancer;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04931|Insulin resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa04976|Bile secretion;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04146|Peroxisome;KEGG:hsa01200|Carbon metabolism;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa_M00087|beta-Oxidation;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-174824|Lipoprotein metabolism;REACT:R-HSA-1643685|Disease;KEGG:hsa00280|Valine, leucine and isoleucine degradation;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05146|Amoebiasis;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-77289|Mitochondrial Fatty Acid Beta-Oxidation;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-193368|Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;KEGG:hsa04216|Ferroptosis;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04210|Apoptosis;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa00590|Arachidonic acid metabolism;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa00640|Propanoate metabolism;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-5362517|Signaling by Retinoic Acid;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-75109|Triglyceride Biosynthesis;REACT:R-HSA-192105|Synthesis of bile acids and bile salts;KEGG:hsa02010|ABC transporters;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer
4964-14-1	KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
497-76-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-392499|Metabolism of proteins
49776-64-9	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System
498-02-2	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05144|Malaria;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa04611|Platelet activation;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05134|Legionellosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04540|Gap junction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04623|Cytosolic DNA-sensing pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04145|Phagosome;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa05162|Measles;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade
499-75-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
50-00-0	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05164|Influenza A;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04210|Apoptosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05162|Measles;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05152|Tuberculosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-212165|Epigenetic regulation of gene expression;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-68886|M Phase;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05034|Alcoholism;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-195258|RHO GTPase Effectors
50-02-2	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04210|Apoptosis;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05161|Hepatitis B;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis
50-06-6	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-68886|M Phase;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-69242|S Phase;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa04110|Cell cycle;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN
50-07-7	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05215|Prostate cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05020|Prion diseases;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05218|Melanoma;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa05134|Legionellosis;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-68886|M Phase;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-73933|Resolution of Abasic Sites (AP sites);REACT:R-HSA-73884|Base Excision Repair;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa05162|Measles;KEGG:hsa05214|Glioma;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-69306|DNA Replication;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;KEGG:hsa05202|Transcriptional misregulation in cancer
50-18-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05162|Measles;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1643685|Disease;KEGG:hsa05134|Legionellosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05132|Salmonella infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-73894|DNA Repair;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05219|Bladder cancer;KEGG:hsa05144|Malaria;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04612|Antigen processing and presentation;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05330|Allograft rejection;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-177929|Signaling by EGFR
50-21-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-68886|M Phase;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-6809371|Formation of the cornified envelope;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-6805567|Keratinization;REACT:R-HSA-427413|NoRC negatively regulates rRNA expression;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-5250941|Negative epigenetic regulation of rRNA expression;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04144|Endocytosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-73777|RNA Polymerase I Chain Elongation;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;REACT:R-HSA-3214847|HATs acetylate histones;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5250924|B-WICH complex positively regulates rRNA expression;REACT:R-HSA-73864|RNA Polymerase I Transcription;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5625740|RHO GTPases activate PKNs;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5625886|Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling
50-22-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04110|Cell cycle;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04931|Insulin resistance;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05133|Pertussis;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05224|Breast cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-69242|S Phase;KEGG:hsa05214|Glioma;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04960|Aldosterone-regulated sodium reabsorption;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05162|Measles;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane
50-23-7	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05144|Malaria;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05164|Influenza A;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05132|Salmonella infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05133|Pertussis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05162|Measles;KEGG:hsa05215|Prostate cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04940|Type I diabetes mellitus;REACT:R-HSA-196071|Metabolism of steroid hormones;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04960|Aldosterone-regulated sodium reabsorption;KEGG:hsa05330|Allograft rejection;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-2980736|Peptide hormone metabolism;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04210|Apoptosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-375276|Peptide ligand-binding receptors
50-24-8	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05162|Measles;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05134|Legionellosis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05144|Malaria;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;KEGG:hsa04510|Focal adhesion;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04210|Apoptosis;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2172127|DAP12 interactions
50-27-1	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05133|Pertussis;KEGG:hsa_M00014|Glucuronate pathway (uronate pathway);KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa00040|Pentose and glucuronate interconversions;KEGG:hsa05161|Hepatitis B;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05164|Influenza A;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-166520|Signalling by NGF
50-28-2	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04210|Apoptosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04360|Axon guidance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05224|Breast cancer;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04530|Tight junction;KEGG:hsa05164|Influenza A
50-29-3	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05164|Influenza A;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05133|Pertussis;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04110|Cell cycle;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05134|Legionellosis
50-32-8	REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-68886|M Phase;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;KEGG:hsa04144|Endocytosis;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04360|Axon guidance;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05203|Viral carcinogenesis
50-33-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
50-35-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05224|Breast cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04510|Focal adhesion;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa05218|Melanoma;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05152|Tuberculosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa05162|Measles;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05144|Malaria;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05210|Colorectal cancer
50-36-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04360|Axon guidance;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04210|Apoptosis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04713|Circadian entrainment;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-2682334|EPH-Ephrin signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04720|Long-term potentiation;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-3928665|EPH-ephrin mediated repulsion of cells;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-442755|Activation of NMDA receptor upon glutamate binding and postsynaptic events;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04915|Estrogen signaling pathway
50-47-5	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
50-48-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05133|Pertussis;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-168256|Immune System;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR
50-49-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules
50-50-0	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05161|Hepatitis B;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168256|Immune System;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05218|Melanoma;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05214|Glioma;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04540|Gap junction;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05034|Alcoholism;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04510|Focal adhesion;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1643685|Disease
50-52-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
50-53-3	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04976|Bile secretion;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa02010|ABC transporters;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05219|Bladder cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04110|Cell cycle;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa01523|Antifolate resistance;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04210|Apoptosis;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04216|Ferroptosis;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05133|Pertussis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-70326|Glucose metabolism;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04931|Insulin resistance;KEGG:hsa00010|Glycolysis / Gluconeogenesis;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05218|Melanoma;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK
50-55-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05034|Alcoholism;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa01522|Endocrine resistance;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04923|Regulation of lipolysis in adipocytes;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05012|Parkinson's disease;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis
50-56-6	KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
50-59-9	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-69242|S Phase;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04110|Cell cycle;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa03030|DNA replication;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-69205|G1/S-Specific Transcription;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-176187|Activation of ATR in response to replication stress;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-180786|Extension of Telomeres;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-68886|M Phase;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109582|Hemostasis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);REACT:R-HSA-68867|Assembly of the pre-replicative complex;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa05164|Influenza A;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-68882|Mitotic Anaphase;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-211859|Biological oxidations
50-60-2	REACT:R-HSA-162582|Signal Transduction
50-63-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
50-65-7	REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05224|Breast cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05160|Hepatitis C;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-72172|mRNA Splicing;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa04510|Focal adhesion;KEGG:hsa05218|Melanoma;KEGG:hsa05164|Influenza A;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05219|Bladder cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05323|Rheumatoid arthritis
50-67-9	KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-375280|Amine ligand-binding receptors;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05034|Alcoholism;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis
50-70-4	KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
50-71-5	KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05016|Huntington's disease;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology
50-76-0	REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05152|Tuberculosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05219|Bladder cancer;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04510|Focal adhesion;KEGG:hsa05162|Measles;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04140|Autophagy - animal;KEGG:hsa05133|Pertussis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05224|Breast cancer;KEGG:hsa05211|Renal cell carcinoma;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05218|Melanoma;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation
50-78-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05162|Measles;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04510|Focal adhesion;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05219|Bladder cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04110|Cell cycle;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04611|Platelet activation;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05144|Malaria
50-81-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05215|Prostate cancer;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04510|Focal adhesion;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04110|Cell cycle;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05164|Influenza A;KEGG:hsa05162|Measles;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05144|Malaria;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05133|Pertussis;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells
50-89-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05012|Parkinson's disease;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05016|Huntington's disease;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa05161|Hepatitis B;KEGG:hsa05162|Measles;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-909733|Interferon alpha/beta signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-6799198|Complex I biogenesis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04260|Cardiac muscle contraction;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa_M00154|Cytochrome c oxidase;REACT:R-HSA-352230|Amino acid transport across the plasma membrane;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa02010|ABC transporters;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;KEGG:hsa05219|Bladder cancer;KEGG:hsa04931|Insulin resistance;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-425397|Transport of vitamins, nucleosides, and related molecules;REACT:R-HSA-877300|Interferon gamma signaling;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa05215|Prostate cancer;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-69231|Cyclin D associated events in G1;REACT:R-HSA-69236|G1 Phase;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa01523|Antifolate resistance;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD)
50-91-9	REACT:R-HSA-73894|DNA Repair;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System
50-99-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-72766|Translation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05133|Pertussis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05164|Influenza A;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-156902|Peptide chain elongation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-192823|Viral mRNA Translation;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2408557|Selenocysteine synthesis;KEGG:hsa05146|Amoebiasis;KEGG:hsa04611|Platelet activation;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa_M00177|Ribosome, eukaryotes
500-44-7	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
500-85-6	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System
501-30-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04110|Cell cycle;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05224|Breast cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-3371556|Cellular response to heat stress;KEGG:hsa05160|Hepatitis C;KEGG:hsa04916|Melanogenesis;KEGG:hsa05162|Measles;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-199991|Membrane Trafficking
502-65-8	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-936837|Ion transport by P-type ATPases;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-5578775|Ion homeostasis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05133|Pertussis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05152|Tuberculosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04972|Pancreatic secretion;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05214|Glioma;KEGG:hsa05224|Breast cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05219|Bladder cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04970|Salivary secretion;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04960|Aldosterone-regulated sodium reabsorption;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05134|Legionellosis;KEGG:hsa05162|Measles;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;REACT:R-HSA-1643685|Disease;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa04961|Endocrine and other factor-regulated calcium reabsorption;KEGG:hsa05144|Malaria;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04978|Mineral absorption;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-74160|Gene Expression
50264-69-2	KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction
504-20-1	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
504-24-5	KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
504-88-1	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05016|Huntington's disease;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
50471-44-8	REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04530|Tight junction;REACT:R-HSA-72172|mRNA Splicing;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-1483257|Phospholipid metabolism;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04144|Endocytosis;REACT:R-HSA-72766|Translation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04066|HIF-1 signaling pathway
505-57-7	REACT:R-HSA-1430728|Metabolism
505-60-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04210|Apoptosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05164|Influenza A;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05152|Tuberculosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04110|Cell cycle;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05146|Amoebiasis;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05133|Pertussis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05140|Leishmaniasis
50585-41-6	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa01200|Carbon metabolism;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
50679-08-8	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05133|Pertussis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
50700-49-7	REACT:R-HSA-168256|Immune System
50700-72-6	KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
5072-26-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05133|Pertussis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05162|Measles;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05134|Legionellosis;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05160|Hepatitis C;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-72766|Translation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168254|Influenza Infection
50722-38-8	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
50773-42-7	REACT:R-HSA-168256|Immune System
508-02-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05164|Influenza A;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05152|Tuberculosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05162|Measles;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1643685|Disease;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05133|Pertussis;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05160|Hepatitis C;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05224|Breast cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04930|Type II diabetes mellitus;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05134|Legionellosis;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade
508-59-8	KEGG:hsa04210|Apoptosis
50892-23-4	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-68886|M Phase;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-69242|S Phase;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-69002|DNA Replication Pre-Initiation
51-03-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1643685|Disease;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69242|S Phase;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-5632684|Hedgehog 'on' state;REACT:R-HSA-68867|Assembly of the pre-replicative complex;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-350562|Regulation of ornithine decarboxylase (ODC);REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;KEGG:hsa03050|Proteasome;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5387390|Hh mutants abrogate ligand secretion;REACT:R-HSA-174178|APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-68886|M Phase;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-69541|Stabilization of p53;REACT:R-HSA-174113|SCF-beta-TrCP mediated degradation of Emi1;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-5358346|Hedgehog ligand biogenesis;REACT:R-HSA-174154|APC/C:Cdc20 mediated degradation of Securin;REACT:R-HSA-5362768|Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;REACT:R-HSA-5658442|Regulation of RAS by GAPs;REACT:R-HSA-68827|CDT1 association with the CDC6:ORC:origin complex;REACT:R-HSA-1236978|Cross-presentation of soluble exogenous antigens (endosomes);REACT:R-HSA-211733|Regulation of activated PAK-2p34 by proteasome mediated degradation;REACT:R-HSA-5610780|Degradation of GLI1 by the proteasome;REACT:R-HSA-69017|CDK-mediated phosphorylation and removal of Cdc6;REACT:R-HSA-174184|Cdc20:Phospho-APC/C mediated degradation of Cyclin A;REACT:R-HSA-180534|Vpu mediated degradation of CD4;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-179419|APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;REACT:R-HSA-69610|p53-Independent DNA Damage Response;REACT:R-HSA-69613|p53-Independent G1/S DNA damage checkpoint;REACT:R-HSA-69601|Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;REACT:R-HSA-169911|Regulation of Apoptosis;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-8854050|FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;REACT:R-HSA-4641257|Degradation of AXIN;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5358351|Signaling by Hedgehog;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-4641258|Degradation of DVL;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-4086400|PCP/CE pathway;REACT:R-HSA-5676590|NIK-->noncanonical NF-kB signaling;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-5610785|GLI3 is processed to GLI3R by the proteasome;REACT:R-HSA-5610783|Degradation of GLI2 by the proteasome;REACT:R-HSA-5607761|Dectin-1 mediated noncanonical NF-kB signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade
51-21-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05224|Breast cancer;REACT:R-HSA-69242|S Phase;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05134|Legionellosis;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-15869|Metabolism of nucleotides;KEGG:hsa05218|Melanoma;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-69306|DNA Replication;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-113510|E2F mediated regulation of DNA replication;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-180292|GAB1 signalosome
51-28-5	REACT:R-HSA-1430728|Metabolism
51-41-2	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05146|Amoebiasis;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05030|Cocaine addiction;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-375280|Amine ligand-binding receptors;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05164|Influenza A;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05132|Salmonella infection;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05034|Alcoholism;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05020|Prion diseases;KEGG:hsa05134|Legionellosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04930|Type II diabetes mellitus;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05160|Hepatitis C;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05224|Breast cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane
51-43-4	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-418597|G alpha (z) signalling events;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-163685|Integration of energy metabolism;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-111885|Opioid Signalling;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04923|Regulation of lipolysis in adipocytes;REACT:R-HSA-422356|Regulation of insulin secretion;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-373080|Class B/2 (Secretin family receptors);REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-418346|Platelet homeostasis;KEGG:hsa05032|Morphine addiction;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05034|Alcoholism;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04931|Insulin resistance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04611|Platelet activation;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1643685|Disease;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6798695|Neutrophil degranulation
51-45-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05132|Salmonella infection;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05144|Malaria;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05134|Legionellosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04931|Insulin resistance;KEGG:hsa05330|Allograft rejection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05160|Hepatitis C;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5663202|Diseases of signal transduction
51-52-5	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1643685|Disease;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04360|Axon guidance;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-1296071|Potassium Channels;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04110|Cell cycle;KEGG:hsa05224|Breast cancer;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-195258|RHO GTPase Effectors
51-55-8	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04110|Cell cycle;KEGG:hsa05164|Influenza A;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04510|Focal adhesion;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04210|Apoptosis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05224|Breast cancer;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules
51-61-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1643685|Disease;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa05134|Legionellosis;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-109582|Hemostasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05034|Alcoholism;REACT:R-HSA-375280|Amine ligand-binding receptors;KEGG:hsa05016|Huntington's disease;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04931|Insulin resistance;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05162|Measles;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04137|Mitophagy - animal;REACT:R-HSA-112310|Neurotransmitter Release Cycle;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-74752|Signaling by Insulin receptor
51-64-9	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-422475|Axon guidance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05034|Alcoholism;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05161|Hepatitis B;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway
51-67-2	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR
51-71-8	REACT:R-HSA-1430728|Metabolism
51-79-6	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04110|Cell cycle;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05224|Breast cancer;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05219|Bladder cancer;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04210|Apoptosis;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-179812|GRB2 events in EGFR signaling
51-84-3	KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-622327|Postsynaptic nicotinic acetylcholine receptors;REACT:R-HSA-181431|Acetylcholine Binding And Downstream Events;REACT:R-HSA-629602|Activation of Nicotinic Acetylcholine Receptors;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-622323|Presynaptic nicotinic acetylcholine receptors;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-422475|Axon guidance
51012-32-9	KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
51037-30-0	REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-71406|Pyruvate metabolism and Citric Acid (TCA) cycle;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05016|Huntington's disease;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05012|Parkinson's disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05010|Alzheimer's disease
5104-49-4	REACT:R-HSA-168256|Immune System;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa_M00014|Glucuronate pathway (uronate pathway);KEGG:hsa00053|Ascorbate and aldarate metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00040|Pentose and glucuronate interconversions;KEGG:hsa05140|Leishmaniasis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;KEGG:hsa00983|Drug metabolism - other enzymes;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa00830|Retinol metabolism;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04370|VEGF signaling pathway;REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa05164|Influenza A;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280218|Adaptive Immune System
51110-01-1	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System
5119-48-2	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression
512-04-9	KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-73887|Death Receptor Signalling;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04931|Insulin resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04976|Bile secretion;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05162|Measles;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05132|Salmonella infection;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR)
51207-31-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5576891|Cardiac conduction;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-390522|Striated Muscle Contraction;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04360|Axon guidance;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-6794362|Protein-protein interactions at synapses;KEGG:hsa05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC);REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa04720|Long-term potentiation;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-373760|L1CAM interactions;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04976|Bile secretion;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04727|GABAergic synapse;REACT:R-HSA-112310|Neurotransmitter Release Cycle;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade
51218-45-2	REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-156902|Peptide chain elongation;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-72766|Translation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa03010|Ribosome;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways
51333-22-3	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05134|Legionellosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins
514-85-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
5142-23-4	KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05164|Influenza A;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1632852|Macroautophagy;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05215|Prostate cancer;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05012|Parkinson's disease;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05160|Hepatitis C;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism
51481-10-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05152|Tuberculosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05160|Hepatitis C;KEGG:hsa05133|Pertussis;KEGG:hsa05162|Measles;KEGG:hsa05134|Legionellosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-380108|Chemokine receptors bind chemokines;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05144|Malaria;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05205|Proteoglycans in cancer
51481-61-9	REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05134|Legionellosis;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-168256|Immune System;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;KEGG:hsa05144|Malaria;KEGG:hsa05133|Pertussis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04151|PI3K-Akt signaling pathway
516-35-8	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04931|Insulin resistance;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;KEGG:hsa05133|Pertussis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05162|Measles;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05146|Amoebiasis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05224|Breast cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04060|Cytokine-cytokine receptor interaction
516-50-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05133|Pertussis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05164|Influenza A;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05162|Measles;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-382551|Transmembrane transport of small molecules
516-90-5	REACT:R-HSA-162582|Signal Transduction
51630-58-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04210|Apoptosis;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-168256|Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-392499|Metabolism of proteins
517-09-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System
518-28-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;KEGG:hsa04110|Cell cycle;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05224|Breast cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05219|Bladder cancer;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04510|Focal adhesion;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05164|Influenza A;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05214|Glioma;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5633007|Regulation of TP53 Activity
518-34-3	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05215|Prostate cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05213|Endometrial cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1643685|Disease;KEGG:hsa05133|Pertussis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05164|Influenza A;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05160|Hepatitis C;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05146|Amoebiasis;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05162|Measles;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic
518-75-2	KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04110|Cell cycle;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF
518-82-1	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05215|Prostate cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05162|Measles;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05146|Amoebiasis;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05224|Breast cancer;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05020|Prion diseases;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04370|VEGF signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05132|Salmonella infection;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05219|Bladder cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04931|Insulin resistance;KEGG:hsa05214|Glioma;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04976|Bile secretion
51803-78-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-72766|Translation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-69242|S Phase;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa03010|Ribosome;REACT:R-HSA-69300|Removal of licensing factors from origins;KEGG:hsa03050|Proteasome;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-5610785|GLI3 is processed to GLI3R by the proteasome;REACT:R-HSA-5610783|Degradation of GLI2 by the proteasome;REACT:R-HSA-5607761|Dectin-1 mediated noncanonical NF-kB signaling;REACT:R-HSA-174113|SCF-beta-TrCP mediated degradation of Emi1;REACT:R-HSA-8854050|FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-350562|Regulation of ornithine decarboxylase (ODC);REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-180534|Vpu mediated degradation of CD4;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-195253|Degradation of beta-catenin by the destruction complex;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-5676590|NIK-->noncanonical NF-kB signaling;REACT:R-HSA-5610780|Degradation of GLI1 by the proteasome;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-174184|Cdc20:Phospho-APC/C mediated degradation of Cyclin A;REACT:R-HSA-69541|Stabilization of p53;REACT:R-HSA-1236978|Cross-presentation of soluble exogenous antigens (endosomes);REACT:R-HSA-211733|Regulation of activated PAK-2p34 by proteasome mediated degradation;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-179419|APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;REACT:R-HSA-174154|APC/C:Cdc20 mediated degradation of Securin;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;REACT:R-HSA-69017|CDK-mediated phosphorylation and removal of Cdc6;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-68867|Assembly of the pre-replicative complex;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-4641258|Degradation of DVL;REACT:R-HSA-69610|p53-Independent DNA Damage Response;REACT:R-HSA-69613|p53-Independent G1/S DNA damage checkpoint;REACT:R-HSA-69601|Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;REACT:R-HSA-169911|Regulation of Apoptosis;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-174178|APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-4641257|Degradation of AXIN;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-5678895|Defective CFTR causes cystic fibrosis;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-5619115|Disorders of transmembrane transporters;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol
519-02-8	KEGG:hsa05210|Colorectal cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
519-23-3	KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism
52-01-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05146|Amoebiasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-392499|Metabolism of proteins
52-24-4	REACT:R-HSA-1430728|Metabolism
52-39-1	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04960|Aldosterone-regulated sodium reabsorption;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05164|Influenza A;KEGG:hsa05146|Amoebiasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR
52-53-9	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05133|Pertussis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
52-67-5	REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa05133|Pertussis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05162|Measles;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05134|Legionellosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1643685|Disease;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05132|Salmonella infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05020|Prion diseases;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04612|Antigen processing and presentation;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System
52-86-8	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05034|Alcoholism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-1643685|Disease;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04720|Long-term potentiation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05161|Hepatitis B;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-111885|Opioid Signalling;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-442755|Activation of NMDA receptor upon glutamate binding and postsynaptic events;KEGG:hsa04916|Melanogenesis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04611|Platelet activation;KEGG:hsa04915|Estrogen signaling pathway
52-90-4	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05164|Influenza A;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05162|Measles;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04510|Focal adhesion;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04110|Cell cycle;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05133|Pertussis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05134|Legionellosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05160|Hepatitis C;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04152|AMPK signaling pathway
520-18-3	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1430728|Metabolism;KEGG:hsa05152|Tuberculosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05162|Measles;KEGG:hsa05215|Prostate cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05134|Legionellosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05144|Malaria;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05211|Renal cell carcinoma;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168643|Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05146|Amoebiasis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04510|Focal adhesion;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05224|Breast cancer;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-450294|MAP kinase activation in TLR cascade
520-26-3	KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05133|Pertussis;KEGG:hsa05162|Measles;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05160|Hepatitis C;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05134|Legionellosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04930|Type II diabetes mellitus;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa05224|Breast cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System
520-27-4	REACT:R-HSA-168256|Immune System
520-33-2	KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05140|Leishmaniasis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05215|Prostate cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05133|Pertussis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways
520-34-3	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
520-36-5	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05134|Legionellosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05162|Measles;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05133|Pertussis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05144|Malaria;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05132|Salmonella infection;KEGG:hsa05016|Huntington's disease;KEGG:hsa05215|Prostate cancer;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05219|Bladder cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-168643|Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane
520-85-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa04510|Focal adhesion;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05152|Tuberculosis;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-422475|Axon guidance;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05144|Malaria;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-216083|Integrin cell surface interactions;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05164|Influenza A;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05134|Legionellosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05162|Measles;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04659|Th17 cell differentiation
5205-32-3	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease
521-18-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05224|Breast cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa04110|Cell cycle;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04520|Adherens junction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-381070|IRE1alpha activates chaperones;KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05164|Influenza A;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa00100|Steroid biosynthesis;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-381038|XBP1(S) activates chaperone genes;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05152|Tuberculosis
521-61-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
522-12-3	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04520|Adherens junction;KEGG:hsa04612|Antigen processing and presentation;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa05162|Measles;KEGG:hsa04530|Tight junction;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa05146|Amoebiasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-202403|TCR signaling;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-202424|Downstream TCR signaling;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04144|Endocytosis;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5663205|Infectious disease
522-17-8	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05224|Breast cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-1643685|Disease;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05164|Influenza A;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05218|Melanoma;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05152|Tuberculosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05211|Renal cell carcinoma;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04916|Melanogenesis;KEGG:hsa05162|Measles;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04520|Adherens junction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05217|Basal cell carcinoma;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa_M00677|Wnt signaling;REACT:R-HSA-195721|Signaling by Wnt
52214-84-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04146|Peroxisome;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction
52286-59-6	KEGG:hsa04931|Insulin resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05133|Pertussis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05162|Measles;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease
523-50-2	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism
52315-07-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-73894|DNA Repair;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1643685|Disease;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05133|Pertussis;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05214|Glioma;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05164|Influenza A;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05134|Legionellosis;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2424491|DAP12 signaling
524-12-9	KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
524-42-5	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
52485-79-7	REACT:R-HSA-162582|Signal Transduction
525-66-6	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04931|Insulin resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-199991|Membrane Trafficking
525-72-4	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System
525-82-6	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction
5250-39-5	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins
526-95-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
52645-53-1	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-168256|Immune System;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05020|Prion diseases;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1643685|Disease;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05146|Amoebiasis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04146|Peroxisome;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa00830|Retinol metabolism;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa00590|Arachidonic acid metabolism;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes
52665-69-7	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04664|Fc epsilon RI signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05132|Salmonella infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa01522|Endocrine resistance;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04370|VEGF signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05020|Prion diseases;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05162|Measles;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade
52665-74-4	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04510|Focal adhesion;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression
528-43-8	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology
528-48-3	KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05134|Legionellosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05162|Measles;REACT:R-HSA-1643685|Disease;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05132|Salmonella infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05224|Breast cancer;REACT:R-HSA-392499|Metabolism of proteins
52806-53-8	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
52820-00-5	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-5576892|Phase 0 - rapid depolarisation;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-373760|L1CAM interactions;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-5576891|Cardiac conduction;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05164|Influenza A;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05034|Alcoholism;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-372790|Signaling by GPCR
529-44-2	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05219|Bladder cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05211|Renal cell carcinoma;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05152|Tuberculosis;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05160|Hepatitis C;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05224|Breast cancer;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05418|Fluid shear stress and atherosclerosis
529-59-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System
53-03-2	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression
53-06-5	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
53-16-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-196071|Metabolism of steroid hormones;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa00040|Pentose and glucuronate interconversions;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa_M00014|Glucuronate pathway (uronate pathway);KEGG:hsa04976|Bile secretion;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05215|Prostate cancer;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05224|Breast cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa00983|Drug metabolism - other enzymes;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04923|Regulation of lipolysis in adipocytes;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-168256|Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05218|Melanoma;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04931|Insulin resistance;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK
53-19-0	KEGG:hsa04210|Apoptosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-196071|Metabolism of steroid hormones;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01100|Metabolic pathways;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology
53-43-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05160|Hepatitis C;KEGG:hsa05219|Bladder cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05214|Glioma;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05218|Melanoma;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05224|Breast cancer;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04976|Bile secretion;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1643685|Disease;KEGG:hsa04931|Insulin resistance;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05164|Influenza A;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05162|Measles;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05016|Huntington's disease;KEGG:hsa04921|Oxytocin signaling pathway
53-59-8	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-162582|Signal Transduction
53-70-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04110|Cell cycle;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-68886|M Phase;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04360|Axon guidance;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05218|Melanoma;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05219|Bladder cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04976|Bile secretion;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade
53-79-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05146|Amoebiasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05100|Bacterial invasion of epithelial cells;KEGG:hsa04530|Tight junction;KEGG:hsa05164|Influenza A;KEGG:hsa05132|Salmonella infection;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04611|Platelet activation;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa05131|Shigellosis;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2682334|EPH-Ephrin signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-2980736|Peptide hormone metabolism;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04360|Axon guidance;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-186763|Downstream signal transduction
53-84-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
53-85-0	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism
53-86-1	REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-72766|Translation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa03010|Ribosome;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-72312|rRNA processing;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-156842|Eukaryotic Translation Elongation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-72764|Eukaryotic Translation Termination;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05134|Legionellosis
53-96-3	KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04110|Cell cycle;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04210|Apoptosis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05162|Measles;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05164|Influenza A;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05224|Breast cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05160|Hepatitis C;KEGG:hsa05214|Glioma;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05218|Melanoma;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa01523|Antifolate resistance;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05133|Pertussis;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04623|Cytosolic DNA-sensing pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69231|Cyclin D associated events in G1;REACT:R-HSA-69236|G1 Phase;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04216|Ferroptosis;KEGG:hsa05134|Legionellosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-8848021|Signaling by PTK6;KEGG:hsa04622|RIG-I-like receptor signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;KEGG:hsa05221|Acute myeloid leukemia
530-78-9	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
5300-03-8	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04930|Type II diabetes mellitus;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04210|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05218|Melanoma;REACT:R-HSA-5362517|Signaling by Retinoic Acid;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05164|Influenza A;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05224|Breast cancer;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05133|Pertussis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05214|Glioma;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05144|Malaria;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-6805567|Keratinization;KEGG:hsa05204|Chemical carcinogenesis
53003-10-4	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05161|Hepatitis B;KEGG:hsa04510|Focal adhesion;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05164|Influenza A;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-68886|M Phase;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-109582|Hemostasis
53005-05-3	KEGG:hsa04210|Apoptosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05164|Influenza A;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction
5307-14-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
531-95-3	KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System
53123-88-9	REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1643685|Disease;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05218|Melanoma;KEGG:hsa05214|Glioma;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05162|Measles;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04213|Longevity regulating pathway - multiple species;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04917|Prolactin signaling pathway
5315-79-7	KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00830|Retinol metabolism;KEGG:hsa00983|Drug metabolism - other enzymes;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
53177-12-1	KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction
53179-13-8	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
53209-27-1	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
53230-10-7	REACT:R-HSA-1430728|Metabolism
53237-59-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways
533-31-3	REACT:R-HSA-168256|Immune System
533-45-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology
533-73-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05134|Legionellosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression
533-75-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05130|Pathogenic Escherichia coli infection;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04145|Phagosome;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-72766|Translation;KEGG:hsa04540|Gap junction;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-72312|rRNA processing;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-8856828|Clathrin-mediated endocytosis;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa03010|Ribosome;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05416|Viral myocarditis;REACT:R-HSA-391251|Protein folding;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1236974|ER-Phagosome pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2682334|EPH-Ephrin signaling;REACT:R-HSA-390466|Chaperonin-mediated protein folding;REACT:R-HSA-373760|L1CAM interactions;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-195258|RHO GTPase Effectors
53468-06-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System
535-83-1	REACT:R-HSA-168256|Immune System
5351-17-7	REACT:R-HSA-168256|Immune System
536-33-4	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
536-59-4	KEGG:hsa05161|Hepatitis B;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
536-69-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
536-71-0	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
53678-77-6	KEGG:hsa05134|Legionellosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05164|Influenza A;KEGG:hsa05133|Pertussis;KEGG:hsa05144|Malaria;KEGG:hsa05132|Salmonella infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05146|Amoebiasis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05162|Measles;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-162582|Signal Transduction
537-15-5	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05133|Pertussis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05164|Influenza A;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology
537-46-2	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04144|Endocytosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05164|Influenza A;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04727|GABAergic synapse;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-388396|GPCR downstream signaling
53714-56-0	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
53716-50-0	REACT:R-HSA-1430728|Metabolism
5392-40-5	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
54-05-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04210|Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05160|Hepatitis C;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05134|Legionellosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04622|RIG-I-like receptor signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05215|Prostate cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways;REACT:R-HSA-5260271|Diseases of Immune System;REACT:R-HSA-5602358|Diseases associated with the TLR signaling cascade;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-5357769|Caspase activation via extrinsic apoptotic signalling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-933542|TRAF6 mediated NF-kB activation;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04623|Cytosolic DNA-sensing pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa_M00686|Toll-like receptor signaling;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions
54-21-7	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa05134|Legionellosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05132|Salmonella infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04931|Insulin resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology
54-31-9	KEGG:hsa04210|Apoptosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5669034|TNFs bind their physiological receptors;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05144|Malaria;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04144|Endocytosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1430728|Metabolism
54-36-4	REACT:R-HSA-196071|Metabolism of steroid hormones;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
54-47-7	REACT:R-HSA-162582|Signal Transduction
54-62-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa05162|Measles;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-198203|PI3K/AKT activation
54-64-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-70326|Glucose metabolism;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;KEGG:hsa05164|Influenza A;REACT:R-HSA-70171|Glycolysis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05161|Hepatitis B;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa_M00001|Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2586552|Signaling by Leptin
54-85-3	KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-6799198|Complex I biogenesis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05133|Pertussis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05162|Measles;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05164|Influenza A;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1643685|Disease;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules
54-95-5	KEGG:hsa03010|Ribosome;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-72766|Translation;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-1643685|Disease;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-5419276|Mitochondrial translation termination;REACT:R-HSA-5368287|Mitochondrial translation;REACT:R-HSA-5368286|Mitochondrial translation initiation;REACT:R-HSA-5389840|Mitochondrial translation elongation;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa03013|RNA transport;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-5653656|Vesicle-mediated transport
540-61-4	KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
540-73-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05224|Breast cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05218|Melanoma;KEGG:hsa05146|Amoebiasis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04210|Apoptosis;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05162|Measles;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-8853659|RET signaling
54024-22-5	KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-140875|Common Pathway of Fibrin Clot Formation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-372790|Signaling by GPCR
541-09-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2029480|Fcgamma receptor (FCGR) dependent phagocytosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04144|Endocytosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-8856828|Clathrin-mediated endocytosis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-112316|Neuronal System
542-78-9	REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05146|Amoebiasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins
543-90-8	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05215|Prostate cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05016|Huntington's disease;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05020|Prion diseases;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05133|Pertussis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05214|Glioma;KEGG:hsa05218|Melanoma;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05224|Breast cancer;KEGG:hsa04110|Cell cycle;KEGG:hsa05146|Amoebiasis;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling
545-47-1	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
545-55-1	REACT:R-HSA-1430728|Metabolism
546-43-0	KEGG:hsa04210|Apoptosis
54724-00-4	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05144|Malaria;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05164|Influenza A;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05133|Pertussis;KEGG:hsa05134|Legionellosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05146|Amoebiasis;KEGG:hsa04210|Apoptosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology
548-83-4	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa00830|Retinol metabolism;KEGG:hsa05224|Breast cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways
54910-89-3	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04713|Circadian entrainment;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa05133|Pertussis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05215|Prostate cancer;KEGG:hsa05224|Breast cancer;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-111885|Opioid Signalling;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05164|Influenza A;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05034|Alcoholism;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04210|Apoptosis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04540|Gap junction;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04730|Long-term depression;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04925|Aldosterone synthesis and secretion;KEGG:hsa04110|Cell cycle;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-157118|Signaling by NOTCH;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04068|FoxO signaling pathway
54952-43-1	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05200|Pathways in cancer;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
54965-21-8	KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
55-18-5	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05164|Influenza A;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04510|Focal adhesion;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis
55-63-0	REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-418346|Platelet homeostasis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05133|Pertussis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
55-91-4	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR
55-98-1	KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-392499|Metabolism of proteins
550-24-3	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
55079-83-9	KEGG:hsa05161|Hepatitis B;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
5508-58-7	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05166|HTLV-I infection;KEGG:hsa05164|Influenza A;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04510|Focal adhesion;KEGG:hsa04110|Cell cycle;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-1430728|Metabolism;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05152|Tuberculosis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05224|Breast cancer;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-1643685|Disease;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-422475|Axon guidance
55097-80-8	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1643685|Disease;REACT:R-HSA-68886|M Phase;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69242|S Phase;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-2990846|SUMOylation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-3108232|SUMO E3 ligases SUMOylate target proteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa03013|RNA transport;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs
551-06-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1643685|Disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5663220|RHO GTPases Activate Formins;KEGG:hsa04976|Bile secretion;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-216083|Integrin cell surface interactions;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-68886|M Phase;KEGG:hsa05133|Pertussis;KEGG:hsa04510|Focal adhesion;KEGG:hsa05146|Amoebiasis;KEGG:hsa04210|Apoptosis;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04145|Phagosome;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05132|Salmonella infection;KEGG:hsa05152|Tuberculosis;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-191273|Cholesterol biosynthesis;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa05164|Influenza A;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-2022090|Assembly of collagen fibrils and other multimeric structures;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05134|Legionellosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway
551-08-6	KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04110|Cell cycle;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-69242|S Phase;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01100|Metabolic pathways
551-11-1	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05133|Pertussis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05132|Salmonella infection;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05160|Hepatitis C;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa05162|Measles;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04510|Focal adhesion;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling
55142-85-3	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease
552-30-7	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-68886|M Phase;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-69242|S Phase;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-1643685|Disease;KEGG:hsa04110|Cell cycle;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);KEGG:hsa03030|DNA replication;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-68962|Activation of the pre-replicative complex;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-176187|Activation of ATR in response to replication stress;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-15869|Metabolism of nucleotides;KEGG:hsa03013|RNA transport;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-68867|Assembly of the pre-replicative complex;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-157579|Telomere Maintenance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;REACT:R-HSA-69052|Switching of origins to a post-replicative state;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa00230|Purine metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5689603|UCH proteinases;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-174417|Telomere C-strand (Lagging Strand) Synthesis;REACT:R-HSA-73933|Resolution of Abasic Sites (AP sites);REACT:R-HSA-73884|Base Excision Repair;REACT:R-HSA-5693579|Homologous DNA Pairing and Strand Exchange;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa03040|Spliceosome;REACT:R-HSA-180786|Extension of Telomeres;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-69205|G1/S-Specific Transcription;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa03440|Homologous recombination;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-69186|Lagging Strand Synthesis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-159236|Transport of Mature mRNA derived from an Intron-Containing Transcript;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-195721|Signaling by Wnt
552-41-0	REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05166|HTLV-I infection;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology
552-58-9	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction
552-66-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression
5522-43-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05133|Pertussis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05160|Hepatitis C;KEGG:hsa05132|Salmonella infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05164|Influenza A;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05134|Legionellosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05218|Melanoma;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05224|Breast cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling
553-12-8	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
5536-17-4	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-69242|S Phase;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05224|Breast cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05162|Measles;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1500620|Meiosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1643685|Disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification
55481-88-4	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
555-60-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
555-66-8	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05164|Influenza A;KEGG:hsa05215|Prostate cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-109581|Apoptosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05160|Hepatitis C;KEGG:hsa05162|Measles;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1430728|Metabolism
55520-40-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05016|Huntington's disease;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-442755|Activation of NMDA receptor upon glutamate binding and postsynaptic events;REACT:R-HSA-442742|CREB phosphorylation through the activation of Ras;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-438064|Post NMDA receptor activation events;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04916|Melanogenesis;KEGG:hsa05160|Hepatitis C;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05034|Alcoholism;KEGG:hsa04720|Long-term potentiation;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05133|Pertussis;KEGG:hsa05134|Legionellosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05164|Influenza A;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04621|NOD-like receptor signaling pathway
556-52-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1630316|Glycosaminoglycan metabolism;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04971|Gastric acid secretion;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-3781865|Diseases of glycosylation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04530|Tight junction;REACT:R-HSA-446728|Cell junction organization;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04210|Apoptosis;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-199991|Membrane Trafficking
55963-74-1	KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04931|Insulin resistance;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease
5598-15-2	REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05016|Huntington's disease;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-6799198|Complex I biogenesis;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04360|Axon guidance;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-373760|L1CAM interactions;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
55985-32-5	REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR
56-04-2	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
56-12-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168256|Immune System;KEGG:hsa04727|GABAergic synapse;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-72766|Translation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);KEGG:hsa05032|Morphine addiction;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa03010|Ribosome;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05033|Nicotine addiction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-977443|GABA receptor activation;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-977441|GABA A receptor activation;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-975298|Ligand-gated ion channel transport;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-112310|Neurotransmitter Release Cycle;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa04530|Tight junction;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04742|Taste transduction
56-23-5	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa00230|Purine metabolism;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-68886|M Phase;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01200|Carbon metabolism
56-25-7	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04510|Focal adhesion;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression
56-38-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04110|Cell cycle;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04972|Pancreatic secretion;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa00830|Retinol metabolism;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-1643685|Disease;KEGG:hsa04360|Axon guidance;KEGG:hsa04510|Focal adhesion;KEGG:hsa05162|Measles;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications
56-40-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04931|Insulin resistance;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-156842|Eukaryotic Translation Elongation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05162|Measles;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-156902|Peptide chain elongation;KEGG:hsa04510|Focal adhesion;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05133|Pertussis;REACT:R-HSA-192823|Viral mRNA Translation;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa_M00177|Ribosome, eukaryotes;KEGG:hsa04146|Peroxisome;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-2408557|Selenocysteine synthesis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05224|Breast cancer;REACT:R-HSA-72764|Eukaryotic Translation Termination
56-41-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04210|Apoptosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-375280|Amine ligand-binding receptors;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05219|Bladder cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05215|Prostate cancer;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05160|Hepatitis C;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05146|Amoebiasis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05134|Legionellosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane
56-49-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-68886|M Phase;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-69242|S Phase;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5663205|Infectious disease
56-53-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05224|Breast cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05162|Measles;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-69206|G1/S Transition;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04510|Focal adhesion;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04115|p53 signaling pathway
56-54-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04727|GABAergic synapse;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
56-55-3	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa05164|Influenza A;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05160|Hepatitis C;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05162|Measles;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04710|Circadian rhythm;KEGG:hsa05219|Bladder cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-72172|mRNA Splicing;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-380108|Chemokine receptors bind chemokines;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05133|Pertussis;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors
56-57-5	KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05133|Pertussis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05132|Salmonella infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa04110|Cell cycle;KEGG:hsa05164|Influenza A;KEGG:hsa05215|Prostate cancer;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1266738|Developmental Biology
56-65-5	REACT:R-HSA-168256|Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-622312|Inflammasomes;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168643|Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05215|Prostate cancer;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1643685|Disease;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01523|Antifolate resistance;KEGG:hsa02010|ABC transporters;KEGG:hsa05160|Hepatitis C;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05162|Measles;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04940|Type I diabetes mellitus;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04666|Fc gamma R-mediated phagocytosis;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation
56-75-7	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism
56-81-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05164|Influenza A;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05162|Measles;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling
56-86-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05161|Hepatitis B;KEGG:hsa04146|Peroxisome;KEGG:hsa05215|Prostate cancer;KEGG:hsa05016|Huntington's disease;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01212|Fatty acid metabolism;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05218|Melanoma;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05164|Influenza A;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05214|Glioma;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa05160|Hepatitis C;KEGG:hsa04510|Focal adhesion;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04630|Jak-STAT signaling pathway
56-87-1	REACT:R-HSA-168256|Immune System
56073-10-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168256|Immune System;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-72766|Translation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-422475|Axon guidance;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-1268020|Mitochondrial protein import;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa03010|Ribosome;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-71406|Pyruvate metabolism and Citric Acid (TCA) cycle;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-8856828|Clathrin-mediated endocytosis;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa00020|Citrate cycle (TCA cycle);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6794362|Protein-protein interactions at synapses;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-8856825|Cargo recognition for clathrin-mediated endocytosis;REACT:R-HSA-373760|L1CAM interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-162587|HIV Life Cycle;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05110|Vibrio cholerae infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-70326|Glucose metabolism;KEGG:hsa04721|Synaptic vesicle cycle;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa03040|Spliceosome;KEGG:hsa00010|Glycolysis / Gluconeogenesis;REACT:R-HSA-373755|Semaphorin interactions;REACT:R-HSA-162599|Late Phase of HIV Life Cycle;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa03013|RNA transport
56092-81-0	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-68886|M Phase;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-69242|S Phase;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05164|Influenza A;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04110|Cell cycle;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-71387|Metabolism of carbohydrates
561-27-3	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
56305-04-5	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05020|Prion diseases;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05211|Renal cell carcinoma;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05016|Huntington's disease;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04014|Ras signaling pathway
56320-22-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology
5635-50-7	REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
564-25-0	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
56411-57-5	REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05133|Pertussis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05162|Measles;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System
56420-45-2	KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05162|Measles;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins
5650-44-2	REACT:R-HSA-168256|Immune System
566-26-7	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System
566-28-9	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05160|Hepatitis C;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways
568-73-0	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05133|Pertussis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05219|Bladder cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05164|Influenza A;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05162|Measles;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04110|Cell cycle;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1640170|Cell Cycle
56803-37-3	REACT:R-HSA-1430728|Metabolism
5697-56-3	KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
57-06-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
57-10-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04931|Insulin resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05164|Influenza A;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa04930|Type II diabetes mellitus;KEGG:hsa05132|Salmonella infection;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05162|Measles;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04213|Longevity regulating pathway - multiple species;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa05144|Malaria;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport
57-11-4	KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction
57-13-6	REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04931|Insulin resistance;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2586552|Signaling by Leptin
57-24-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
57-27-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05164|Influenza A;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05133|Pertussis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05162|Measles;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04720|Long-term potentiation;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04730|Long-term depression;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05032|Morphine addiction;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa05132|Salmonella infection;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04540|Gap junction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-442755|Activation of NMDA receptor upon glutamate binding and postsynaptic events;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-111885|Opioid Signalling;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05033|Nicotine addiction;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05034|Alcoholism;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-418597|G alpha (z) signalling events;REACT:R-HSA-6798695|Neutrophil degranulation
57-41-0	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05215|Prostate cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05164|Influenza A;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05146|Amoebiasis;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05224|Breast cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05144|Malaria;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05218|Melanoma;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05134|Legionellosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05219|Bladder cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2022090|Assembly of collagen fibrils and other multimeric structures;KEGG:hsa04110|Cell cycle;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05214|Glioma;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-3000178|ECM proteoglycans;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-5683057|MAPK family signaling cascades
57-50-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04930|Type II diabetes mellitus;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-191273|Cholesterol biosynthesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1296071|Potassium Channels;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04975|Fat digestion and absorption;REACT:R-HSA-75109|Triglyceride Biosynthesis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04923|Regulation of lipolysis in adipocytes;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa00100|Steroid biosynthesis;KEGG:hsa05160|Hepatitis C;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05146|Amoebiasis;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa00561|Glycerolipid metabolism;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer
57-63-6	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-68886|M Phase;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-73894|DNA Repair;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-72766|Translation;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;KEGG:hsa04144|Endocytosis;REACT:R-HSA-69242|S Phase;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa04110|Cell cycle;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa03040|Spliceosome;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05016|Huntington's disease
57-66-9	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
57-83-0	REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05161|Hepatitis B;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05164|Influenza A;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05133|Pertussis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04210|Apoptosis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-1474290|Collagen formation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-202733|Cell surface interactions at the vascular wall
57-85-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins
57-87-4	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05162|Measles;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05134|Legionellosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74160|Gene Expression
57-88-5	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04931|Insulin resistance;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05164|Influenza A;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-174824|Lipoprotein metabolism;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa05144|Malaria;REACT:R-HSA-1643685|Disease;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05132|Salmonella infection;KEGG:hsa05160|Hepatitis C;KEGG:hsa05215|Prostate cancer;KEGG:hsa05162|Measles;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05134|Legionellosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04976|Bile secretion;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-191273|Cholesterol biosynthesis;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05222|Small cell lung cancer
57-95-4	KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-372790|Signaling by GPCR
57-97-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04210|Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04510|Focal adhesion;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05152|Tuberculosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05210|Colorectal cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05214|Glioma;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04530|Tight junction
5701-82-6	REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System
57117-31-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction
57444-62-9	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
57465-28-8	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05146|Amoebiasis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05144|Malaria;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05224|Breast cancer;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-425407|SLC-mediated transmembrane transport
57564-91-7	REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
57644-54-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
577-85-5	KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
57817-89-7	KEGG:hsa04931|Insulin resistance;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-372790|Signaling by GPCR
5786-21-0	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05034|Alcoholism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04720|Long-term potentiation;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04713|Circadian entrainment;KEGG:hsa05161|Hepatitis B;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-111885|Opioid Signalling;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-163685|Integration of energy metabolism;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-442755|Activation of NMDA receptor upon glutamate binding and postsynaptic events;KEGG:hsa04730|Long-term depression;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04540|Gap junction;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;KEGG:hsa04912|GnRH signaling pathway
58-00-4	REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling
58-05-9	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05224|Breast cancer;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
58-08-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-72766|Translation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-156842|Eukaryotic Translation Elongation;KEGG:hsa05133|Pertussis;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05146|Amoebiasis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-72689|Formation of a pool of free 40S subunits
58-14-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
58-18-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-68886|M Phase;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04110|Cell cycle;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-72766|Translation;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-73894|DNA Repair;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168254|Influenza Infection;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69242|S Phase;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-69275|G2/M Transition;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa03010|Ribosome;KEGG:hsa04210|Apoptosis;KEGG:hsa04144|Endocytosis;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-6811442|Intra-Golgi and retrograde Golgi-to-ER traffic;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa03040|Spliceosome;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5633007|Regulation of TP53 Activity
58-22-0	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-68886|M Phase;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-73894|DNA Repair;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C
58-27-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-68886|M Phase;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-977225|Amyloid fiber formation;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-68875|Mitotic Prophase;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-212165|Epigenetic regulation of gene expression;KEGG:hsa04110|Cell cycle;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5334118|DNA methylation;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-73864|RNA Polymerase I Transcription;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-427389|ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-73886|Chromosome Maintenance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-5250924|B-WICH complex positively regulates rRNA expression;REACT:R-HSA-5625740|RHO GTPases activate PKNs;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-912446|Meiotic recombination;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-1500620|Meiosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5625886|Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-427413|NoRC negatively regulates rRNA expression;KEGG:hsa05034|Alcoholism;REACT:R-HSA-69242|S Phase;REACT:R-HSA-427359|SIRT1 negatively regulates rRNA Expression;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;REACT:R-HSA-5250941|Negative epigenetic regulation of rRNA expression;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane
58-32-2	KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05144|Malaria;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa00230|Purine metabolism;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling
58-54-8	KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-166520|Signalling by NGF
58-55-9	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04510|Focal adhesion;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04931|Insulin resistance;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04916|Melanogenesis
58-60-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05146|Amoebiasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05100|Bacterial invasion of epithelial cells;KEGG:hsa04530|Tight junction;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05133|Pertussis;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa04611|Platelet activation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2682334|EPH-Ephrin signaling;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-2980736|Peptide hormone metabolism;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04360|Axon guidance;REACT:R-HSA-1643685|Disease;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05016|Huntington's disease;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling
58-61-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04510|Focal adhesion;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05162|Measles;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05134|Legionellosis;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05215|Prostate cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5675482|Regulation of necroptotic cell death;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5213460|RIPK1-mediated regulated necrosis;REACT:R-HSA-5218859|Regulated Necrosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa04611|Platelet activation;REACT:R-HSA-140534|Ligand-dependent caspase activation;REACT:R-HSA-5357769|Caspase activation via extrinsic apoptotic signalling pathway
58-64-0	REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04611|Platelet activation;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04510|Focal adhesion;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1643685|Disease;REACT:R-HSA-388396|GPCR downstream signaling
58-73-1	KEGG:hsa05133|Pertussis;KEGG:hsa05142|Chagas disease (American trypanosomiasis)
58-82-2	REACT:R-HSA-162582|Signal Transduction
58-85-5	REACT:R-HSA-1430728|Metabolism
58-93-5	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
58-94-6	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
58-96-8	KEGG:hsa04210|Apoptosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-15869|Metabolism of nucleotides;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa00240|Pyrimidine metabolism;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification
584-84-9	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04110|Cell cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69306|DNA Replication;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-69242|S Phase;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa03030|DNA replication;REACT:R-HSA-176187|Activation of ATR in response to replication stress;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-69205|G1/S-Specific Transcription;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa00240|Pyrimidine metabolism;KEGG:hsa05132|Salmonella infection;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-69304|Regulation of DNA replication;KEGG:hsa04672|Intestinal immune network for IgA production;KEGG:hsa05144|Malaria;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-174417|Telomere C-strand (Lagging Strand) Synthesis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-69186|Lagging Strand Synthesis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-69300|Removal of licensing factors from origins;KEGG:hsa04914|Progesterone-mediated oocyte maturation;REACT:R-HSA-180786|Extension of Telomeres;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1538133|G0 and Early G1;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05219|Bladder cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05310|Asthma;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1643685|Disease;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-68867|Assembly of the pre-replicative complex;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05330|Allograft rejection;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05169|Epstein-Barr virus infection
5843-65-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
58479-68-8	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05210|Colorectal cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05133|Pertussis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05224|Breast cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05160|Hepatitis C;KEGG:hsa04931|Insulin resistance;KEGG:hsa05162|Measles;KEGG:hsa05219|Bladder cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05134|Legionellosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05214|Glioma;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04660|T cell receptor signaling pathway
58543-16-1	KEGG:hsa04931|Insulin resistance;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-372790|Signaling by GPCR
58546-54-6	REACT:R-HSA-168256|Immune System
586-06-1	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
58880-19-6	REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04360|Axon guidance;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;KEGG:hsa05224|Breast cancer;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04110|Cell cycle;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04144|Endocytosis;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade
58957-92-9	REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-162582|Signal Transduction
59-01-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
59-02-9	REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05166|HTLV-I infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05132|Salmonella infection;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04931|Insulin resistance;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05134|Legionellosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05144|Malaria;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-166520|Signalling by NGF
59-05-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa05162|Measles;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-198203|PI3K/AKT activation
59-14-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
59-30-3	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05224|Breast cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa05217|Basal cell carcinoma;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04360|Axon guidance;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05134|Legionellosis;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04916|Melanogenesis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05133|Pertussis
59-42-7	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04931|Insulin resistance;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05152|Tuberculosis;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05164|Influenza A;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04916|Melanogenesis;KEGG:hsa05214|Glioma;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04360|Axon guidance;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05160|Hepatitis C;KEGG:hsa04922|Glucagon signaling pathway
59-43-8	KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
59-46-1	REACT:R-HSA-162582|Signal Transduction
59-52-9	REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction
59-66-5	REACT:R-HSA-1475029|Reversible hydration of carbon dioxide;KEGG:hsa00910|Nitrogen metabolism;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
59-85-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04978|Mineral absorption;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05224|Breast cancer;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04360|Axon guidance;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04210|Apoptosis;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-373760|L1CAM interactions;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04668|TNF signaling pathway
59-87-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
59-89-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-168256|Immune System;KEGG:hsa01200|Carbon metabolism;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa00280|Valine, leucine and isoleucine degradation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa00270|Cysteine and methionine metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa00010|Glycolysis / Gluconeogenesis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa05200|Pathways in cancer;KEGG:hsa00380|Tryptophan metabolism;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-70326|Glucose metabolism;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04145|Phagosome;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-15869|Metabolism of nucleotides;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-390466|Chaperonin-mediated protein folding;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-391251|Protein folding;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04931|Insulin resistance;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04510|Focal adhesion
59-96-1	REACT:R-HSA-162582|Signal Transduction
59122-46-2	REACT:R-HSA-162582|Signal Transduction
5915-41-3	REACT:R-HSA-1430728|Metabolism
592-62-1	REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5653656|Vesicle-mediated transport
592-88-1	KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168256|Immune System;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease
5928-25-6	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
593-57-7	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System
59467-70-8	REACT:R-HSA-1430728|Metabolism
5956-87-6	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology
5970-45-6	REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05164|Influenza A;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04110|Cell cycle;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04978|Mineral absorption;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-3371556|Cellular response to heat stress;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05162|Measles;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease
59729-33-8	KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
5976-61-4	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
5986-55-0	REACT:R-HSA-168256|Immune System
59864-04-9	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05224|Breast cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05164|Influenza A;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways
59865-13-3	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-68886|M Phase;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-69275|G2/M Transition;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-69242|S Phase;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-6811442|Intra-Golgi and retrograde Golgi-to-ER traffic;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04144|Endocytosis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-5617833|Cilium Assembly;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04210|Apoptosis;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds
59880-97-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04664|Fc epsilon RI signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04666|Fc gamma R-mediated phagocytosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2029480|Fcgamma receptor (FCGR) dependent phagocytosis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04611|Platelet activation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism
599-79-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05146|Amoebiasis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa05162|Measles;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05164|Influenza A;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05144|Malaria;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-1643685|Disease;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01523|Antifolate resistance;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04622|RIG-I-like receptor signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04931|Insulin resistance;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-202403|TCR signaling;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-451927|Interleukin-2 signaling
60-00-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways
60-01-5	REACT:R-HSA-168256|Immune System
60-12-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05164|Influenza A;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-109582|Hemostasis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05134|Legionellosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05133|Pertussis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05162|Measles;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05020|Prion diseases;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05143|African trypanosomiasis
60-23-1	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
60-24-2	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism
60-35-5	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1643685|Disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa04110|Cell cycle;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa00280|Valine, leucine and isoleucine degradation;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-68886|M Phase;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04510|Focal adhesion;KEGG:hsa04514|Cell adhesion molecules (CAMs);REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-69242|S Phase;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04670|Leukocyte transendothelial migration
60-40-2	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05164|Influenza A;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR
60-51-5	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins
60-54-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa01212|Fatty acid metabolism;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04976|Bile secretion;REACT:R-HSA-75109|Triglyceride Biosynthesis;REACT:R-HSA-192105|Synthesis of bile acids and bile salts;REACT:R-HSA-168256|Immune System;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-193368|Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;KEGG:hsa04146|Peroxisome;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa02010|ABC transporters;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-390918|Peroxisomal lipid metabolism;KEGG:hsa00120|Primary bile acid biosynthesis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa00280|Valine, leucine and isoleucine degradation;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-75105|Fatty Acyl-CoA Biosynthesis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04975|Fat digestion and absorption;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-1483255|PI Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa00562|Inositol phosphate metabolism;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-211976|Endogenous sterols;KEGG:hsa00650|Butanoate metabolism;KEGG:hsa00380|Tryptophan metabolism;REACT:R-HSA-1643685|Disease;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-174824|Lipoprotein metabolism;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04070|Phosphatidylinositol signaling system;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-428157|Sphingolipid metabolism;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1660499|Synthesis of PIPs at the plasma membrane;REACT:R-HSA-70326|Glucose metabolism;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-2187338|Visual phototransduction;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04216|Ferroptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05224|Breast cancer;KEGG:hsa05214|Glioma;KEGG:hsa05212|Pancreatic cancer
60-56-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;KEGG:hsa05133|Pertussis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05224|Breast cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05214|Glioma;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69242|S Phase;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05132|Salmonella infection;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
60-57-1	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05152|Tuberculosis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05218|Melanoma;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05214|Glioma;REACT:R-HSA-375165|NCAM signaling for neurite out-growth
60-80-0	KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05144|Malaria;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05132|Salmonella infection;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism
60-81-1	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa00280|Valine, leucine and isoleucine degradation;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-168256|Immune System;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00020|Citrate cycle (TCA cycle);KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-5658442|Regulation of RAS by GAPs;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5676590|NIK-->noncanonical NF-kB signaling;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-5607761|Dectin-1 mediated noncanonical NF-kB signaling;KEGG:hsa_M00009|Citrate cycle (TCA cycle, Krebs cycle);REACT:R-HSA-174084|Autodegradation of Cdh1 by Cdh1:APC/C;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-174154|APC/C:Cdc20 mediated degradation of Securin;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-2871837|FCERI mediated NF-kB activation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-69541|Stabilization of p53;REACT:R-HSA-174113|SCF-beta-TrCP mediated degradation of Emi1;REACT:R-HSA-8854050|FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-174184|Cdc20:Phospho-APC/C mediated degradation of Cyclin A;REACT:R-HSA-174178|APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;REACT:R-HSA-179419|APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;REACT:R-HSA-71403|Citric acid cycle (TCA cycle);REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-5619115|Disorders of transmembrane transporters;REACT:R-HSA-5610780|Degradation of GLI1 by the proteasome;REACT:R-HSA-5610785|GLI3 is processed to GLI3R by the proteasome;REACT:R-HSA-5610783|Degradation of GLI2 by the proteasome;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-211733|Regulation of activated PAK-2p34 by proteasome mediated degradation;REACT:R-HSA-156590|Glutathione conjugation;REACT:R-HSA-202424|Downstream TCR signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-69017|CDK-mediated phosphorylation and removal of Cdc6;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-180534|Vpu mediated degradation of CD4;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-5689603|UCH proteinases;REACT:R-HSA-69610|p53-Independent DNA Damage Response;REACT:R-HSA-69613|p53-Independent G1/S DNA damage checkpoint;REACT:R-HSA-69601|Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;REACT:R-HSA-169911|Regulation of Apoptosis;REACT:R-HSA-5619084|ABC transporter disorders;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-4641257|Degradation of AXIN;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-5362768|Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;KEGG:hsa04120|Ubiquitin mediated proteolysis;REACT:R-HSA-4641258|Degradation of DVL;REACT:R-HSA-5387390|Hh mutants abrogate ligand secretion;REACT:R-HSA-68827|CDT1 association with the CDC6:ORC:origin complex;REACT:R-HSA-5678895|Defective CFTR causes cystic fibrosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-202403|TCR signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-195253|Degradation of beta-catenin by the destruction complex;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-4608870|Asymmetric localization of PCP proteins;REACT:R-HSA-5358346|Hedgehog ligand biogenesis;REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-1236974|ER-Phagosome pathway
60-82-2	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
60-87-7	REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04110|Cell cycle;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System
60-92-4	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-196071|Metabolism of steroid hormones;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04923|Regulation of lipolysis in adipocytes;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05215|Prostate cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04611|Platelet activation;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04976|Bile secretion;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04925|Aldosterone synthesis and secretion;KEGG:hsa05032|Morphine addiction;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05133|Pertussis;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05162|Measles;KEGG:hsa04916|Melanogenesis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-211976|Endogenous sterols;REACT:R-HSA-5683057|MAPK family signaling cascades
600-14-6	REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1474290|Collagen formation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1474228|Degradation of the extracellular matrix;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2022090|Assembly of collagen fibrils and other multimeric structures;REACT:R-HSA-1650814|Collagen biosynthesis and modifying enzymes;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-216083|Integrin cell surface interactions;REACT:R-HSA-8948216|Collagen chain trimerization;REACT:R-HSA-168256|Immune System;KEGG:hsa04974|Protein digestion and absorption;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-372790|Signaling by GPCR
60044-26-0	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
60168-88-9	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
60203-57-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
60207-90-1	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1643685|Disease;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa04210|Apoptosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05164|Influenza A;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-381070|IRE1alpha activates chaperones;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-381038|XBP1(S) activates chaperone genes;REACT:R-HSA-72766|Translation;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04931|Insulin resistance;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04137|Mitophagy - animal;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-68886|M Phase;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04146|Peroxisome;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05202|Transcriptional misregulation in cancer
60268-85-1	KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System
60282-87-3	KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-140875|Common Pathway of Fibrin Clot Formation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins
604-59-1	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05224|Breast cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05215|Prostate cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04210|Apoptosis;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05152|Tuberculosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05164|Influenza A;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04110|Cell cycle;KEGG:hsa05214|Glioma;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa00010|Glycolysis / Gluconeogenesis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05162|Measles;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5683057|MAPK family signaling cascades
60423-21-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05130|Pathogenic Escherichia coli infection;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04145|Phagosome;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-72766|Translation;KEGG:hsa04540|Gap junction;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-72764|Eukaryotic Translation Termination;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-8856828|Clathrin-mediated endocytosis;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa03010|Ribosome;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1236974|ER-Phagosome pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2682334|EPH-Ephrin signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-373760|L1CAM interactions;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-391251|Protein folding;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-162906|HIV Infection;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-195258|RHO GTPase Effectors
6051-87-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-168256|Immune System;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa00590|Arachidonic acid metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-191273|Cholesterol biosynthesis;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa00053|Ascorbate and aldarate metabolism;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;REACT:R-HSA-211976|Endogenous sterols;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04976|Bile secretion;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa_M00014|Glucuronate pathway (uronate pathway);KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1643685|Disease;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa00983|Drug metabolism - other enzymes;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa00040|Pentose and glucuronate interconversions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-6805567|Keratinization;REACT:R-HSA-156588|Glucuronidation;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1566948|Elastic fibre formation;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa05146|Amoebiasis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04920|Adipocytokine signaling pathway
60569-19-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04146|Peroxisome;REACT:R-HSA-1643685|Disease;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-168256|Immune System;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-72766|Translation;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-74160|Gene Expression;KEGG:hsa03010|Ribosome;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-162582|Signal Transduction
606-20-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;KEGG:hsa03013|RNA transport;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-68886|M Phase;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-162587|HIV Life Cycle;REACT:R-HSA-199977|ER to Golgi Anterograde Transport;REACT:R-HSA-72766|Translation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-948021|Transport to the Golgi and subsequent modification;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-162599|Late Phase of HIV Life Cycle;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-15869|Metabolism of nucleotides;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-73857|RNA Polymerase II Transcription;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa03040|Spliceosome
60643-86-9	REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72766|Translation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;KEGG:hsa03010|Ribosome;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;KEGG:hsa01100|Metabolic pathways
607-57-8	REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-1643685|Disease;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-69242|S Phase;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-350562|Regulation of ornithine decarboxylase (ODC);REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-174154|APC/C:Cdc20 mediated degradation of Securin;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69541|Stabilization of p53;REACT:R-HSA-174113|SCF-beta-TrCP mediated degradation of Emi1;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-174184|Cdc20:Phospho-APC/C mediated degradation of Cyclin A;REACT:R-HSA-174178|APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;KEGG:hsa03050|Proteasome;REACT:R-HSA-179419|APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-1236978|Cross-presentation of soluble exogenous antigens (endosomes);REACT:R-HSA-211733|Regulation of activated PAK-2p34 by proteasome mediated degradation;REACT:R-HSA-69017|CDK-mediated phosphorylation and removal of Cdc6;REACT:R-HSA-180534|Vpu mediated degradation of CD4;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-68867|Assembly of the pre-replicative complex;REACT:R-HSA-69610|p53-Independent DNA Damage Response;REACT:R-HSA-69613|p53-Independent G1/S DNA damage checkpoint;REACT:R-HSA-69601|Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;REACT:R-HSA-169911|Regulation of Apoptosis;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-8854050|FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;REACT:R-HSA-4641257|Degradation of AXIN;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-5362768|Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;REACT:R-HSA-4641258|Degradation of DVL;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-5676590|NIK-->noncanonical NF-kB signaling;REACT:R-HSA-5387390|Hh mutants abrogate ligand secretion;REACT:R-HSA-68827|CDT1 association with the CDC6:ORC:origin complex;REACT:R-HSA-5610780|Degradation of GLI1 by the proteasome;REACT:R-HSA-5610785|GLI3 is processed to GLI3R by the proteasome;REACT:R-HSA-5610783|Degradation of GLI2 by the proteasome;REACT:R-HSA-5607761|Dectin-1 mediated noncanonical NF-kB signaling;REACT:R-HSA-5678895|Defective CFTR causes cystic fibrosis;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-174084|Autodegradation of Cdh1 by Cdh1:APC/C;REACT:R-HSA-1236974|ER-Phagosome pathway;REACT:R-HSA-4608870|Asymmetric localization of PCP proteins;REACT:R-HSA-5358346|Hedgehog ligand biogenesis;REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;REACT:R-HSA-72766|Translation;REACT:R-HSA-5619084|ABC transporter disorders;REACT:R-HSA-5658442|Regulation of RAS by GAPs;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5619115|Disorders of transmembrane transporters;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation
607-91-0	REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-5693579|Homologous DNA Pairing and Strand Exchange;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-5685938|HDR through Single Strand Annealing (SSA);REACT:R-HSA-5693616|Presynaptic phase of homologous DNA pairing and strand exchange;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression
608-93-5	REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
60940-34-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05133|Pertussis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology
60976-49-0	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
61-33-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05144|Malaria;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05133|Pertussis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04151|PI3K-Akt signaling pathway
61-68-7	KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
61-72-3	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System
61-73-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
61-82-5	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
61-90-5	REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology
610-48-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-5675221|Negative regulation of MAPK pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05218|Melanoma;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5663202|Diseases of signal transduction
61276-17-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04110|Cell cycle;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05214|Glioma;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-168256|Immune System;KEGG:hsa05164|Influenza A;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression
613-13-8	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
61318-90-9	REACT:R-HSA-1430728|Metabolism
61413-54-5	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR
6147-11-1	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05152|Tuberculosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
615-58-7	REACT:R-HSA-1430728|Metabolism
616-91-1	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05164|Influenza A;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05166|HTLV-I infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04931|Insulin resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05162|Measles;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05210|Colorectal cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade
617-35-6	REACT:R-HSA-168256|Immune System
61789-97-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-68886|M Phase;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives
61789-99-9	REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
618-80-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
61805-96-7	KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05134|Legionellosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1266738|Developmental Biology
61869-08-7	KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168256|Immune System;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-168249|Innate Immune System
6199-67-3	REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168256|Immune System
62-38-4	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04360|Axon guidance;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04514|Cell adhesion molecules (CAMs);REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04144|Endocytosis;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05032|Morphine addiction;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04921|Oxytocin signaling pathway
62-44-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
62-46-4	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04931|Insulin resistance;KEGG:hsa05162|Measles;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05215|Prostate cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05020|Prion diseases;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05134|Legionellosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05224|Breast cancer;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04370|VEGF signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-2142753|Arachidonic acid metabolism
62-49-7	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa04110|Cell cycle;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-68886|M Phase;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05152|Tuberculosis;KEGG:hsa04360|Axon guidance;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04144|Endocytosis;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling
62-50-0	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-72312|rRNA processing;KEGG:hsa05164|Influenza A;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6790901|rRNA modification in the nucleus and cytosol;KEGG:hsa04210|Apoptosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-877300|Interferon gamma signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-72172|mRNA Splicing;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05162|Measles;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-5617833|Cilium Assembly;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa00230|Purine metabolism;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa03008|Ribosome biogenesis in eukaryotes;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-168898|Toll-Like Receptors Cascades
62-51-1	REACT:R-HSA-162582|Signal Transduction
62-53-3	KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05164|Influenza A;KEGG:hsa05162|Measles;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05133|Pertussis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05131|Shigellosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04110|Cell cycle;KEGG:hsa05160|Hepatitis C;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04530|Tight junction;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins
62-55-5	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04110|Cell cycle;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-422475|Axon guidance;KEGG:hsa01200|Carbon metabolism;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-68886|M Phase;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-5663220|RHO GTPases Activate Formins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-72312|rRNA processing;KEGG:hsa05164|Influenza A;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-69242|S Phase;KEGG:hsa05160|Hepatitis C;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+
62-56-6	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05134|Legionellosis;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-1643685|Disease;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05162|Measles;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05218|Melanoma;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05144|Malaria;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05330|Allograft rejection;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF
62-73-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease
62-75-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05164|Influenza A;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04210|Apoptosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-69052|Switching of origins to a post-replicative state;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-1236975|Antigen processing-Cross presentation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-69300|Removal of licensing factors from origins;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1236974|ER-Phagosome pathway;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+
620-94-8	KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-375280|Amine ligand-binding receptors;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-111885|Opioid Signalling;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04925|Aldosterone synthesis and secretion;KEGG:hsa04611|Platelet activation;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04540|Gap junction;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05034|Alcoholism;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression
621-42-1	REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280218|Adaptive Immune System
621-82-9	KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
622-78-6	REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
62218-08-0	REACT:R-HSA-1430728|Metabolism
62218-13-7	REACT:R-HSA-168256|Immune System
62340-29-8	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
624-15-7	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04110|Cell cycle;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05164|Influenza A;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05224|Breast cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05219|Bladder cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05133|Pertussis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1643685|Disease;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-69205|G1/S-Specific Transcription;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05214|Glioma;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa05216|Thyroid cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05218|Melanoma;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05144|Malaria;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-68886|M Phase;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction
62499-27-8	KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
625-45-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04110|Cell cycle;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1643685|Disease;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05152|Tuberculosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05160|Hepatitis C;KEGG:hsa05164|Influenza A;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling
62596-29-6	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System
627-03-2	REACT:R-HSA-1430728|Metabolism
627-72-5	KEGG:hsa05161|Hepatitis B;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
6284-40-8	KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
62883-00-5	KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
629-59-4	REACT:R-HSA-168256|Immune System
62938-14-1	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
62996-74-1	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05215|Prostate cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa05224|Breast cancer;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05218|Melanoma;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05146|Amoebiasis;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04664|Fc epsilon RI signaling pathway
63-05-8	REACT:R-HSA-196071|Metabolism of steroid hormones;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins
63-25-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins
63-68-3	REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04210|Apoptosis;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05142|Chagas disease (American trypanosomiasis)
63-75-2	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05215|Prostate cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-372790|Signaling by GPCR
63-84-3	KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05031|Amphetamine addiction;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-168256|Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05034|Alcoholism;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04210|Apoptosis;KEGG:hsa05012|Parkinson's disease;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway
63-91-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-1643685|Disease;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses
630-08-0	REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05134|Legionellosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05144|Malaria;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05162|Measles;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology
630-60-4	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05214|Glioma;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa05215|Prostate cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04110|Cell cycle;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05218|Melanoma;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS)
632-85-9	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05224|Breast cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1643685|Disease;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5663202|Diseases of signal transduction
63223-86-9	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
635-65-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05164|Influenza A;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04210|Apoptosis;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa00830|Retinol metabolism;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280218|Adaptive Immune System
63527-52-6	REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System
637-03-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05164|Influenza A;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05133|Pertussis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05162|Measles;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04810|Regulation of actin cytoskeleton
637-07-0	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa01200|Carbon metabolism;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-72766|Translation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa00071|Fatty acid degradation;KEGG:hsa04146|Peroxisome;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04210|Apoptosis;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa00280|Valine, leucine and isoleucine degradation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-202403|TCR signaling;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint
637-92-3	REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
639-58-7	REACT:R-HSA-1430728|Metabolism
63968-64-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
64-17-5	REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04144|Endocytosis;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04360|Axon guidance;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04062|Chemokine signaling pathway
64-19-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05164|Influenza A;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05152|Tuberculosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05146|Amoebiasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05160|Hepatitis C;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05144|Malaria;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-3371556|Cellular response to heat stress;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05162|Measles;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04978|Mineral absorption;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1643685|Disease
64-69-7	REACT:R-HSA-162582|Signal Transduction
64-77-7	REACT:R-HSA-1430728|Metabolism
64-85-7	KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05215|Prostate cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05152|Tuberculosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins
64-86-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04110|Cell cycle;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-1500620|Meiosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-912446|Meiotic recombination;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-68886|M Phase;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-69242|S Phase;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05162|Measles;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;KEGG:hsa05133|Pertussis;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-69205|G1/S-Specific Transcription;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-877300|Interferon gamma signaling;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05322|Systemic lupus erythematosus;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5693554|Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;KEGG:hsa05134|Legionellosis;KEGG:hsa05130|Pathogenic Escherichia coli infection;REACT:R-HSA-1221632|Meiotic synapsis;KEGG:hsa04145|Phagosome;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);KEGG:hsa04630|Jak-STAT signaling pathway
640-79-9	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
64091-91-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168256|Immune System;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-69242|S Phase;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-69541|Stabilization of p53;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells
641-38-3	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
642-15-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05134|Legionellosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04210|Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa05152|Tuberculosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1643685|Disease;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression
64224-21-1	KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa02010|ABC transporters;KEGG:hsa04976|Bile secretion;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways
64280-14-4	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04611|Platelet activation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04530|Tight junction;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05224|Breast cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa_M00014|Glucuronate pathway (uronate pathway);KEGG:hsa00053|Ascorbate and aldarate metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa00040|Pentose and glucuronate interconversions;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-156588|Glucuronidation;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa00983|Drug metabolism - other enzymes;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04916|Melanogenesis;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa05217|Basal cell carcinoma;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa00830|Retinol metabolism;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-422356|Regulation of insulin secretion;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-163685|Integration of energy metabolism;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04730|Long-term depression;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04540|Gap junction;KEGG:hsa04727|GABAergic synapse;KEGG:hsa04510|Focal adhesion;KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04360|Axon guidance;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation
643-56-1	KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
643-79-8	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
64584-34-5	KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa05134|Legionellosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05164|Influenza A;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04210|Apoptosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System
64628-44-0	REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
6493-05-6	KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05134|Legionellosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa05146|Amoebiasis;KEGG:hsa05162|Measles;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05132|Salmonella infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05144|Malaria;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-73887|Death Receptor Signalling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-372790|Signaling by GPCR
65-46-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04210|Apoptosis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04110|Cell cycle;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05217|Basal cell carcinoma;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05164|Influenza A;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05162|Measles;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05219|Bladder cancer;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05160|Hepatitis C;KEGG:hsa05168|Herpes simplex infection
65-86-1	REACT:R-HSA-162582|Signal Transduction
651-48-9	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
65119-89-3	KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction
65141-46-0	REACT:R-HSA-168256|Immune System
65199-11-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations
65271-80-9	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05416|Viral myocarditis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-5576891|Cardiac conduction;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05016|Huntington's disease;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane
65277-42-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-196071|Metabolism of steroid hormones;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-211976|Endogenous sterols;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa00100|Steroid biosynthesis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa00830|Retinol metabolism;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05162|Measles;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04976|Bile secretion;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1643685|Disease;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-382551|Transmembrane transport of small molecules
6533-00-2	KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-140875|Common Pathway of Fibrin Clot Formation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1266738|Developmental Biology
65595-90-6	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05133|Pertussis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-388396|GPCR downstream signaling
65646-68-6	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04360|Axon guidance;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05224|Breast cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04110|Cell cycle;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa_M00177|Ribosome, eukaryotes;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-74751|Insulin receptor signalling cascade
657-24-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04931|Insulin resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05160|Hepatitis C;KEGG:hsa05164|Influenza A;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04110|Cell cycle;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05162|Measles;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04213|Longevity regulating pathway - multiple species;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04930|Type II diabetes mellitus;REACT:R-HSA-1643685|Disease;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05134|Legionellosis;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05224|Breast cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05133|Pertussis
65914-17-2	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR
66-22-8	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04360|Axon guidance;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04210|Apoptosis;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04110|Cell cycle;KEGG:hsa05161|Hepatitis B;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05224|Breast cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-195258|RHO GTPase Effectors
66-25-1	KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
66-27-3	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-68886|M Phase;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-5617833|Cilium Assembly;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-72306|tRNA processing;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa03013|RNA transport;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-69242|S Phase;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-6790901|rRNA modification in the nucleus and cytosol;KEGG:hsa00230|Purine metabolism;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04110|Cell cycle;KEGG:hsa03040|Spliceosome;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-73857|RNA Polymerase II Transcription;REACT:R-HSA-6811442|Intra-Golgi and retrograde Golgi-to-ER traffic;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)
66-71-7	KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology
66-72-8	REACT:R-HSA-162582|Signal Transduction
66-76-2	KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05132|Salmonella infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
66-79-5	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System
66-81-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05215|Prostate cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05224|Breast cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1643685|Disease;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling
66-97-7	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1430728|Metabolism
66085-59-4	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism
66104-22-1	REACT:R-HSA-162582|Signal Transduction
66108-95-0	KEGG:hsa05164|Influenza A;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
6621-47-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
66357-35-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05134|Legionellosis;KEGG:hsa05133|Pertussis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05146|Amoebiasis;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-6798695|Neutrophil degranulation
66376-36-1	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism
6640-24-0	KEGG:hsa04080|Neuroactive ligand-receptor interaction
6659-45-6	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer
66635-83-4	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
66772-14-3	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-372790|Signaling by GPCR
66796-54-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology
6699-20-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04210|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-109582|Hemostasis;KEGG:hsa05132|Salmonella infection;KEGG:hsa05160|Hepatitis C;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04510|Focal adhesion;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins
67-20-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
67-30-1	KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
67-42-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01522|Endocrine resistance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05020|Prion diseases;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05162|Measles;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05214|Glioma;KEGG:hsa04540|Gap junction;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04662|B cell receptor signaling pathway
67-43-6	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05133|Pertussis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology
67-56-1	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
67-63-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
67-64-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
67-66-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05166|HTLV-I infection;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1643685|Disease
67-68-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05216|Thyroid cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05134|Legionellosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05132|Salmonella infection;KEGG:hsa05162|Measles;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05219|Bladder cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04940|Type I diabetes mellitus;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa05020|Prion diseases;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05144|Malaria;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1221632|Meiotic synapsis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa05034|Alcoholism;REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05322|Systemic lupus erythematosus;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa04062|Chemokine signaling pathway
67-97-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04110|Cell cycle;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04510|Focal adhesion;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-68886|M Phase;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05164|Influenza A;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-69242|S Phase;KEGG:hsa05133|Pertussis;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05160|Hepatitis C;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa05162|Measles;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-68882|Mitotic Anaphase
67-99-2	KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
67227-56-9	REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction
67287-49-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-168256|Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa00010|Glycolysis / Gluconeogenesis;REACT:R-HSA-70263|Gluconeogenesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa_M00003|Gluconeogenesis, oxaloacetate => fructose-6P;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-71406|Pyruvate metabolism and Citric Acid (TCA) cycle;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa00020|Citrate cycle (TCA cycle);REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-70171|Glycolysis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-70326|Glucose metabolism;KEGG:hsa_M00001|Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa_M00009|Citrate cycle (TCA cycle, Krebs cycle);REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-390466|Chaperonin-mediated protein folding;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-391251|Protein folding;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-6814122|Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;REACT:R-HSA-195253|Degradation of beta-catenin by the destruction complex;REACT:R-HSA-111885|Opioid Signalling;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05034|Alcoholism;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-180534|Vpu mediated degradation of CD4;REACT:R-HSA-174113|SCF-beta-TrCP mediated degradation of Emi1;REACT:R-HSA-8854050|FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5676590|NIK-->noncanonical NF-kB signaling;REACT:R-HSA-5610780|Degradation of GLI1 by the proteasome;REACT:R-HSA-5610785|GLI3 is processed to GLI3R by the proteasome
674-38-4	REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction
6740-88-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-442755|Activation of NMDA receptor upon glutamate binding and postsynaptic events;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-438064|Post NMDA receptor activation events;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05020|Prion diseases;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05133|Pertussis;REACT:R-HSA-442742|CREB phosphorylation through the activation of Ras;KEGG:hsa05216|Thyroid cancer;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05033|Nicotine addiction;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04720|Long-term potentiation;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05134|Legionellosis;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04727|GABAergic synapse;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04020|Calcium signaling pathway
67526-95-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa04110|Cell cycle;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6799198|Complex I biogenesis;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-68886|M Phase;KEGG:hsa05164|Influenza A;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-381070|IRE1alpha activates chaperones;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-381038|XBP1(S) activates chaperone genes;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05215|Prostate cancer;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-199977|ER to Golgi Anterograde Transport;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-948021|Transport to the Golgi and subsequent modification;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1268020|Mitochondrial protein import;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6811442|Intra-Golgi and retrograde Golgi-to-ER traffic;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6807878|COPI-mediated anterograde transport;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04915|Estrogen signaling pathway
67527-18-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-156590|Glutathione conjugation;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-71291|Metabolism of amino acids and derivatives
6754-13-8	KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05134|Legionellosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;REACT:R-HSA-168256|Immune System;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-162582|Signal Transduction
6754-58-1	KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways
67747-09-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-196071|Metabolism of steroid hormones;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-168256|Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-211976|Endogenous sterols;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-6794362|Protein-protein interactions at synapses;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-5576892|Phase 0 - rapid depolarisation;KEGG:hsa05224|Breast cancer;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-6794361|Interactions of neurexins and neuroligins at synapses;KEGG:hsa04925|Aldosterone synthesis and secretion;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules
67924-63-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05164|Influenza A;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05133|Pertussis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05134|Legionellosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05162|Measles;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05146|Amoebiasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism
6795-23-9	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-68886|M Phase;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-5617833|Cilium Assembly;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168256|Immune System;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling
68-10-0	REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System
68-12-2	REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
68-19-9	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
68-22-4	KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System
68-88-2	REACT:R-HSA-1430728|Metabolism
68-96-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
68006-83-7	REACT:R-HSA-1430728|Metabolism
68085-85-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05034|Alcoholism;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System
683-18-1	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System
68359-37-5	REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
68392-35-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05215|Prostate cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05164|Influenza A;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05224|Breast cancer;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04510|Focal adhesion;KEGG:hsa04914|Progesterone-mediated oocyte maturation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05211|Renal cell carcinoma;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type
684-93-5	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa05218|Melanoma;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05214|Glioma;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05160|Hepatitis C;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04370|VEGF signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05216|Thyroid cancer;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04664|Fc epsilon RI signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04110|Cell cycle;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04140|Autophagy - animal
68684-63-9	KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism
68694-11-1	REACT:R-HSA-1430728|Metabolism
688-73-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04510|Focal adhesion;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05162|Measles;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-909733|Interferon alpha/beta signaling;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05214|Glioma;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-5362517|Signaling by Retinoic Acid;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04360|Axon guidance
68844-77-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways
6893-02-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05224|Breast cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05215|Prostate cancer;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05218|Melanoma;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04210|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04923|Regulation of lipolysis in adipocytes;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1368082|RORA activates gene expression;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1226099|Signaling by FGFR in disease;REACT:R-HSA-109704|PI3K Cascade;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05219|Bladder cancer;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05418|Fluid shear stress and atherosclerosis
6894-43-5	KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
69-53-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05146|Amoebiasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05016|Huntington's disease;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction
69-65-8	KEGG:hsa05161|Hepatitis B;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology
69-72-7	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05140|Leishmaniasis;KEGG:hsa05164|Influenza A;KEGG:hsa05133|Pertussis;KEGG:hsa05134|Legionellosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression
69-89-6	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01200|Carbon metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
69-93-2	KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05133|Pertussis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
6900-87-4	REACT:R-HSA-1430728|Metabolism
6902-77-8	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR
6917-35-7	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05215|Prostate cancer;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05219|Bladder cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05133|Pertussis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05218|Melanoma;REACT:R-HSA-1483249|Inositol phosphate metabolism;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05152|Tuberculosis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa04070|Phosphatidylinositol signaling system;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis
6923-22-4	KEGG:hsa04210|Apoptosis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System
693-07-2	KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05132|Salmonella infection;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04110|Cell cycle;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05162|Measles;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
6956-96-3	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-68886|M Phase;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04110|Cell cycle;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168256|Immune System;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression
69648-38-0	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
69839-83-4	REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
70-18-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1643685|Disease;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05164|Influenza A;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05215|Prostate cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04510|Focal adhesion;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa05134|Legionellosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04931|Insulin resistance;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05160|Hepatitis C;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa03040|Spliceosome;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-72172|mRNA Splicing;KEGG:hsa05218|Melanoma;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa04062|Chemokine signaling pathway
70-22-4	REACT:R-HSA-162582|Signal Transduction
70-25-7	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05219|Bladder cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05218|Melanoma;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04110|Cell cycle;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05214|Glioma;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling
70-34-8	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05133|Pertussis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05162|Measles;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System
70-51-9	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05012|Parkinson's disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa04216|Ferroptosis;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05219|Bladder cancer;KEGG:hsa05016|Huntington's disease;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05134|Legionellosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa05144|Malaria;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-917937|Iron uptake and transport;KEGG:hsa05224|Breast cancer;KEGG:hsa05214|Glioma;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05218|Melanoma;KEGG:hsa05146|Amoebiasis;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade
700-06-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04210|Apoptosis;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa05215|Prostate cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01523|Antifolate resistance;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05162|Measles;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05224|Breast cancer;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05133|Pertussis;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04976|Bile secretion;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05144|Malaria;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04630|Jak-STAT signaling pathway
7004-03-7	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1643685|Disease;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04210|Apoptosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05162|Measles;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events
7012-37-5	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-68886|M Phase;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa04110|Cell cycle;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-68962|Activation of the pre-replicative complex;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05224|Breast cancer;REACT:R-HSA-69242|S Phase;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa05218|Melanoma;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-6811434|COPI-dependent Golgi-to-ER retrograde traffic;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-983189|Kinesins;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-442742|CREB phosphorylation through the activation of Ras;REACT:R-HSA-176187|Activation of ATR in response to replication stress;REACT:R-HSA-438064|Post NMDA receptor activation events
70288-86-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-3371556|Cellular response to heat stress;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05134|Legionellosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;KEGG:hsa05132|Salmonella infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05133|Pertussis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;KEGG:hsa05146|Amoebiasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05162|Measles;KEGG:hsa04612|Antigen processing and presentation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05144|Malaria;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane
70563-58-5	KEGG:hsa05140|Leishmaniasis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
70649-54-6	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05016|Huntington's disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism
7084-24-4	KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-388396|GPCR downstream signaling
7085-55-4	KEGG:hsa04210|Apoptosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-168256|Immune System;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism
71-00-1	REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System
71-30-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-379716|Cytosolic tRNA aminoacylation;KEGG:hsa_M00359|Aminoacyl-tRNA biosynthesis, eukaryotes;REACT:R-HSA-379724|tRNA Aminoacylation;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04210|Apoptosis;KEGG:hsa00970|Aminoacyl-tRNA biosynthesis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-168256|Immune System;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-1280218|Adaptive Immune System
71-36-3	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1643685|Disease;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04666|Fc gamma R-mediated phagocytosis;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05214|Glioma;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04144|Endocytosis;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04370|VEGF signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05133|Pertussis;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05146|Amoebiasis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05132|Salmonella infection;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05215|Prostate cancer;KEGG:hsa04520|Adherens junction;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05224|Breast cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa04730|Long-term depression;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-69278|Cell Cycle, Mitotic
71-43-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05164|Influenza A;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05162|Measles;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05134|Legionellosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05215|Prostate cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05133|Pertussis;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R
71-44-3	REACT:R-HSA-390522|Striated Muscle Contraction;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05160|Hepatitis C;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1643685|Disease
71-58-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa04510|Focal adhesion;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05133|Pertussis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05152|Tuberculosis;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05219|Bladder cancer;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa05144|Malaria;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-216083|Integrin cell surface interactions;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05164|Influenza A;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05134|Legionellosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05162|Measles;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
71-63-6	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05164|Influenza A;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168249|Innate Immune System
71125-38-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism
71160-24-2	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05140|Leishmaniasis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1430728|Metabolism
71441-28-6	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
71751-41-2	REACT:R-HSA-168256|Immune System
7187-62-4	REACT:R-HSA-162582|Signal Transduction
72-20-8	REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
72-33-3	REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
72-43-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04210|Apoptosis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05162|Measles;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05164|Influenza A;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05214|Glioma;KEGG:hsa04919|Thyroid hormone signaling pathway
72-48-0	KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism
72-54-8	REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
72-55-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05215|Prostate cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05162|Measles;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-211976|Endogenous sterols;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05224|Breast cancer;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-912526|Interleukin receptor SHC signaling
72-69-5	REACT:R-HSA-1430728|Metabolism
72025-60-6	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
723-46-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
7235-40-7	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05160|Hepatitis C;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05162|Measles;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05224|Breast cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1280218|Adaptive Immune System
72509-76-3	REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
72559-06-9	KEGG:hsa05140|Leishmaniasis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
7261-97-4	KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins
72795-19-8	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-168256|Immune System
72909-34-3	KEGG:hsa05016|Huntington's disease;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
72956-09-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05143|African trypanosomiasis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04931|Insulin resistance;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04510|Focal adhesion;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa05162|Measles;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa04611|Platelet activation;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-74751|Insulin receptor signalling cascade
72962-43-7	KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04110|Cell cycle;KEGG:hsa05161|Hepatitis B;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
73-03-0	KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04210|Apoptosis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
73-24-5	REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05134|Legionellosis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa05160|Hepatitis C;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05132|Salmonella infection;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-1643685|Disease;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1632852|Macroautophagy;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-114452|Activation of BH3-only proteins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade
73-31-4	REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05164|Influenza A;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05133|Pertussis;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05162|Measles;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05224|Breast cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04137|Mitophagy - animal;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05166|HTLV-I infection;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05132|Salmonella infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05214|Glioma;REACT:R-HSA-74160|Gene Expression
73-40-5	KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa01523|Antifolate resistance;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-69242|S Phase;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168249|Innate Immune System
7324-41-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
73348-75-1	REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04978|Mineral absorption;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease
73536-69-3	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
73590-58-6	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-1643685|Disease;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-72766|Translation;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;KEGG:hsa00983|Drug metabolism - other enzymes;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;KEGG:hsa_M00014|Glucuronate pathway (uronate pathway);REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;KEGG:hsa03010|Ribosome;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-74160|Gene Expression;KEGG:hsa00040|Pentose and glucuronate interconversions;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa00053|Ascorbate and aldarate metabolism;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04976|Bile secretion;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05133|Pertussis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-1236974|ER-Phagosome pathway;KEGG:hsa00010|Glycolysis / Gluconeogenesis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-72312|rRNA processing;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-1236975|Antigen processing-Cross presentation;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-5607761|Dectin-1 mediated noncanonical NF-kB signaling;KEGG:hsa00590|Arachidonic acid metabolism;REACT:R-HSA-5678895|Defective CFTR causes cystic fibrosis;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-2871837|FCERI mediated NF-kB activation;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-5619084|ABC transporter disorders;REACT:R-HSA-69206|G1/S Transition
73836-78-9	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR
73945-47-8	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
73963-72-1	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins
74-79-3	KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
74-84-0	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05215|Prostate cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05222|Small cell lung cancer
74-90-8	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1430728|Metabolism;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05134|Legionellosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04510|Focal adhesion;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05162|Measles;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04730|Long-term depression;KEGG:hsa05132|Salmonella infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04916|Melanogenesis;KEGG:hsa05202|Transcriptional misregulation in cancer
74-98-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways
74050-98-9	REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction
74191-85-8	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168256|Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins
7429-90-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168256|Immune System;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04740|Olfactory transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-381753|Olfactory Signaling Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05161|Hepatitis B;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1643685|Disease;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05146|Amoebiasis;KEGG:hsa05133|Pertussis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05162|Measles;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-375280|Amine ligand-binding receptors;KEGG:hsa05320|Autoimmune thyroid disease;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-6805567|Keratinization;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05310|Asthma;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-8856828|Clathrin-mediated endocytosis;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04623|Cytosolic DNA-sensing pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling
7439-89-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04216|Ferroptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05134|Legionellosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05133|Pertussis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-917937|Iron uptake and transport;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05215|Prostate cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05144|Malaria;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04978|Mineral absorption;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05162|Measles;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04931|Insulin resistance;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1643685|Disease;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05020|Prion diseases;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04115|p53 signaling pathway;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05211|Renal cell carcinoma;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05218|Melanoma;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-156590|Glutathione conjugation;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade
7439-91-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR
7439-92-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04210|Apoptosis;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04012|ErbB signaling pathway
7439-93-2	REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05164|Influenza A;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05030|Cocaine addiction;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05162|Measles;KEGG:hsa05132|Salmonella infection;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling
7439-95-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-8853659|RET signaling;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04145|Phagosome;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1643685|Disease;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05133|Pertussis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05146|Amoebiasis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death
7439-96-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109582|Hemostasis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05134|Legionellosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05164|Influenza A;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04137|Mitophagy - animal;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05012|Parkinson's disease;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04510|Focal adhesion
7439-97-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05164|Influenza A;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa05162|Measles;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05132|Salmonella infection;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04662|B cell receptor signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04976|Bile secretion;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa05020|Prion diseases
7439-98-7	KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05218|Melanoma;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05224|Breast cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05214|Glioma;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04210|Apoptosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05152|Tuberculosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
7440-02-0	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05164|Influenza A;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-71387|Metabolism of carbohydrates
7440-06-4	KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168256|Immune System
7440-09-7	REACT:R-HSA-1296071|Potassium Channels;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1296065|Inwardly rectifying K+ channels;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-5576886|Phase 4 - resting membrane potential;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF
7440-22-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05162|Measles;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04510|Focal adhesion;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade
7440-23-5	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-5576892|Phase 0 - rapid depolarisation;REACT:R-HSA-445095|Interaction between L1 and Ankyrins;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;REACT:R-HSA-373760|L1CAM interactions;REACT:R-HSA-2672351|Stimuli-sensing channels;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins
7440-28-0	REACT:R-HSA-1296071|Potassium Channels;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05215|Prostate cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression
7440-32-6	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05133|Pertussis;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05164|Influenza A;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04210|Apoptosis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04145|Phagosome;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04360|Axon guidance;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-216083|Integrin cell surface interactions;REACT:R-HSA-2871796|FCERI mediated MAPK activation
7440-33-7	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-72766|Translation;KEGG:hsa03010|Ribosome;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05016|Huntington's disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-68886|M Phase;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-109582|Hemostasis;KEGG:hsa03040|Spliceosome;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-3108232|SUMO E3 ligases SUMOylate target proteins;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-2990846|SUMOylation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-162906|HIV Infection;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-69242|S Phase;REACT:R-HSA-3108214|SUMOylation of DNA damage response and repair proteins;REACT:R-HSA-5663220|RHO GTPases Activate Formins
7440-36-0	KEGG:hsa05164|Influenza A;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway
7440-38-2	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05224|Breast cancer;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05162|Measles;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04210|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-73894|DNA Repair;KEGG:hsa04510|Focal adhesion;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation
7440-39-3	REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-1296071|Potassium Channels;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-1296065|Inwardly rectifying K+ channels;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-1296059|G protein gated Potassium channels;REACT:R-HSA-1296041|Activation of G protein gated Potassium channels;REACT:R-HSA-997272|Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-977444|GABA B receptor activation;REACT:R-HSA-991365|Activation of GABAB receptors;REACT:R-HSA-422356|Regulation of insulin secretion;REACT:R-HSA-400042|Adrenaline,noradrenaline inhibits insulin secretion;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-977443|GABA receptor activation;REACT:R-HSA-163685|Integration of energy metabolism;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04727|GABAergic synapse;REACT:R-HSA-5576893|Phase 2 - plateau phase;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);REACT:R-HSA-418346|Platelet homeostasis;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04260|Cardiac muscle contraction;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-111885|Opioid Signalling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology
7440-41-7	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05332|Graft-versus-host disease;KEGG:hsa05161|Hepatitis B;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1643685|Disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05224|Breast cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-392499|Metabolism of proteins
7440-43-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04210|Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling
7440-44-0	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04510|Focal adhesion;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-68886|M Phase;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04360|Axon guidance;KEGG:hsa05164|Influenza A;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications
7440-45-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05164|Influenza A;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05134|Legionellosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05162|Measles;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa05144|Malaria;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5260271|Diseases of Immune System;REACT:R-HSA-5602358|Diseases associated with the TLR signaling cascade;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-446652|Interleukin-1 signaling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-1236975|Antigen processing-Cross presentation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05010|Alzheimer's disease
7440-46-2	REACT:R-HSA-1430728|Metabolism
7440-47-3	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72766|Translation;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa03010|Ribosome;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04510|Focal adhesion;KEGG:hsa05164|Influenza A;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05162|Measles;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05210|Colorectal cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-69206|G1/S Transition
7440-48-4	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-68886|M Phase;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-69242|S Phase;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04210|Apoptosis;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa04110|Cell cycle;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04931|Insulin resistance;KEGG:hsa04144|Endocytosis;KEGG:hsa05152|Tuberculosis
7440-50-8	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-72766|Translation;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-68886|M Phase;KEGG:hsa01200|Carbon metabolism;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05164|Influenza A;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR)
7440-54-2	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05146|Amoebiasis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05162|Measles;KEGG:hsa05161|Hepatitis B;KEGG:hsa05144|Malaria;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2672351|Stimuli-sensing channels;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease
7440-55-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05134|Legionellosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism
7440-57-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05161|Hepatitis B;KEGG:hsa05134|Legionellosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05162|Measles;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa01200|Carbon metabolism;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-168643|Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;KEGG:hsa05224|Breast cancer;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05133|Pertussis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-75153|Apoptotic execution  phase;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-111465|Apoptotic cleavage of cellular proteins;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04213|Longevity regulating pathway - multiple species;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05132|Salmonella infection
7440-61-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04144|Endocytosis;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05224|Breast cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05164|Influenza A;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs
7440-62-2	REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04611|Platelet activation;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05161|Hepatitis B;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04931|Insulin resistance;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa05162|Measles;KEGG:hsa05164|Influenza A;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04540|Gap junction;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04970|Salivary secretion;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling
7440-66-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05164|Influenza A;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05152|Tuberculosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05134|Legionellosis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling
7440-67-7	REACT:R-HSA-168256|Immune System
7440-70-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-168256|Immune System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-5576891|Cardiac conduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04611|Platelet activation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04911|Insulin secretion;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-1643685|Disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);REACT:R-HSA-5578775|Ion homeostasis;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa04510|Focal adhesion;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-418346|Platelet homeostasis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-3295583|TRP channels;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04370|VEGF signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04970|Salivary secretion;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-2672351|Stimuli-sensing channels;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04540|Gap junction;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04730|Long-term depression;REACT:R-HSA-422356|Regulation of insulin secretion;REACT:R-HSA-418360|Platelet calcium homeostasis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-163685|Integration of energy metabolism;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05161|Hepatitis B;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04925|Aldosterone synthesis and secretion;KEGG:hsa04972|Pancreatic secretion;KEGG:hsa05164|Influenza A;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05214|Glioma;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04720|Long-term potentiation
7440-74-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins
74431-23-5	KEGG:hsa04976|Bile secretion;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
7446-09-5	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05016|Huntington's disease;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05134|Legionellosis;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05144|Malaria;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05164|Influenza A;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05146|Amoebiasis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05162|Measles;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1430728|Metabolism
7447-39-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109581|Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05164|Influenza A;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-69304|Regulation of DNA replication;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa03050|Proteasome;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-69541|Stabilization of p53;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-69610|p53-Independent DNA Damage Response;REACT:R-HSA-69613|p53-Independent G1/S DNA damage checkpoint;REACT:R-HSA-69601|Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R
7447-40-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04930|Type II diabetes mellitus;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04911|Insulin secretion;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05152|Tuberculosis;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04510|Focal adhesion;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05164|Influenza A;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-74751|Insulin receptor signalling cascade
7447-41-8	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05224|Breast cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04110|Cell cycle;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05217|Basal cell carcinoma;KEGG:hsa04210|Apoptosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04510|Focal adhesion;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa_M00677|Wnt signaling;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05162|Measles;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-69242|S Phase;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05216|Thyroid cancer;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05214|Glioma;KEGG:hsa04931|Insulin resistance
745-65-3	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-392499|Metabolism of proteins
74772-77-3	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05133|Pertussis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05219|Bladder cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa05166|HTLV-I infection;KEGG:hsa05224|Breast cancer;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05218|Melanoma;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR
7481-89-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05016|Huntington's disease;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04260|Cardiac muscle contraction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-6799198|Complex I biogenesis;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04110|Cell cycle;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1474244|Extracellular matrix organization
7487-94-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05164|Influenza A;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05133|Pertussis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05134|Legionellosis;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05162|Measles;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04380|Osteoclast differentiation
7488-70-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05224|Breast cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05218|Melanoma;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05221|Acute myeloid leukemia;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-209968|Thyroxine biosynthesis;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa04923|Regulation of lipolysis in adipocytes;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa01523|Antifolate resistance;KEGG:hsa05160|Hepatitis C;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04015|Rap1 signaling pathway
749-02-0	KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-162582|Signal Transduction
75-01-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168256|Immune System;KEGG:hsa04931|Insulin resistance;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification
75-07-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04931|Insulin resistance;KEGG:hsa05219|Bladder cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05146|Amoebiasis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05133|Pertussis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa00010|Glycolysis / Gluconeogenesis;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04216|Ferroptosis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-196071|Metabolism of steroid hormones;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-1643685|Disease;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-379716|Cytosolic tRNA aminoacylation;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa00330|Arginine and proline metabolism;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05160|Hepatitis C;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance
75-09-2	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-400253|Circadian Clock;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-191273|Cholesterol biosynthesis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;KEGG:hsa05133|Pertussis;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05162|Measles;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04210|Apoptosis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis
75-15-0	KEGG:hsa04140|Autophagy - animal;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
75-27-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
75-35-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa00280|Valine, leucine and isoleucine degradation;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-6788656|Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-68886|M Phase;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-69242|S Phase;KEGG:hsa04142|Lysosome;KEGG:hsa00260|Glycine, serine and threonine metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa00630|Glyoxylate and dicarboxylate metabolism;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-70895|Branched-chain amino acid catabolism;REACT:R-HSA-549132|Organic cation/anion/zwitterion transport;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69306|DNA Replication;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa00230|Purine metabolism;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa00640|Propanoate metabolism;KEGG:hsa00380|Tryptophan metabolism;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa04145|Phagosome;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04360|Axon guidance;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-397014|Muscle contraction
75-44-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05152|Tuberculosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway
75-60-5	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05164|Influenza A;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05219|Bladder cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05160|Hepatitis C;KEGG:hsa05162|Measles;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05133|Pertussis;KEGG:hsa05224|Breast cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05134|Legionellosis;KEGG:hsa05218|Melanoma;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04110|Cell cycle;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05214|Glioma;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04931|Insulin resistance
75-65-0	REACT:R-HSA-168256|Immune System
75-91-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05164|Influenza A;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05152|Tuberculosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05162|Measles;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN
751-03-1	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
7512-17-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System
75330-75-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01522|Endocrine resistance;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05160|Hepatitis C;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05224|Breast cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05162|Measles;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04110|Cell cycle;KEGG:hsa05214|Glioma;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-112399|IRS-mediated signalling
7535-00-4	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04210|Apoptosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05134|Legionellosis;KEGG:hsa05164|Influenza A;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05133|Pertussis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05146|Amoebiasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05144|Malaria;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05162|Measles;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05215|Prostate cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways
7553-56-2	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
7554-12-3	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa04360|Axon guidance;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-168256|Immune System;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-388396|GPCR downstream signaling
7554-65-6	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-372790|Signaling by GPCR
7562-87-0	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-68886|M Phase;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1643685|Disease;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04120|Ubiquitin mediated proteolysis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa03013|RNA transport;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04360|Axon guidance;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa03018|RNA degradation;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-72202|Transport of Mature Transcript to Cytoplasm;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-69242|S Phase;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa00230|Purine metabolism;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5368286|Mitochondrial translation initiation;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-162587|HIV Life Cycle;KEGG:hsa04144|Endocytosis;REACT:R-HSA-162599|Late Phase of HIV Life Cycle;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5368287|Mitochondrial translation
75695-93-1	REACT:R-HSA-1430728|Metabolism
75706-12-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-68886|M Phase;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-69242|S Phase;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-174178|APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04210|Apoptosis
75847-73-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05146|Amoebiasis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05144|Malaria;REACT:R-HSA-168256|Immune System;KEGG:hsa05164|Influenza A;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05162|Measles;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-2980736|Peptide hormone metabolism;KEGG:hsa05160|Hepatitis C;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System
759-73-9	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1643685|Disease;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05215|Prostate cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04110|Cell cycle;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05214|Glioma;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-5358351|Signaling by Hedgehog;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5610787|Hedgehog 'off' state;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05218|Melanoma;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5617833|Cilium Assembly;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04730|Long-term depression;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa04210|Apoptosis;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway
76-03-9	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
76-06-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-72766|Translation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-156842|Eukaryotic Translation Elongation;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1643685|Disease;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa03010|Ribosome;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-72649|Translation initiation complex formation;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-611105|Respiratory electron transport;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-162909|Host Interactions of HIV factors;KEGG:hsa05130|Pathogenic Escherichia coli infection;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1236975|Antigen processing-Cross presentation;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1236974|ER-Phagosome pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen
76-22-2	REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6794362|Protein-protein interactions at synapses;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5576893|Phase 2 - plateau phase;KEGG:hsa05033|Nicotine addiction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6794361|Interactions of neurexins and neuroligins at synapses;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5576892|Phase 0 - rapid depolarisation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05224|Breast cancer;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC);REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04260|Cardiac muscle contraction;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-168256|Immune System;KEGG:hsa04360|Axon guidance;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5576891|Cardiac conduction;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-442755|Activation of NMDA receptor upon glutamate binding and postsynaptic events;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-112310|Neurotransmitter Release Cycle;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;KEGG:hsa05215|Prostate cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa04727|GABAergic synapse;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;KEGG:hsa04720|Long-term potentiation;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04110|Cell cycle
76-25-5	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
76-42-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-162582|Signal Transduction
76-44-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05224|Breast cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;KEGG:hsa05214|Glioma;KEGG:hsa05215|Prostate cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05218|Melanoma;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04210|Apoptosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04540|Gap junction;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05034|Alcoholism;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-68886|M Phase;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism
76-57-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa01100|Metabolic pathways;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress
76-74-4	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05033|Nicotine addiction;REACT:R-HSA-168256|Immune System;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05032|Morphine addiction;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04727|GABAergic synapse;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05034|Alcoholism;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-977443|GABA receptor activation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05224|Breast cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis
76-75-5	REACT:R-HSA-162582|Signal Transduction
76-80-2	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction
76-99-3	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR
7601-89-0	REACT:R-HSA-1430728|Metabolism
7614-21-3	KEGG:hsa04510|Focal adhesion;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology
76150-91-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04110|Cell cycle;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-68886|M Phase;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69242|S Phase;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69306|DNA Replication;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05224|Breast cancer;KEGG:hsa05218|Melanoma;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05214|Glioma;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-68962|Activation of the pre-replicative complex;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1257604|PIP3 activates AKT signaling
76180-96-6	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
7631-86-9	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04210|Apoptosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-68886|M Phase;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05034|Alcoholism;KEGG:hsa05162|Measles;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05145|Toxoplasmosis
7631-90-5	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
7631-99-4	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System
7632-00-0	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
7646-79-9	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-68886|M Phase;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-69242|S Phase;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04210|Apoptosis;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04931|Insulin resistance;KEGG:hsa04110|Cell cycle;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5689880|Ub-specific processing proteases
7646-85-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05164|Influenza A;KEGG:hsa05133|Pertussis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04978|Mineral absorption;REACT:R-HSA-425410|Metal ion SLC transporters;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1643685|Disease;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04510|Focal adhesion;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-435354|Zinc transporters;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa05131|Shigellosis;KEGG:hsa04137|Mitophagy - animal;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04216|Ferroptosis;KEGG:hsa05162|Measles;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System
7647-01-0	REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa05224|Breast cancer;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-72766|Translation;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-162906|HIV Infection;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04144|Endocytosis;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-114608|Platelet degranulation
76543-15-2	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-68886|M Phase;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04110|Cell cycle;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-69242|S Phase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);KEGG:hsa03030|DNA replication;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-176187|Activation of ATR in response to replication stress;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-174417|Telomere C-strand (Lagging Strand) Synthesis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-180786|Extension of Telomeres;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;REACT:R-HSA-5693579|Homologous DNA Pairing and Strand Exchange;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-69186|Lagging Strand Synthesis;REACT:R-HSA-110373|Resolution of AP sites via the multiple-nucleotide patch replacement pathway;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-5693616|Presynaptic phase of homologous DNA pairing and strand exchange;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-73933|Resolution of Abasic Sites (AP sites);REACT:R-HSA-73884|Base Excision Repair;REACT:R-HSA-5651801|PCNA-Dependent Long Patch Base Excision Repair;REACT:R-HSA-176974|Unwinding of DNA;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2565942|Regulation of PLK1 Activity at G2/M Transition;REACT:R-HSA-5685938|HDR through Single Strand Annealing (SSA);KEGG:hsa03460|Fanconi anemia pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa03440|Homologous recombination;REACT:R-HSA-174411|Polymerase switching on the C-strand of the telomere;REACT:R-HSA-69109|Leading Strand Synthesis;REACT:R-HSA-69091|Polymerase switching;REACT:R-HSA-69205|G1/S-Specific Transcription;KEGG:hsa03430|Mismatch repair;REACT:R-HSA-110314|Recognition of DNA damage by PCNA-containing replication complex;REACT:R-HSA-69183|Processive synthesis on the lagging strand;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-5696397|Gap-filling DNA repair synthesis and ligation in GG-NER;REACT:R-HSA-8854518|AURKA Activation by TPX2;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-5696400|Dual Incision in GG-NER;REACT:R-HSA-2990846|SUMOylation;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-69166|Removal of the Flap Intermediate;REACT:R-HSA-3108232|SUMO E3 ligases SUMOylate target proteins;REACT:R-HSA-380270|Recruitment of mitotic centrosome proteins and complexes;REACT:R-HSA-380287|Centrosome maturation;KEGG:hsa03410|Base excision repair;REACT:R-HSA-73893|DNA Damage Bypass;REACT:R-HSA-5617833|Cilium Assembly;REACT:R-HSA-5656169|Termination of translesion DNA synthesis;KEGG:hsa03420|Nucleotide excision repair;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-5358565|Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-380284|Loss of proteins required for interphase microtubule organization from the centrosome;REACT:R-HSA-380259|Loss of Nlp from mitotic centrosomes
7664-39-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-72766|Translation;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05012|Parkinson's disease;KEGG:hsa03010|Ribosome;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa00010|Glycolysis / Gluconeogenesis;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa04540|Gap junction;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-72312|rRNA processing;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05130|Pathogenic Escherichia coli infection;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;KEGG:hsa05146|Amoebiasis;KEGG:hsa04922|Glucagon signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-70326|Glucose metabolism;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling
7664-41-7	KEGG:hsa05134|Legionellosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05162|Measles;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-109582|Hemostasis
7665-99-8	KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392154|Nitric oxide stimulates guanylate cyclase;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-418346|Platelet homeostasis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05152|Tuberculosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04611|Platelet activation;KEGG:hsa00230|Purine metabolism;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04210|Apoptosis;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa05161|Hepatitis B;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa05164|Influenza A;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01100|Metabolic pathways
768-94-5	KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR
7681-49-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05016|Huntington's disease;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-72766|Translation;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-156902|Peptide chain elongation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168254|Influenza Infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05012|Parkinson's disease;KEGG:hsa03010|Ribosome;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04510|Focal adhesion;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-422475|Axon guidance;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05130|Pathogenic Escherichia coli infection;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05215|Prostate cancer;KEGG:hsa00010|Glycolysis / Gluconeogenesis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04922|Glucagon signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04540|Gap junction;REACT:R-HSA-70326|Glucose metabolism;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04621|NOD-like receptor signaling pathway
76824-35-6	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05140|Leishmaniasis;KEGG:hsa05164|Influenza A;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05330|Allograft rejection;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05134|Legionellosis;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05162|Measles;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05146|Amoebiasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1266738|Developmental Biology
7683-59-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05152|Tuberculosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05134|Legionellosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05133|Pertussis;KEGG:hsa05146|Amoebiasis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05162|Measles;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05215|Prostate cancer;KEGG:hsa04213|Longevity regulating pathway - multiple species;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05414|Dilated cardiomyopathy;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-74752|Signaling by Insulin receptor
7689-03-4	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-68886|M Phase;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5663220|RHO GTPases Activate Formins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-69242|S Phase;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa05215|Prostate cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-3108232|SUMO E3 ligases SUMOylate target proteins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2990846|SUMOylation;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa05162|Measles;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05152|Tuberculosis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-69481|G2/M Checkpoints
76896-80-5	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
76898-47-0	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
7690-51-9	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
7697-37-2	KEGG:hsa04110|Cell cycle;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05134|Legionellosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05152|Tuberculosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-74160|Gene Expression;KEGG:hsa05133|Pertussis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1643685|Disease;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05215|Prostate cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05132|Salmonella infection;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-6804114|TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05162|Measles;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-3371556|Cellular response to heat stress;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04978|Mineral absorption;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1538133|G0 and Early G1;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05144|Malaria;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-69231|Cyclin D associated events in G1;REACT:R-HSA-69236|G1 Phase;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa01200|Carbon metabolism;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade
77-10-1	KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05034|Alcoholism;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-168256|Immune System;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
77-21-4	REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
77-52-1	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05164|Influenza A;KEGG:hsa05160|Hepatitis C;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04931|Insulin resistance;KEGG:hsa05133|Pertussis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05219|Bladder cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05134|Legionellosis;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1643685|Disease;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-74160|Gene Expression
77-67-8	KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
77-92-9	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
77-95-2	KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression
7705-08-0	KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
77086-22-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05031|Amphetamine addiction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-442755|Activation of NMDA receptor upon glutamate binding and postsynaptic events;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04713|Circadian entrainment;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04210|Apoptosis;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-438064|Post NMDA receptor activation events;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04720|Long-term potentiation;KEGG:hsa05034|Alcoholism;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05152|Tuberculosis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01100|Metabolic pathways
77094-11-2	REACT:R-HSA-1430728|Metabolism
77102-82-0	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
7718-54-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05164|Influenza A;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04110|Cell cycle;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05162|Measles;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05133|Pertussis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05134|Legionellosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-168643|Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05224|Breast cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints
7722-84-1	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04210|Apoptosis;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05164|Influenza A;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04621|NOD-like receptor signaling pathway
7723-14-0	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways
7726-95-6	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction
7727-37-9	REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
7727-43-7	KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
7732-18-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-432047|Passive transport by Aquaporins;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-445717|Aquaporin-mediated transport;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05133|Pertussis;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-69242|S Phase;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05152|Tuberculosis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05161|Hepatitis B;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-392499|Metabolism of proteins
7733-02-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05224|Breast cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05134|Legionellosis;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05214|Glioma;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05162|Measles;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05218|Melanoma;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05219|Bladder cancer
77500-04-0	KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04110|Cell cycle;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-73894|DNA Repair;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress
7755-01-3	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression
7758-01-2	KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-166520|Signalling by NGF
7758-95-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05152|Tuberculosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05164|Influenza A;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis
7758-98-7	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-68886|M Phase;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-69473|G2/M DNA damage checkpoint
7761-88-8	KEGG:hsa04110|Cell cycle;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-1538133|G0 and Early G1;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-6804114|TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-69231|Cyclin D associated events in G1;REACT:R-HSA-69236|G1 Phase;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2559585|Oncogene Induced Senescence;KEGG:hsa04978|Mineral absorption;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-176187|Activation of ATR in response to replication stress;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69306|DNA Replication;KEGG:hsa04350|TGF-beta signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-69242|S Phase;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1430728|Metabolism;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa05164|Influenza A;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease
7773-01-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05152|Tuberculosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05164|Influenza A;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1643685|Disease;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05140|Leishmaniasis;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization
7775-11-3	REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression
7778-39-4	KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05224|Breast cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-372790|Signaling by GPCR
7778-50-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04210|Apoptosis;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2022090|Assembly of collagen fibrils and other multimeric structures;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05218|Melanoma;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04110|Cell cycle;KEGG:hsa05164|Influenza A;REACT:R-HSA-1650814|Collagen biosynthesis and modifying enzymes;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04360|Axon guidance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-1474228|Degradation of the extracellular matrix;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-170968|Frs2-mediated activation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-8948216|Collagen chain trimerization;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-74752|Signaling by Insulin receptor
7780-20-3	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04210|Apoptosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05218|Melanoma;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05214|Glioma;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-1643685|Disease;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05132|Salmonella infection;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05160|Hepatitis C;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-74160|Gene Expression
7782-42-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-390522|Striated Muscle Contraction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05134|Legionellosis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04210|Apoptosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1442490|Collagen degradation;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05161|Hepatitis B;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-193704|p75 NTR receptor-mediated signalling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05164|Influenza A;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05162|Measles;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04530|Tight junction;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-71387|Metabolism of carbohydrates
7782-44-7	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04510|Focal adhesion;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-8853659|RET signaling
7782-49-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04210|Apoptosis;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05164|Influenza A;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05215|Prostate cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa05016|Huntington's disease;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05152|Tuberculosis;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05132|Salmonella infection;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05162|Measles;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04144|Endocytosis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R
7782-50-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-163685|Integration of energy metabolism;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05164|Influenza A;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04210|Apoptosis;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04730|Long-term depression
7782-77-6	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05134|Legionellosis;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05146|Amoebiasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05160|Hepatitis C;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05162|Measles;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05206|MicroRNAs in cancer
7783-00-8	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-72766|Translation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);KEGG:hsa03010|Ribosome;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-192823|Viral mRNA Translation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-168254|Influenza Infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04510|Focal adhesion;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-109582|Hemostasis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05164|Influenza A;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
7783-06-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1643685|Disease;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05162|Measles;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05133|Pertussis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05134|Legionellosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04140|Autophagy - animal;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04110|Cell cycle;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-422475|Axon guidance
7784-34-1	KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
7786-30-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
7786-34-7	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
7786-81-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04510|Focal adhesion;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05146|Amoebiasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05162|Measles;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade
7789-00-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04360|Axon guidance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04144|Endocytosis;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5617833|Cilium Assembly;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04210|Apoptosis;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-194840|Rho GTPase cycle;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-68886|M Phase;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-170984|ARMS-mediated activation;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade
7789-47-1	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04360|Axon guidance;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-446728|Cell junction organization;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-421270|Cell-cell junction organization;KEGG:hsa04216|Ferroptosis;KEGG:hsa04978|Mineral absorption;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04514|Cell adhesion molecules (CAMs);REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05032|Morphine addiction;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04916|Melanogenesis
7790-86-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05146|Amoebiasis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05162|Measles;KEGG:hsa05164|Influenza A;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05132|Salmonella infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-112316|Neuronal System
7790-92-3	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-195253|Degradation of beta-catenin by the destruction complex;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2871837|FCERI mediated NF-kB activation;REACT:R-HSA-68886|M Phase;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade
78-30-8	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System
78-51-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04976|Bile secretion;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-74160|Gene Expression;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-2980736|Peptide hormone metabolism;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-6806667|Metabolism of fat-soluble vitamins;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-75109|Triglyceride Biosynthesis;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2187338|Visual phototransduction;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-174824|Lipoprotein metabolism;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04210|Apoptosis;KEGG:hsa04918|Thyroid hormone synthesis;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-15869|Metabolism of nucleotides;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04260|Cardiac muscle contraction;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1630316|Glycosaminoglycan metabolism
78-70-6	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05215|Prostate cancer;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05219|Bladder cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05224|Breast cancer;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1643685|Disease;KEGG:hsa04110|Cell cycle;KEGG:hsa05164|Influenza A;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-392499|Metabolism of proteins
78-83-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-68886|M Phase;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-162906|HIV Infection;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;KEGG:hsa05166|HTLV-I infection
78-98-8	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05146|Amoebiasis;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05132|Salmonella infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
7803-49-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
78111-17-8	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05211|Renal cell carcinoma;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04110|Cell cycle;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05164|Influenza A;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05133|Pertussis;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05224|Breast cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05016|Huntington's disease;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
789-02-6	REACT:R-HSA-74160|Gene Expression;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05133|Pertussis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05134|Legionellosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;KEGG:hsa05164|Influenza A;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168643|Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-72766|Translation;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-5675482|Regulation of necroptotic cell death;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;REACT:R-HSA-69541|Stabilization of p53;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-68886|M Phase;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5357769|Caspase activation via extrinsic apoptotic signalling pathway;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-174184|Cdc20:Phospho-APC/C mediated degradation of Cyclin A
78919-13-8	REACT:R-HSA-162582|Signal Transduction
78950-78-4	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR
79-01-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-68886|M Phase;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04210|Apoptosis;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);KEGG:hsa05020|Prion diseases
79-06-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04510|Focal adhesion;KEGG:hsa04210|Apoptosis;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-68886|M Phase;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04360|Axon guidance;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04141|Protein processing in endoplasmic reticulum
79-09-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
79-11-8	KEGG:hsa04210|Apoptosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-392499|Metabolism of proteins
79-17-4	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05164|Influenza A;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1643685|Disease;KEGG:hsa01100|Metabolic pathways
79-43-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-75109|Triglyceride Biosynthesis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-75105|Fatty Acyl-CoA Biosynthesis;REACT:R-HSA-68886|M Phase;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04146|Peroxisome;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01212|Fatty acid metabolism;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-977606|Regulation of Complement cascade;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05164|Influenza A;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-977225|Amyloid fiber formation;KEGG:hsa04976|Bile secretion;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-68875|Mitotic Prophase;KEGG:hsa04110|Cell cycle;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-156590|Glutathione conjugation;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166658|Complement cascade;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-400253|Circadian Clock;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05133|Pertussis;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-5334118|DNA methylation;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05134|Legionellosis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;KEGG:hsa05034|Alcoholism;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-1643685|Disease;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening
79-46-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
79-57-2	REACT:R-HSA-168256|Immune System
79-63-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction
79-81-2	REACT:R-HSA-1430728|Metabolism
79-83-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa00564|Glycerophospholipid metabolism;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04530|Tight junction;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5683057|MAPK family signaling cascades
79-94-7	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05224|Breast cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05164|Influenza A;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05162|Measles;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04310|Wnt signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05133|Pertussis;KEGG:hsa05219|Bladder cancer;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05134|Legionellosis;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05144|Malaria;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-6783783|Interleukin-10 signaling
79-95-8	REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism
79032-48-7	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1643685|Disease;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05160|Hepatitis C;KEGG:hsa04510|Focal adhesion;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins
79352-78-6	KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1430728|Metabolism;KEGG:hsa00830|Retinol metabolism;KEGG:hsa01100|Metabolic pathways
79551-86-3	REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
79617-96-2	KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05164|Influenza A;KEGG:hsa05134|Legionellosis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04728|Dopaminergic synapse;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05133|Pertussis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1643685|Disease;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05152|Tuberculosis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF
797-63-7	KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-199991|Membrane Trafficking
79794-75-5	REACT:R-HSA-1430728|Metabolism
79902-63-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05164|Influenza A;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1643685|Disease;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05133|Pertussis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05160|Hepatitis C;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05162|Measles;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05144|Malaria;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05214|Glioma;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;KEGG:hsa05218|Melanoma
80-05-7	REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-68886|M Phase;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04144|Endocytosis;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-162906|HIV Infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa05016|Huntington's disease;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-5617833|Cilium Assembly;REACT:R-HSA-6811442|Intra-Golgi and retrograde Golgi-to-ER traffic;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-69275|G2/M Transition
80-08-0	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
80-09-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04510|Focal adhesion;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1474290|Collagen formation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-1650814|Collagen biosynthesis and modifying enzymes;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa05224|Breast cancer;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-216083|Integrin cell surface interactions;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2022090|Assembly of collagen fibrils and other multimeric structures;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-8948216|Collagen chain trimerization;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1566948|Elastic fibre formation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04931|Insulin resistance;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-390522|Striated Muscle Contraction;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05146|Amoebiasis;KEGG:hsa04611|Platelet activation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04360|Axon guidance;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1500931|Cell-Cell communication;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-3781865|Diseases of glycosylation;KEGG:hsa04530|Tight junction;KEGG:hsa05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC);KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-446728|Cell junction organization;KEGG:hsa04916|Melanogenesis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04610|Complement and coagulation cascades
80-15-9	KEGG:hsa00480|Glutathione metabolism;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
80-62-6	REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-8866654|E3 ubiquitin ligases ubiquitinate target proteins;REACT:R-HSA-171306|Packaging Of Telomere Ends;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-8852135|Protein ubiquitination;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;REACT:R-HSA-5334118|DNA methylation;REACT:R-HSA-5625886|Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;REACT:R-HSA-427359|SIRT1 negatively regulates rRNA Expression;REACT:R-HSA-5693571|Nonhomologous End-Joining (NHEJ);REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-5693565|Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;REACT:R-HSA-427389|ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;REACT:R-HSA-5693606|DNA Double Strand Break Response;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-1221632|Meiotic synapsis;KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-73777|RNA Polymerase I Chain Elongation;REACT:R-HSA-5250924|B-WICH complex positively regulates rRNA expression;REACT:R-HSA-5625740|RHO GTPases activate PKNs;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;REACT:R-HSA-977225|Amyloid fiber formation;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;REACT:R-HSA-427413|NoRC negatively regulates rRNA expression;REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-5250941|Negative epigenetic regulation of rRNA expression;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;REACT:R-HSA-73864|RNA Polymerase I Transcription;REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-211000|Gene Silencing by RNA;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-68875|Mitotic Prophase;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-3214847|HATs acetylate histones;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05034|Alcoholism;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-68886|M Phase;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
8001-22-7	KEGG:hsa04976|Bile secretion;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
8001-26-1	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction
8001-28-3	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04110|Cell cycle;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-380108|Chemokine receptors bind chemokines;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress
8001-30-7	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
8001-35-2	REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
8002-31-1	REACT:R-HSA-168256|Immune System
8007-02-1	REACT:R-HSA-1430728|Metabolism;KEGG:hsa_M00009|Citrate cycle (TCA cycle, Krebs cycle);KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa00020|Citrate cycle (TCA cycle);REACT:R-HSA-71403|Citric acid cycle (TCA cycle);KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-71406|Pyruvate metabolism and Citric Acid (TCA) cycle;KEGG:hsa_M00011|Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-3371556|Cellular response to heat stress;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
8007-45-2	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-68886|M Phase;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-597592|Post-translational protein modification
8008-74-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa03010|Ribosome;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-70326|Glucose metabolism;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72766|Translation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;KEGG:hsa05200|Pathways in cancer;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-68886|M Phase;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa00010|Glycolysis / Gluconeogenesis;REACT:R-HSA-162587|HIV Life Cycle;REACT:R-HSA-6811442|Intra-Golgi and retrograde Golgi-to-ER traffic;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-162599|Late Phase of HIV Life Cycle;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5663220|RHO GTPases Activate Formins;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-8873719|RAB geranylgeranylation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-8876198|RAB GEFs exchange GTP for GDP on RABs;REACT:R-HSA-2565942|Regulation of PLK1 Activity at G2/M Transition
8018-01-7	KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa05215|Prostate cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05162|Measles;KEGG:hsa05016|Huntington's disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01100|Metabolic pathways
8021-39-4	REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa01100|Metabolic pathways
80214-83-1	REACT:R-HSA-168256|Immune System
8029-82-1	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
80471-63-2	REACT:R-HSA-168256|Immune System
80529-93-7	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
8059-24-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins
80751-65-1	KEGG:hsa04713|Circadian entrainment;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-111931|PKA-mediated phosphorylation of CREB;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-111885|Opioid Signalling;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-111933|Calmodulin induced events;REACT:R-HSA-111997|CaM pathway;REACT:R-HSA-111996|Ca-dependent events;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-1489509|DAG and IP3 signaling;REACT:R-HSA-167021|PLC-gamma1 signalling;REACT:R-HSA-212718|EGFR interacts with phospholipase C-gamma;KEGG:hsa04911|Insulin secretion;REACT:R-HSA-112043|PLC beta mediated events;REACT:R-HSA-112040|G-protein mediated events;KEGG:hsa05166|HTLV-I infection;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04918|Thyroid hormone synthesis;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04925|Aldosterone synthesis and secretion;KEGG:hsa04540|Gap junction;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04970|Salivary secretion;KEGG:hsa05032|Morphine addiction;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04972|Pancreatic secretion;KEGG:hsa04916|Melanogenesis;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-388396|GPCR downstream signaling
80751-85-5	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01200|Carbon metabolism;KEGG:hsa01100|Metabolic pathways;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-70263|Gluconeogenesis;KEGG:hsa00010|Glycolysis / Gluconeogenesis;KEGG:hsa_M00003|Gluconeogenesis, oxaloacetate => fructose-6P;REACT:R-HSA-70326|Glucose metabolism;REACT:R-HSA-70171|Glycolysis;KEGG:hsa_M00001|Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69278|Cell Cycle, Mitotic
81-07-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
81-24-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa01522|Endocrine resistance;KEGG:hsa05164|Influenza A;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04976|Bile secretion;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04931|Insulin resistance;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05133|Pertussis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05160|Hepatitis C;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05162|Measles;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04510|Focal adhesion;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05020|Prion diseases;KEGG:hsa04137|Mitophagy - animal;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04215|Apoptosis - multiple species;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells
81-25-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04976|Bile secretion;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-159418|Recycling of bile acids and salts;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05161|Hepatitis B;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa02010|ABC transporters;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-156590|Glutathione conjugation;REACT:R-HSA-168256|Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05166|HTLV-I infection;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-174824|Lipoprotein metabolism;KEGG:hsa04931|Insulin resistance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05164|Influenza A;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression
81-81-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-163841|Gamma carboxylation, hypusine formation and arylsulfatase activation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05134|Legionellosis;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1643685|Disease;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05164|Influenza A;KEGG:hsa05162|Measles;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04530|Tight junction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05166|HTLV-I infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-212436|Generic Transcription Pathway
81093-37-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04976|Bile secretion;KEGG:hsa05200|Pathways in cancer;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04146|Peroxisome;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa02010|ABC transporters;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01212|Fatty acid metabolism;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05160|Hepatitis C;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05215|Prostate cancer;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05164|Influenza A;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-382556|ABC-family proteins mediated transport;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05162|Measles;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-186797|Signaling by PDGF
81103-11-9	REACT:R-HSA-1430728|Metabolism
81443-73-4	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05215|Prostate cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05213|Endometrial cancer;KEGG:hsa05224|Breast cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05160|Hepatitis C;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05164|Influenza A;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression
81485-25-8	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
81608-60-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168256|Immune System
81790-82-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
82-05-3	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
82-08-6	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05224|Breast cancer;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05214|Glioma;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05218|Melanoma;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04370|VEGF signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04666|Fc gamma R-mediated phagocytosis;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa05162|Measles;KEGG:hsa05213|Endometrial cancer;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05133|Pertussis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05132|Salmonella infection;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04931|Insulin resistance
82-89-3	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction
82-93-9	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology
822-06-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System
82258-36-4	REACT:R-HSA-1430728|Metabolism
823-40-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
82419-36-1	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04510|Focal adhesion;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05164|Influenza A;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04931|Insulin resistance;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04145|Phagosome;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology
82586-55-8	REACT:R-HSA-162582|Signal Transduction
82657-04-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05152|Tuberculosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05134|Legionellosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6798695|Neutrophil degranulation
82834-16-0	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins
83-34-1	REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
83-43-2	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05146|Amoebiasis;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05162|Measles;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05132|Salmonella infection;KEGG:hsa05134|Legionellosis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05144|Malaria;KEGG:hsa05133|Pertussis;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05160|Hepatitis C;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04210|Apoptosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-1643685|Disease;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1280218|Adaptive Immune System
83-44-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05164|Influenza A;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04931|Insulin resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-194068|Bile acid and bile salt metabolism;REACT:R-HSA-109582|Hemostasis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04976|Bile secretion;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04110|Cell cycle;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-192105|Synthesis of bile acids and bile salts;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04510|Focal adhesion;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-193368|Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa00983|Drug metabolism - other enzymes;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa01212|Fatty acid metabolism;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
83-48-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System
83-67-0	KEGG:hsa04210|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-168256|Immune System;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05133|Pertussis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05134|Legionellosis;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05146|Amoebiasis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;KEGG:hsa05162|Measles;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05132|Salmonella infection;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05144|Malaria;REACT:R-HSA-73887|Death Receptor Signalling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1643685|Disease;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-372790|Signaling by GPCR
83-79-4	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa00190|Oxidative phosphorylation;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa05224|Breast cancer;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa04931|Insulin resistance;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04015|Rap1 signaling pathway
83-86-3	KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism
83-88-5	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways
83-89-6	KEGG:hsa05210|Colorectal cancer;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism
83-98-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-194840|Rho GTPase cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-194315|Signaling by Rho GTPases
830-03-5	REACT:R-HSA-1430728|Metabolism
83003-12-7	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway
83150-76-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa04350|TGF-beta signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6798695|Neutrophil degranulation
832-01-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
832-69-9	REACT:R-HSA-1430728|Metabolism
83314-01-6	REACT:R-HSA-168256|Immune System
83366-66-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-351202|Metabolism of polyamines;KEGG:hsa03050|Proteasome;REACT:R-HSA-350562|Regulation of ornithine decarboxylase (ODC);REACT:R-HSA-5676590|NIK-->noncanonical NF-kB signaling;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-5607761|Dectin-1 mediated noncanonical NF-kB signaling;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-8854050|FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;REACT:R-HSA-180534|Vpu mediated degradation of CD4;REACT:R-HSA-5610780|Degradation of GLI1 by the proteasome;REACT:R-HSA-5610785|GLI3 is processed to GLI3R by the proteasome;REACT:R-HSA-5610783|Degradation of GLI2 by the proteasome;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211733|Regulation of activated PAK-2p34 by proteasome mediated degradation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-69017|CDK-mediated phosphorylation and removal of Cdc6;REACT:R-HSA-69541|Stabilization of p53;REACT:R-HSA-174113|SCF-beta-TrCP mediated degradation of Emi1;REACT:R-HSA-195253|Degradation of beta-catenin by the destruction complex;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-5678895|Defective CFTR causes cystic fibrosis;REACT:R-HSA-69610|p53-Independent DNA Damage Response;REACT:R-HSA-69613|p53-Independent G1/S DNA damage checkpoint;REACT:R-HSA-69601|Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;REACT:R-HSA-169911|Regulation of Apoptosis;REACT:R-HSA-5362768|Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-5619115|Disorders of transmembrane transporters;REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-1236978|Cross-presentation of soluble exogenous antigens (endosomes);REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-4641258|Degradation of DVL;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;REACT:R-HSA-5387390|Hh mutants abrogate ligand secretion;REACT:R-HSA-4641257|Degradation of AXIN;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-4608870|Asymmetric localization of PCP proteins;REACT:R-HSA-5619084|ABC transporter disorders;REACT:R-HSA-68827|CDT1 association with the CDC6:ORC:origin complex;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-4086400|PCP/CE pathway;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-5358346|Hedgehog ligand biogenesis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-5658442|Regulation of RAS by GAPs;REACT:R-HSA-69242|S Phase;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase
83373-60-8	REACT:R-HSA-168256|Immune System
834-12-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1643685|Disease;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System
83509-42-6	KEGG:hsa01522|Endocrine resistance;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction
83905-01-5	REACT:R-HSA-168256|Immune System
84-11-7	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
84-61-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04976|Bile secretion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04972|Pancreatic secretion;KEGG:hsa04611|Platelet activation;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1474228|Degradation of the extracellular matrix;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05224|Breast cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04914|Progesterone-mediated oocyte maturation;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05152|Tuberculosis;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-157118|Signaling by NOTCH
84-66-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis
84-69-5	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04142|Lysosome;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa00531|Glycosaminoglycan degradation;KEGG:hsa00100|Steroid biosynthesis;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-379716|Cytosolic tRNA aminoacylation;KEGG:hsa04913|Ovarian steroidogenesis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa_M00359|Aminoacyl-tRNA biosynthesis, eukaryotes;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-379724|tRNA Aminoacylation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa00970|Aminoacyl-tRNA biosynthesis;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04210|Apoptosis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1630316|Glycosaminoglycan metabolism;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05160|Hepatitis C;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-390466|Chaperonin-mediated protein folding;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-2132295|MHC class II antigen presentation;REACT:R-HSA-391251|Protein folding;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-428157|Sphingolipid metabolism;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-15869|Metabolism of nucleotides;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-8856828|Clathrin-mediated endocytosis;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-5576891|Cardiac conduction;KEGG:hsa05224|Breast cancer;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-194138|Signaling by VEGF
84-74-2	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-68886|M Phase;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04110|Cell cycle;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-69242|S Phase;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-112316|Neuronal System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00230|Purine metabolism;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton
84-75-3	REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1430728|Metabolism
84-80-0	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
84057-84-1	REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism
842-07-9	REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1430728|Metabolism
84225-95-6	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05034|Alcoholism;REACT:R-HSA-372790|Signaling by GPCR
84226-12-0	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
84371-65-3	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05215|Prostate cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1643685|Disease;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05224|Breast cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa04210|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05160|Hepatitis C;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05214|Glioma;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05144|Malaria;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1474228|Degradation of the extracellular matrix;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR)
84477-87-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05152|Tuberculosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05164|Influenza A;KEGG:hsa05133|Pertussis;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04510|Focal adhesion;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04210|Apoptosis;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-450282|MAPK targets/ Nuclear events mediated by MAP kinases;REACT:R-HSA-450294|MAP kinase activation in TLR cascade;KEGG:hsa05215|Prostate cancer;KEGG:hsa04071|Sphingolipid signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04917|Prolactin signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa04720|Long-term potentiation;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05231|Choline metabolism in cancer;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05134|Legionellosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04919|Thyroid hormone signaling pathway
84625-61-6	REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
84680-54-6	REACT:R-HSA-162582|Signal Transduction
85-01-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress
85-44-9	KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa05164|Influenza A
85-61-0	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa01100|Metabolic pathways
85-66-5	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
85-68-7	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04913|Ovarian steroidogenesis;KEGG:hsa05224|Breast cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05216|Thyroid cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05213|Endometrial cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-168256|Immune System;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa05214|Glioma;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa05218|Melanoma;KEGG:hsa04510|Focal adhesion;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04210|Apoptosis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1643685|Disease;KEGG:hsa05016|Huntington's disease;KEGG:hsa04010|MAPK signaling pathway
85166-31-0	REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK
85233-19-8	KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism
85509-19-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa05224|Breast cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-168256|Immune System;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-5653656|Vesicle-mediated transport
85539-83-9	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
85622-93-1	KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05215|Prostate cancer;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa01522|Endocrine resistance;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-69473|G2/M DNA damage checkpoint;KEGG:hsa05146|Amoebiasis;KEGG:hsa05162|Measles;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05224|Breast cancer;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1643685|Disease;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280218|Adaptive Immune System
85721-33-1	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04210|Apoptosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05164|Influenza A;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism
85760-74-3	KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
86-01-1	REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa04611|Platelet activation;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04360|Axon guidance;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04510|Focal adhesion;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins
86-21-5	REACT:R-HSA-1430728|Metabolism
86-42-0	KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;KEGG:hsa01522|Endocrine resistance;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-168249|Innate Immune System
86-54-4	REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-72766|Translation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;KEGG:hsa03010|Ribosome;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-5610780|Degradation of GLI1 by the proteasome;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5610787|Hedgehog 'off' state;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-5358351|Signaling by Hedgehog;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-195253|Degradation of beta-catenin by the destruction complex;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-5610785|GLI3 is processed to GLI3R by the proteasome;REACT:R-HSA-5610783|Degradation of GLI2 by the proteasome;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-69242|S Phase;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5632684|Hedgehog 'on' state;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-5607761|Dectin-1 mediated noncanonical NF-kB signaling;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-68886|M Phase;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-169911|Regulation of Apoptosis;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-2871796|FCERI mediated MAPK activation
863-03-6	KEGG:hsa05152|Tuberculosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05133|Pertussis;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction
86386-73-4	REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways
865-21-4	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04210|Apoptosis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-68886|M Phase;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1643685|Disease;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05219|Bladder cancer;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05144|Malaria;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05133|Pertussis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-69306|DNA Replication;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-69242|S Phase;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05162|Measles
86541-75-5	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05164|Influenza A;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04210|Apoptosis;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism
868-77-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
86819-20-7	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1430728|Metabolism
86925-97-5	REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism
87-66-1	REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168256|Immune System;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5693579|Homologous DNA Pairing and Strand Exchange;KEGG:hsa04110|Cell cycle;REACT:R-HSA-5685938|HDR through Single Strand Annealing (SSA);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-5693616|Presynaptic phase of homologous DNA pairing and strand exchange;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-156842|Eukaryotic Translation Elongation;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04210|Apoptosis;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-72766|Translation;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5693565|Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;REACT:R-HSA-5693606|DNA Double Strand Break Response;KEGG:hsa05012|Parkinson's disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1500620|Meiosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa03010|Ribosome;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF
87-68-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
87-86-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69242|S Phase;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-68886|M Phase;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-69481|G2/M Checkpoints;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-68867|Assembly of the pre-replicative complex;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;KEGG:hsa04110|Cell cycle;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa05161|Hepatitis B;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1169408|ISG15 antiviral mechanism;REACT:R-HSA-1169410|Antiviral mechanism by IFN-stimulated genes;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;KEGG:hsa05164|Influenza A;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05160|Hepatitis C
87081-35-4	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04110|Cell cycle;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05215|Prostate cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05164|Influenza A;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05214|Glioma;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05219|Bladder cancer;KEGG:hsa05218|Melanoma;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05224|Breast cancer;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05160|Hepatitis C;KEGG:hsa05162|Measles;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5689880|Ub-specific processing proteases;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-68886|M Phase;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1266738|Developmental Biology
87333-19-5	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System
87625-62-5	REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04512|ECM-receptor interaction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway
87687-70-5	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168256|Immune System;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-69242|S Phase;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa03030|DNA replication;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-68886|M Phase;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-176187|Activation of ATR in response to replication stress;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-5663220|RHO GTPases Activate Formins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-5693579|Homologous DNA Pairing and Strand Exchange;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-5693616|Presynaptic phase of homologous DNA pairing and strand exchange;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05146|Amoebiasis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-1474228|Degradation of the extracellular matrix;REACT:R-HSA-1643685|Disease;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04145|Phagosome;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-74160|Gene Expression
88-12-0	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction
88-72-2	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa05224|Breast cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04510|Focal adhesion;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System
88-88-0	KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins
88-99-3	REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
88150-42-9	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-168256|Immune System;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression
882-09-7	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-72766|Translation;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-168254|Influenza Infection;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-2408522|Selenoamino acid metabolism;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-72312|rRNA processing;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-8868773|rRNA processing in the nucleus and cytosol;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa03010|Ribosome;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa05016|Huntington's disease;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04146|Peroxisome;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry
88337-96-6	REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-388396|GPCR downstream signaling
88899-55-2	KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa04211|Longevity regulating pathway;KEGG:hsa04140|Autophagy - animal;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05164|Influenza A;KEGG:hsa05134|Legionellosis;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109581|Apoptosis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1257604|PIP3 activates AKT signaling;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04150|mTOR signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression
89-00-9	REACT:R-HSA-168256|Immune System
89-02-1	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-168256|Immune System
89-25-8	KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05144|Malaria;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05164|Influenza A;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05132|Salmonella infection;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05133|Pertussis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa01100|Metabolic pathways
89-57-6	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa05152|Tuberculosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
89-83-8	KEGG:hsa05161|Hepatitis B;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04210|Apoptosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
892-21-7	KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
89565-68-4	REACT:R-HSA-168256|Immune System
89750-14-1	REACT:R-HSA-168256|Immune System
90-04-0	KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-168256|Immune System;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05162|Measles;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-5260271|Diseases of Immune System;REACT:R-HSA-5602358|Diseases associated with the TLR signaling cascade;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04622|RIG-I-like receptor signaling pathway;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05134|Legionellosis;REACT:R-HSA-445989|TAK1 activates NFkB by phosphorylation and activation of IKKs complex;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa_M00686|Toll-like receptor signaling;KEGG:hsa05144|Malaria;REACT:R-HSA-1606322|ZBP1(DAI) mediated induction of type I IFNs;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1810476|RIP-mediated NFkB activation via ZBP1;REACT:R-HSA-73887|Death Receptor Signalling;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-933542|TRAF6 mediated NF-kB activation;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1834949|Cytosolic sensors of pathogen-associated DNA;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-5357956|TNFR1-induced NFkappaB signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-75893|TNF signaling;REACT:R-HSA-446652|Interleukin-1 signaling;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05146|Amoebiasis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05133|Pertussis;KEGG:hsa05132|Salmonella infection;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2871837|FCERI mediated NF-kB activation;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-597592|Post-translational protein modification
90-05-1	KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05200|Pathways in cancer;KEGG:hsa05133|Pertussis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04210|Apoptosis;KEGG:hsa05146|Amoebiasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-162582|Signal Transduction
90-15-3	KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-211981|Xenobiotics;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-1430728|Metabolism;KEGG:hsa00983|Drug metabolism - other enzymes;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa01100|Metabolic pathways
90-33-5	KEGG:hsa_M00014|Glucuronate pathway (uronate pathway);KEGG:hsa00053|Ascorbate and aldarate metabolism;KEGG:hsa00983|Drug metabolism - other enzymes;KEGG:hsa00040|Pentose and glucuronate interconversions;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-156588|Glucuronidation;KEGG:hsa00860|Porphyrin and chlorophyll metabolism;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
90-34-6	REACT:R-HSA-1430728|Metabolism
90-41-5	REACT:R-HSA-168256|Immune System
9000-07-1	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05132|Salmonella infection;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05164|Influenza A;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05144|Malaria;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling
9002-60-2	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168249|Innate Immune System
9002-93-1	REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;KEGG:hsa05164|Influenza A;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction
9002-98-6	KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05161|Hepatitis B;KEGG:hsa05134|Legionellosis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05152|Tuberculosis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-168256|Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression
9003-11-6	REACT:R-HSA-168256|Immune System
9004-54-0	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04976|Bile secretion;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05152|Tuberculosis;KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05133|Pertussis;KEGG:hsa04972|Pancreatic secretion;KEGG:hsa04072|Phospholipase D signaling pathway;KEGG:hsa04978|Mineral absorption;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04974|Protein digestion and absorption;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-373080|Class B/2 (Secretin family receptors);REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04022|cGMP-PKG signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04726|Serotonergic synapse;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2672351|Stimuli-sensing channels;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-74752|Signaling by Insulin receptor
9004-61-9	REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1643685|Disease;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05164|Influenza A;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05133|Pertussis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05215|Prostate cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05219|Bladder cancer;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05211|Renal cell carcinoma;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05132|Salmonella infection;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05020|Prion diseases;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05131|Shigellosis;KEGG:hsa04912|GnRH signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade
9004-66-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism
9005-25-8	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05164|Influenza A;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;KEGG:hsa04915|Estrogen signaling pathway;KEGG:hsa04931|Insulin resistance;KEGG:hsa05133|Pertussis;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05160|Hepatitis C;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04510|Focal adhesion;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04144|Endocytosis;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-372790|Signaling by GPCR
9005-49-6	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05218|Melanoma;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;KEGG:hsa05224|Breast cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2219530|Constitutive Signaling by Aberrant PI3K in Cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-190236|Signaling by FGFR;REACT:R-HSA-109704|PI3K Cascade;REACT:R-HSA-5654727|Negative regulation of FGFR2 signaling;REACT:R-HSA-2033519|Activated point mutants of FGFR2;KEGG:hsa05144|Malaria;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04210|Apoptosis;REACT:R-HSA-5654221|Phospholipase C-mediated cascade; FGFR2;REACT:R-HSA-190241|FGFR2 ligand binding and activation;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa05210|Colorectal cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1226099|Signaling by FGFR in disease;REACT:R-HSA-5654726|Negative regulation of FGFR1 signaling;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-5654695|PI-3K cascade:FGFR2;REACT:R-HSA-5654699|SHC-mediated cascade:FGFR2;KEGG:hsa05230|Central carbon metabolism in cancer
9006-59-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05162|Measles;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05164|Influenza A;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-380108|Chemokine receptors bind chemokines;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa05134|Legionellosis;KEGG:hsa05144|Malaria;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05146|Amoebiasis;KEGG:hsa05132|Salmonella infection;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04672|Intestinal immune network for IgA production;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-1643685|Disease;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-5260271|Diseases of Immune System;REACT:R-HSA-5602358|Diseases associated with the TLR signaling cascade;REACT:R-HSA-198933|Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-877300|Interferon gamma signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04622|RIG-I-like receptor signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04623|Cytosolic DNA-sensing pathway;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-216083|Integrin cell surface interactions;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05330|Allograft rejection;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168928|RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways;KEGG:hsa_M00684|JAK-STAT signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-6783589|Interleukin-6 family signaling;KEGG:hsa04068|FoxO signaling pathway
9007-27-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-2219530|Constitutive Signaling by Aberrant PI3K in Cancer;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04210|Apoptosis;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling
9007-28-7	REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05134|Legionellosis;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04210|Apoptosis;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling
9007-81-2	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05164|Influenza A;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05134|Legionellosis;KEGG:hsa05162|Measles;KEGG:hsa05133|Pertussis;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05144|Malaria;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05330|Allograft rejection;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1643685|Disease;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa04622|RIG-I-like receptor signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling
9007-92-5	KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
9008-11-1	KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05162|Measles;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System
9009-62-5	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression
9010-72-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05133|Pertussis;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05144|Malaria;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05164|Influenza A;KEGG:hsa04920|Adipocytokine signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05134|Legionellosis;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05160|Hepatitis C;KEGG:hsa05162|Measles;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05143|African trypanosomiasis;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04145|Phagosome;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04210|Apoptosis;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05131|Shigellosis;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04664|Fc epsilon RI signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05120|Epithelial cell signaling in Helicobacter pylori infection;KEGG:hsa04622|RIG-I-like receptor signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04640|Hematopoietic cell lineage
9012-63-9	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-372790|Signaling by GPCR
9012-76-4	KEGG:hsa05161|Hepatitis B;KEGG:hsa05152|Tuberculosis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways
9015-71-8	REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-162582|Signal Transduction
9036-19-5	REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05164|Influenza A;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-73894|DNA Repair;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction
9041-90-1	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System
9042-14-2	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-418594|G alpha (i) signalling events;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04024|cAMP signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-418555|G alpha (s) signalling events;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6783783|Interleukin-10 signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04510|Focal adhesion;KEGG:hsa05146|Amoebiasis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04976|Bile secretion;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa04270|Vascular smooth muscle contraction;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05152|Tuberculosis;KEGG:hsa04972|Pancreatic secretion;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04072|Phospholipase D signaling pathway;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-373080|Class B/2 (Secretin family receptors);KEGG:hsa05224|Breast cancer;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05133|Pertussis;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04978|Mineral absorption;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04310|Wnt signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05164|Influenza A;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-1474290|Collagen formation;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2672351|Stimuli-sensing channels;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04916|Melanogenesis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;KEGG:hsa04724|Glutamatergic synapse
9050-30-0	REACT:R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;REACT:R-HSA-190236|Signaling by FGFR;REACT:R-HSA-199418|Negative regulation of the PI3K/AKT network;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-2219530|Constitutive Signaling by Aberrant PI3K in Cancer;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-5654727|Negative regulation of FGFR2 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1226099|Signaling by FGFR in disease;KEGG:hsa05218|Melanoma;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-109704|PI3K Cascade;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5654736|Signaling by FGFR1;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5654738|Signaling by FGFR2;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05224|Breast cancer;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis
9072-19-9	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-168256|Immune System;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-162582|Signal Transduction
90780-52-2	KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins
908-54-3	KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System
91-20-3	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05210|Colorectal cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa00590|Arachidonic acid metabolism;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05215|Prostate cancer;KEGG:hsa05134|Legionellosis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa04530|Tight junction;REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04670|Leukocyte transendothelial migration;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04510|Focal adhesion;KEGG:hsa05224|Breast cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05160|Hepatitis C;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;KEGG:hsa05164|Influenza A;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05146|Amoebiasis;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-5663220|RHO GTPases Activate Formins
91-22-5	KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR
91-53-2	KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-156590|Glutathione conjugation;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa01100|Metabolic pathways
91-56-5	KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism
91-59-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology
91-64-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-156590|Glutathione conjugation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-69242|S Phase;REACT:R-HSA-168256|Immune System;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system
91-80-5	REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa01200|Carbon metabolism;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-196849|Metabolism of water-soluble vitamins and cofactors;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-983712|Ion channel transport;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04360|Axon guidance;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5621481|C-type lectin receptors (CLRs)
91-84-9	REACT:R-HSA-162582|Signal Transduction
911-45-5	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression
91161-71-6	KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1266738|Developmental Biology
91374-21-9	REACT:R-HSA-168256|Immune System
91674-26-9	KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism
92-13-7	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa04724|Glutamatergic synapse;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa04020|Calcium signaling pathway;KEGG:hsa04723|Retrograde endocannabinoid signaling;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04727|GABAergic synapse;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05033|Nicotine addiction;KEGG:hsa04810|Regulation of actin cytoskeleton;KEGG:hsa05031|Amphetamine addiction;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04725|Cholinergic synapse;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05133|Pertussis;REACT:R-HSA-375276|Peptide ligand-binding receptors;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04728|Dopaminergic synapse;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC);KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05146|Amoebiasis;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05030|Cocaine addiction;REACT:R-HSA-373760|L1CAM interactions;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04720|Long-term potentiation;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05132|Salmonella infection;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04540|Gap junction;KEGG:hsa05162|Measles;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04713|Circadian entrainment;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04930|Type II diabetes mellitus;KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04912|GnRH signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04750|Inflammatory mediator regulation of TRP channels;REACT:R-HSA-375280|Amine ligand-binding receptors;KEGG:hsa04370|VEGF signaling pathway
92-61-5	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
92-67-1	REACT:R-HSA-73894|DNA Repair;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa01100|Metabolic pathways
92593-91-4	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04110|Cell cycle;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-68886|M Phase;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-168256|Immune System;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression
93-15-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168256|Immune System;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa01200|Carbon metabolism;KEGG:hsa04976|Bile secretion;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-6788656|Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04146|Peroxisome;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-211981|Xenobiotics;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa00380|Tryptophan metabolism;KEGG:hsa00260|Glycine, serine and threonine metabolism;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04975|Fat digestion and absorption;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa00630|Glyoxylate and dicarboxylate metabolism;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa00120|Primary bile acid biosynthesis;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-2142753|Arachidonic acid metabolism;KEGG:hsa04726|Serotonergic synapse;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-194068|Bile acid and bile salt metabolism;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-977606|Regulation of Complement cascade;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa00650|Butanoate metabolism;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-69473|G2/M DNA damage checkpoint;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2187338|Visual phototransduction;REACT:R-HSA-193368|Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;KEGG:hsa04270|Vascular smooth muscle contraction;REACT:R-HSA-6806667|Metabolism of fat-soluble vitamins;KEGG:hsa04611|Platelet activation;REACT:R-HSA-166658|Complement cascade;REACT:R-HSA-192105|Synthesis of bile acids and bile salts;REACT:R-HSA-975634|Retinoid metabolism and transport;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-163685|Integration of energy metabolism;KEGG:hsa00250|Alanine, aspartate and glutamate metabolism;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5173105|O-linked glycosylation;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-174824|Lipoprotein metabolism;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa00590|Arachidonic acid metabolism;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling
93-35-6	REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1430728|Metabolism
93-65-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72766|Translation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System
93-76-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways
930-55-2	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-68886|M Phase;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-168256|Immune System;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;REACT:R-HSA-2299718|Condensation of Prophase Chromosomes;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-73886|Chromosome Maintenance;KEGG:hsa05322|Systemic lupus erythematosus;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05034|Alcoholism;REACT:R-HSA-3214815|HDACs deacetylate histones;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-212300|PRC2 methylates histones and DNA;REACT:R-HSA-977225|Amyloid fiber formation;REACT:R-HSA-73728|RNA Polymerase I Promoter Opening;REACT:R-HSA-5334118|DNA methylation;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-5625740|RHO GTPases activate PKNs;REACT:R-HSA-5625886|Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;REACT:R-HSA-3214847|HATs acetylate histones;REACT:R-HSA-427359|SIRT1 negatively regulates rRNA Expression;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-427389|ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-983189|Kinesins;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-1500620|Meiosis;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex;REACT:R-HSA-73777|RNA Polymerase I Chain Elongation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5619507|Activation of HOX genes during differentiation;REACT:R-HSA-5617472|Activation of anterior HOX genes in hindbrain development during early embryogenesis;REACT:R-HSA-5250924|B-WICH complex positively regulates rRNA expression;REACT:R-HSA-69473|G2/M DNA damage checkpoint;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-5578749|Transcriptional regulation by small RNAs;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-427413|NoRC negatively regulates rRNA expression;REACT:R-HSA-5250913|Positive epigenetic regulation of rRNA expression;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-171306|Packaging Of Telomere Ends;REACT:R-HSA-5250941|Negative epigenetic regulation of rRNA expression;REACT:R-HSA-73854|RNA Polymerase I Promoter Clearance;REACT:R-HSA-73864|RNA Polymerase I Transcription;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-983231|Factors involved in megakaryocyte development and platelet production;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-212165|Epigenetic regulation of gene expression;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-3214858|RMTs methylate histone arginines;REACT:R-HSA-1221632|Meiotic synapsis;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-211000|Gene Silencing by RNA;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-6811434|COPI-dependent Golgi-to-ER retrograde traffic;REACT:R-HSA-5693571|Nonhomologous End-Joining (NHEJ);KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04110|Cell cycle;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-504046|RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-5693565|Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;REACT:R-HSA-5693606|DNA Double Strand Break Response;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa03320|PPAR signaling pathway
937-13-3	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-168249|Innate Immune System
937-40-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-68886|M Phase;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5687128|MAPK6/MAPK4 signaling;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-68827|CDT1 association with the CDC6:ORC:origin complex;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-69242|S Phase;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-68867|Assembly of the pre-replicative complex
93957-54-1	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05152|Tuberculosis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System
94-07-5	REACT:R-HSA-162582|Signal Transduction
94-13-3	KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04110|Cell cycle;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;REACT:R-HSA-109581|Apoptosis;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5633008|TP53 Regulates Transcription of Cell Death Genes;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);REACT:R-HSA-1538133|G0 and Early G1;KEGG:hsa05224|Breast cancer;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05152|Tuberculosis;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05223|Non-small cell lung cancer;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05218|Melanoma;REACT:R-HSA-69242|S Phase;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04152|AMPK signaling pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04114|Oocyte meiosis;KEGG:hsa04914|Progesterone-mediated oocyte maturation;KEGG:hsa05010|Alzheimer's disease;KEGG:hsa05162|Measles;KEGG:hsa05164|Influenza A;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-1643685|Disease;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-453274|Mitotic G2-G2/M phases;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane
94-26-8	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-168256|Immune System;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;REACT:R-HSA-74751|Insulin receptor signalling cascade;KEGG:hsa04921|Oxytocin signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-5576893|Phase 2 - plateau phase;REACT:R-HSA-6794362|Protein-protein interactions at synapses;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-6794361|Interactions of neurexins and neuroligins at synapses;REACT:R-HSA-5576892|Phase 0 - rapid depolarisation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-198203|PI3K/AKT activation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-1643685|Disease;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05033|Nicotine addiction;KEGG:hsa04723|Retrograde endocannabinoid signaling;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC);REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05410|Hypertrophic cardiomyopathy (HCM);REACT:R-HSA-112310|Neurotransmitter Release Cycle;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);KEGG:hsa05219|Bladder cancer;KEGG:hsa05414|Dilated cardiomyopathy;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+
94-36-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
94-41-7	KEGG:hsa05161|Hepatitis B;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05152|Tuberculosis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05132|Salmonella infection;KEGG:hsa05215|Prostate cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05168|Herpes simplex infection;KEGG:hsa05160|Hepatitis C;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression
94-59-7	REACT:R-HSA-1430728|Metabolism
94-74-6	REACT:R-HSA-1430728|Metabolism;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-72766|Translation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-74160|Gene Expression;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
94-75-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-156842|Eukaryotic Translation Elongation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-72766|Translation;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway
944-22-9	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04514|Cell adhesion molecules (CAMs);REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-112316|Neuronal System;KEGG:hsa04972|Pancreatic secretion;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-5576891|Cardiac conduction;REACT:R-HSA-418555|G alpha (s) signalling events;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04974|Protein digestion and absorption;KEGG:hsa04724|Glutamatergic synapse;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa04360|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-425366|Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04713|Circadian entrainment;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-416476|G alpha (q) signalling events;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-425393|Transport of inorganic cations/anions and amino acids/oligopeptides;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04611|Platelet activation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04371|Apelin signaling pathway;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;KEGG:hsa04261|Adrenergic signaling in cardiomyocytes;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04144|Endocytosis;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-76002|Platelet activation, signaling and aggregation
94421-68-8	REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System
94497-51-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04145|Phagosome;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05164|Influenza A;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05161|Hepatitis B;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05162|Measles;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-1643685|Disease;REACT:R-HSA-877300|Interferon gamma signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04650|Natural killer cell mediated cytotoxicity;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05323|Rheumatoid arthritis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04612|Antigen processing and presentation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04666|Fc gamma R-mediated phagocytosis;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-909733|Interferon alpha/beta signaling;KEGG:hsa05330|Allograft rejection;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05210|Colorectal cancer;KEGG:hsa05332|Graft-versus-host disease;KEGG:hsa04110|Cell cycle;KEGG:hsa04940|Type I diabetes mellitus;REACT:R-HSA-2029480|Fcgamma receptor (FCGR) dependent phagocytosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-202433|Generation of second messenger molecules;KEGG:hsa04672|Intestinal immune network for IgA production;KEGG:hsa04510|Focal adhesion;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-202403|TCR signaling;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04514|Cell adhesion molecules (CAMs);KEGG:hsa04931|Insulin resistance;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa05160|Hepatitis C;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-198933|Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;KEGG:hsa04611|Platelet activation;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04725|Cholinergic synapse;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05310|Asthma
94613-45-3	KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa05016|Huntington's disease;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05010|Alzheimer's disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1430728|Metabolism;KEGG:hsa04260|Cardiac muscle contraction
94840-66-1	KEGG:hsa05200|Pathways in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04110|Cell cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1430728|Metabolism
95-47-6	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
95-63-6	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1643685|Disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-212436|Generic Transcription Pathway
95-76-1	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System
95-80-7	REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-69242|S Phase;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-68886|M Phase;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04110|Cell cycle;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-1643685|Disease
950-99-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-168256|Immune System;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-372790|Signaling by GPCR
951-77-9	REACT:R-HSA-168256|Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04210|Apoptosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-1643685|Disease;KEGG:hsa05219|Bladder cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05224|Breast cancer;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05012|Parkinson's disease;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05016|Huntington's disease;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-611105|Respiratory electron transport;KEGG:hsa05162|Measles;KEGG:hsa05144|Malaria;KEGG:hsa05164|Influenza A;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-163200|Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa00190|Oxidative phosphorylation;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05152|Tuberculosis;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05134|Legionellosis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;KEGG:hsa05218|Melanoma;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism
951-78-0	KEGG:hsa04210|Apoptosis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05161|Hepatitis B;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-392499|Metabolism of proteins
956-48-9	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System
95975-55-6	KEGG:hsa05200|Pathways in cancer;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-383280|Nuclear Receptor transcription pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology
96-09-3	KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1430728|Metabolism
96-23-1	KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04210|Apoptosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System
96-24-2	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa01200|Carbon metabolism;KEGG:hsa04210|Apoptosis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1643685|Disease;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05200|Pathways in cancer;KEGG:hsa05010|Alzheimer's disease;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa01230|Biosynthesis of amino acids;KEGG:hsa05164|Influenza A;REACT:R-HSA-156590|Glutathione conjugation;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05152|Tuberculosis;KEGG:hsa00480|Glutathione metabolism;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05134|Legionellosis;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa00280|Valine, leucine and isoleucine degradation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa04510|Focal adhesion;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa00010|Glycolysis / Gluconeogenesis;KEGG:hsa05016|Huntington's disease;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-422475|Axon guidance;KEGG:hsa00260|Glycine, serine and threonine metabolism;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-72766|Translation;REACT:R-HSA-168255|Influenza Life Cycle;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05160|Hepatitis C;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05215|Prostate cancer;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04931|Insulin resistance;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;REACT:R-HSA-168254|Influenza Infection;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-70326|Glucose metabolism;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;KEGG:hsa00630|Glyoxylate and dicarboxylate metabolism;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa01212|Fatty acid metabolism;KEGG:hsa00620|Pyruvate metabolism;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-352230|Amino acid transport across the plasma membrane;KEGG:hsa05133|Pertussis;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-70171|Glycolysis;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa00071|Fatty acid degradation
96-45-7	REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism
96-48-0	REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-68886|M Phase;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04110|Cell cycle;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-168256|Immune System;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-73886|Chromosome Maintenance;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-69242|S Phase;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5693532|DNA Double-Strand Break Repair;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-5693538|Homology Directed Repair;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa03030|DNA replication;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-5693567|HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);REACT:R-HSA-1430728|Metabolism;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-69473|G2/M DNA damage checkpoint;REACT:R-HSA-157579|Telomere Maintenance;REACT:R-HSA-5685942|HDR through Homologous Recombination (HRR);REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-176187|Activation of ATR in response to replication stress;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-174417|Telomere C-strand (Lagging Strand) Synthesis;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-180786|Extension of Telomeres;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-68875|Mitotic Prophase;REACT:R-HSA-1643685|Disease;REACT:R-HSA-774815|Nucleosome assembly;REACT:R-HSA-606279|Deposition of new CENPA-containing nucleosomes at the centromere;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5633007|Regulation of TP53 Activity;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-5693607|Processing of DNA double-strand break ends;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5693579|Homologous DNA Pairing and Strand Exchange;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6804756|Regulation of TP53 Activity through Phosphorylation;REACT:R-HSA-69186|Lagging Strand Synthesis;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-110373|Resolution of AP sites via the multiple-nucleotide patch replacement pathway;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-5693616|Presynaptic phase of homologous DNA pairing and strand exchange;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1500620|Meiosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-2559580|Oxidative Stress Induced Senescence;REACT:R-HSA-5651801|PCNA-Dependent Long Patch Base Excision Repair;REACT:R-HSA-73933|Resolution of Abasic Sites (AP sites);REACT:R-HSA-73884|Base Excision Repair;REACT:R-HSA-912446|Meiotic recombination;REACT:R-HSA-176974|Unwinding of DNA;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04210|Apoptosis;REACT:R-HSA-2565942|Regulation of PLK1 Activity at G2/M Transition;REACT:R-HSA-5685938|HDR through Single Strand Annealing (SSA);KEGG:hsa03460|Fanconi anemia pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-174411|Polymerase switching on the C-strand of the telomere;REACT:R-HSA-69109|Leading Strand Synthesis;REACT:R-HSA-69091|Polymerase switching;REACT:R-HSA-69205|G1/S-Specific Transcription;KEGG:hsa03440|Homologous recombination;KEGG:hsa03430|Mismatch repair;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-69183|Processive synthesis on the lagging strand;REACT:R-HSA-110314|Recognition of DNA damage by PCNA-containing replication complex;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-5696397|Gap-filling DNA repair synthesis and ligation in GG-NER
96-64-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1643685|Disease;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05152|Tuberculosis;KEGG:hsa04210|Apoptosis;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05133|Pertussis;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-500792|GPCR ligand binding;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194840|Rho GTPase cycle;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-446203|Asparagine N-linked glycosylation;KEGG:hsa05134|Legionellosis;REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04142|Lysosome;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04670|Leukocyte transendothelial migration;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04360|Axon guidance;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-166054|Activated TLR4 signalling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-913531|Interferon Signaling;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05132|Salmonella infection;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling
961-07-9	REACT:R-HSA-1430728|Metabolism
961-29-5	KEGG:hsa05200|Pathways in cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04210|Apoptosis;KEGG:hsa05152|Tuberculosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa00140|Steroid hormone biosynthesis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05222|Small cell lung cancer;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa05146|Amoebiasis;KEGG:hsa05212|Pancreatic cancer;KEGG:hsa00830|Retinol metabolism;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa04931|Insulin resistance;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05133|Pertussis;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05162|Measles;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05164|Influenza A;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-1280218|Adaptive Immune System
96489-71-3	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins
965-93-5	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-168256|Immune System;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-72766|Translation;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-927802|Nonsense-Mediated Decay (NMD);REACT:R-HSA-975957|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-156827|L13a-mediated translational silencing of Ceruloplasmin expression;REACT:R-HSA-975956|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);REACT:R-HSA-1368082|RORA activates gene expression;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-2408522|Selenoamino acid metabolism;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-72613|Eukaryotic Translation Initiation;REACT:R-HSA-72737|Cap-dependent Translation Initiation;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-72706|GTP hydrolysis and joining of the 60S ribosomal subunit;REACT:R-HSA-156842|Eukaryotic Translation Elongation;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-72649|Translation initiation complex formation;REACT:R-HSA-72662|Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-72689|Formation of a pool of free 40S subunits;REACT:R-HSA-72695|Formation of the ternary complex, and subsequently, the 43S complex;REACT:R-HSA-168254|Influenza Infection;KEGG:hsa04520|Adherens junction;REACT:R-HSA-156902|Peptide chain elongation;REACT:R-HSA-1799339|SRP-dependent cotranslational protein targeting to membrane;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-72764|Eukaryotic Translation Termination;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-168255|Influenza Life Cycle;REACT:R-HSA-2151201|Transcriptional activation of mitochondrial biogenesis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-72702|Ribosomal scanning and start codon recognition;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-109582|Hemostasis;KEGG:hsa_M00177|Ribosome, eukaryotes;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1592230|Mitochondrial biogenesis;REACT:R-HSA-192823|Viral mRNA Translation;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-72312|rRNA processing;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2408557|Selenocysteine synthesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05219|Bladder cancer;KEGG:hsa01230|Biosynthesis of amino acids;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-168273|Influenza Viral RNA Transcription and Replication;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;KEGG:hsa04510|Focal adhesion;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-109581|Apoptosis;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-6791226|Major pathway of rRNA processing in the nucleolus and cytosol
96829-58-2	REACT:R-HSA-162582|Signal Transduction;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05215|Prostate cancer;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04110|Cell cycle;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-168256|Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression
97-00-7	REACT:R-HSA-168256|Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04062|Chemokine signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04630|Jak-STAT signaling pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05133|Pertussis;KEGG:hsa05164|Influenza A;KEGG:hsa05321|Inflammatory bowel disease (IBD);REACT:R-HSA-380108|Chemokine receptors bind chemokines;KEGG:hsa05132|Salmonella infection;KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-69242|S Phase;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-3299685|Detoxification of Reactive Oxygen Species;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05134|Legionellosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04658|Th1 and Th2 cell differentiation;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa05144|Malaria;REACT:R-HSA-69306|DNA Replication;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-69239|Synthesis of DNA;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa05152|Tuberculosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04210|Apoptosis;REACT:R-HSA-156590|Glutathione conjugation;REACT:R-HSA-69190|DNA strand elongation;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa03030|DNA replication;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-375276|Peptide ligand-binding receptors;REACT:R-HSA-113510|E2F mediated regulation of DNA replication;REACT:R-HSA-1643685|Disease;REACT:R-HSA-418594|G alpha (i) signalling events;REACT:R-HSA-176187|Activation of ATR in response to replication stress;KEGG:hsa04660|T cell receptor signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-68962|Activation of the pre-replicative complex;REACT:R-HSA-69205|G1/S-Specific Transcription;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-15869|Metabolism of nucleotides;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;KEGG:hsa00240|Pyrimidine metabolism;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05330|Allograft rejection;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa00982|Drug metabolism - cytochrome P450
97-53-0	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa05166|HTLV-I infection;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05161|Hepatitis B;KEGG:hsa04610|Complement and coagulation cascades;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04210|Apoptosis;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05215|Prostate cancer;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-156580|Phase II conjugation;KEGG:hsa04110|Cell cycle;KEGG:hsa00830|Retinol metabolism;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05224|Breast cancer;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa05133|Pertussis;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;KEGG:hsa05219|Bladder cancer;KEGG:hsa05134|Legionellosis;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa05152|Tuberculosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05140|Leishmaniasis;KEGG:hsa01200|Carbon metabolism;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa04064|NF-kappa B signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04976|Bile secretion;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa05132|Salmonella infection;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05218|Melanoma;KEGG:hsa00983|Drug metabolism - other enzymes;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-193368|Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-194068|Bile acid and bile salt metabolism;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05162|Measles;REACT:R-HSA-2142753|Arachidonic acid metabolism;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04917|Prolactin signaling pathway
97-54-1	REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05164|Influenza A;KEGG:hsa05132|Salmonella infection;KEGG:hsa05134|Legionellosis;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05161|Hepatitis B;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-168256|Immune System;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05162|Measles;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa04659|Th17 cell differentiation;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins
97-77-8	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1643685|Disease;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05164|Influenza A;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05161|Hepatitis B;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa01100|Metabolic pathways;KEGG:hsa05166|HTLV-I infection;KEGG:hsa05133|Pertussis;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05152|Tuberculosis;KEGG:hsa04510|Focal adhesion;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05134|Legionellosis;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa05215|Prostate cancer;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa01522|Endocrine resistance;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade;REACT:R-HSA-937061|TRIF-mediated TLR3/TLR4 signaling;REACT:R-HSA-168164|Toll Like Receptor 3 (TLR3) Cascade;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa05162|Measles;KEGG:hsa04621|NOD-like receptor signaling pathway;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168181|Toll Like Receptor 7/8 (TLR7/8) Cascade;REACT:R-HSA-975155|MyD88 dependent cascade initiated on endosome;KEGG:hsa05020|Prion diseases;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-168142|Toll Like Receptor 10 (TLR10) Cascade;REACT:R-HSA-168176|Toll Like Receptor 5 (TLR5) Cascade;REACT:R-HSA-975871|MyD88 cascade initiated on plasma membrane;KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa04360|Axon guidance;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05146|Amoebiasis;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-109581|Apoptosis
97161-97-2	KEGG:hsa04210|Apoptosis;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-168256|Immune System
97240-79-4	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-112314|Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-162582|Signal Transduction
97322-87-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04110|Cell cycle;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa03320|PPAR signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-76002|Platelet activation, signaling and aggregation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-422475|Axon guidance;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04931|Insulin resistance;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;REACT:R-HSA-73923|Lipid digestion, mobilization, and transport;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-69242|S Phase;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05152|Tuberculosis;KEGG:hsa05164|Influenza A;KEGG:hsa05220|Chronic myeloid leukemia;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa00071|Fatty acid degradation;REACT:R-HSA-5633007|Regulation of TP53 Activity;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-68886|M Phase;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-400253|Circadian Clock;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-5693538|Homology Directed Repair;KEGG:hsa04910|Insulin signaling pathway;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-69620|Cell Cycle Checkpoints;KEGG:hsa03030|DNA replication;KEGG:hsa05224|Breast cancer;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-5693532|DNA Double-Strand Break Repair
97666-60-9	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168256|Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1430728|Metabolism
979-92-0	REACT:R-HSA-1430728|Metabolism
98-54-4	REACT:R-HSA-162582|Signal Transduction
98-82-8	REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
98-92-0	KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-162582|Signal Transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa04210|Apoptosis;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa01521|EGFR tyrosine kinase inhibitor resistance;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-1643685|Disease;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa05164|Influenza A;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04917|Prolactin signaling pathway;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05152|Tuberculosis;KEGG:hsa04910|Insulin signaling pathway;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa04012|ErbB signaling pathway;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04380|Osteoclast differentiation;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05214|Glioma;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05221|Acute myeloid leukemia;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa05223|Non-small cell lung cancer;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa04211|Longevity regulating pathway;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05218|Melanoma;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05224|Breast cancer;KEGG:hsa04215|Apoptosis - multiple species;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04722|Neurotrophin signaling pathway;KEGG:hsa05231|Choline metabolism in cancer;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa04110|Cell cycle;REACT:R-HSA-1430728|Metabolism;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05160|Hepatitis C;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa05213|Endometrial cancer;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-109606|Intrinsic Pathway for Apoptosis;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa04150|mTOR signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa04152|AMPK signaling pathway;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04919|Thyroid hormone signaling pathway;KEGG:hsa05133|Pertussis;KEGG:hsa05230|Central carbon metabolism in cancer;REACT:R-HSA-2219528|PI3K/AKT Signaling in Cancer
98-96-4	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04976|Bile secretion;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa03320|PPAR signaling pathway;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-381119|Unfolded Protein Response (UPR);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-212436|Generic Transcription Pathway
98-98-6	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
98048-97-6	REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System
983-30-2	REACT:R-HSA-162582|Signal Transduction
98319-26-7	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-5368286|Mitochondrial translation initiation;REACT:R-HSA-5368287|Mitochondrial translation;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-5389840|Mitochondrial translation elongation;REACT:R-HSA-5419276|Mitochondrial translation termination;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-450531|Regulation of mRNA stability by proteins that bind AU-rich elements;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa03050|Proteasome;REACT:R-HSA-180585|Vif-mediated degradation of APOBEC3G;REACT:R-HSA-1643685|Disease;REACT:R-HSA-450408|AUF1 (hnRNP D0) binds and destabilizes mRNA;REACT:R-HSA-350562|Regulation of ornithine decarboxylase (ODC);REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-5658442|Regulation of RAS by GAPs;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-68827|CDT1 association with the CDC6:ORC:origin complex;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5610780|Degradation of GLI1 by the proteasome;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-8854050|FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;REACT:R-HSA-1236978|Cross-presentation of soluble exogenous antigens (endosomes);REACT:R-HSA-211733|Regulation of activated PAK-2p34 by proteasome mediated degradation;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-69017|CDK-mediated phosphorylation and removal of Cdc6;REACT:R-HSA-195253|Degradation of beta-catenin by the destruction complex;REACT:R-HSA-5362768|Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-180534|Vpu mediated degradation of CD4;REACT:R-HSA-349425|Autodegradation of the E3 ubiquitin ligase COP1;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-4641258|Degradation of DVL;REACT:R-HSA-69610|p53-Independent DNA Damage Response;REACT:R-HSA-69613|p53-Independent G1/S DNA damage checkpoint;REACT:R-HSA-69601|Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;REACT:R-HSA-169911|Regulation of Apoptosis;REACT:R-HSA-69239|Synthesis of DNA;REACT:R-HSA-5387390|Hh mutants abrogate ligand secretion;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-5610785|GLI3 is processed to GLI3R by the proteasome;REACT:R-HSA-5610783|Degradation of GLI2 by the proteasome;REACT:R-HSA-68886|M Phase;REACT:R-HSA-69541|Stabilization of p53;REACT:R-HSA-174113|SCF-beta-TrCP mediated degradation of Emi1;REACT:R-HSA-4641257|Degradation of AXIN;REACT:R-HSA-174154|APC/C:Cdc20 mediated degradation of Securin;REACT:R-HSA-5678895|Defective CFTR causes cystic fibrosis;REACT:R-HSA-68867|Assembly of the pre-replicative complex;REACT:R-HSA-174084|Autodegradation of Cdh1 by Cdh1:APC/C;REACT:R-HSA-69306|DNA Replication;REACT:R-HSA-69580|p53-Dependent G1/S DNA damage checkpoint;REACT:R-HSA-69563|p53-Dependent G1 DNA Damage Response;REACT:R-HSA-69002|DNA Replication Pre-Initiation;REACT:R-HSA-68874|M/G1 Transition;REACT:R-HSA-68949|Orc1 removal from chromatin;REACT:R-HSA-69052|Switching of origins to a post-replicative state;REACT:R-HSA-5676590|NIK-->noncanonical NF-kB signaling;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-69242|S Phase;REACT:R-HSA-174184|Cdc20:Phospho-APC/C mediated degradation of Cyclin A;REACT:R-HSA-174178|APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;REACT:R-HSA-5358346|Hedgehog ligand biogenesis;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-5607761|Dectin-1 mediated noncanonical NF-kB signaling;REACT:R-HSA-69300|Removal of licensing factors from origins;REACT:R-HSA-179419|APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;REACT:R-HSA-1169091|Activation of NF-kappaB in B cells;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-162906|HIV Infection;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-5619084|ABC transporter disorders;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-69304|Regulation of DNA replication;REACT:R-HSA-167044|Signalling to RAS
989-51-5	REACT:R-HSA-168256|Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280218|Adaptive Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05161|Hepatitis B;KEGG:hsa04210|Apoptosis;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-422475|Axon guidance;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05212|Pancreatic cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05142|Chagas disease (American trypanosomiasis);REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa05215|Prostate cancer;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05164|Influenza A;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-166016|Toll Like Receptor 4 (TLR4) Cascade;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-168898|Toll-Like Receptors Cascades;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05152|Tuberculosis;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05162|Measles;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa04380|Osteoclast differentiation;REACT:R-HSA-166054|Activated TLR4 signalling;KEGG:hsa04144|Endocytosis;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05210|Colorectal cancer;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa05224|Breast cancer;REACT:R-HSA-181438|Toll Like Receptor 2 (TLR2) Cascade;REACT:R-HSA-168179|Toll Like Receptor TLR1:TLR2 Cascade;REACT:R-HSA-168188|Toll Like Receptor TLR6:TLR2 Cascade;REACT:R-HSA-166058|MyD88:Mal cascade initiated on plasma membrane;KEGG:hsa05220|Chronic myeloid leukemia;KEGG:hsa04660|T cell receptor signaling pathway;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-168138|Toll Like Receptor 9 (TLR9) Cascade;REACT:R-HSA-975138|TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;REACT:R-HSA-166166|MyD88-independent TLR3/TLR4 cascade
99-20-7	KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-1430728|Metabolism
99-50-3	KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-162582|Signal Transduction
99-51-4	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction
99-56-9	REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction
99-65-0	REACT:R-HSA-168256|Immune System;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-176814|Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-174178|APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-176409|APC/C:Cdc20 mediated degradation of mitotic proteins;REACT:R-HSA-176408|Regulation of APC/C activators between G1/S and early anaphase;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-174154|APC/C:Cdc20 mediated degradation of Securin;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-68886|M Phase;REACT:R-HSA-174184|Cdc20:Phospho-APC/C mediated degradation of Cyclin A;REACT:R-HSA-179419|APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1234176|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04120|Ubiquitin mediated proteolysis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2467813|Separation of Sister Chromatids;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-1234174|Regulation of Hypoxia-inducible Factor (HIF) by oxygen;REACT:R-HSA-2262749|Cellular response to hypoxia;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-8852276|The role of GTSE1 in G2/M progression after G2 checkpoint;REACT:R-HSA-5607764|CLEC7A (Dectin-1) signaling;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-174084|Autodegradation of Cdh1 by Cdh1:APC/C;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa04210|Apoptosis;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);REACT:R-HSA-3858494|Beta-catenin independent WNT signaling;REACT:R-HSA-187577|SCF(Skp2)-mediated degradation of p27/p21;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-195253|Degradation of beta-catenin by the destruction complex;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2871837|FCERI mediated NF-kB activation;REACT:R-HSA-1236974|ER-Phagosome pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-162909|Host Interactions of HIV factors;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-69615|G1/S DNA Damage Checkpoints;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69229|Ubiquitin-dependent degradation of Cyclin D1;REACT:R-HSA-75815|Ubiquitin-dependent degradation of Cyclin D;REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-453279|Mitotic G1-G1/S phases
99-66-1	REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-71387|Metabolism of carbohydrates;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04144|Endocytosis;REACT:R-HSA-73894|DNA Repair;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-68886|M Phase;REACT:R-HSA-112315|Transmission across Chemical Synapses;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa04510|Focal adhesion;KEGG:hsa04360|Axon guidance;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-6811442|Intra-Golgi and retrograde Golgi-to-ER traffic;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-162906|HIV Infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-983712|Ion channel transport;REACT:R-HSA-1483257|Phospholipid metabolism;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-69620|Cell Cycle Checkpoints
99-76-3	REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04110|Cell cycle;REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2559583|Cellular Senescence;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-68886|M Phase;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa03040|Spliceosome;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-194315|Signaling by Rho GTPases;KEGG:hsa05203|Viral carcinogenesis;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-1643685|Disease;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-69206|G1/S Transition;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-2559582|Senescence-Associated Secretory Phenotype (SASP);REACT:R-HSA-109582|Hemostasis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-170834|Signaling by TGF-beta Receptor Complex;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-2173793|Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;REACT:R-HSA-68882|Mitotic Anaphase;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;REACT:R-HSA-69242|S Phase;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-68877|Mitotic Prometaphase;REACT:R-HSA-3371556|Cellular response to heat stress;REACT:R-HSA-3371453|Regulation of HSF1-mediated heat shock response;KEGG:hsa04210|Apoptosis;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-2467813|Separation of Sister Chromatids;KEGG:hsa05206|MicroRNAs in cancer;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-5688426|Deubiquitination;KEGG:hsa01524|Platinum drug resistance;KEGG:hsa04914|Progesterone-mediated oocyte maturation;REACT:R-HSA-159236|Transport of Mature mRNA derived from an Intron-Containing Transcript;KEGG:hsa04915|Estrogen signaling pathway;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-2559586|DNA Damage/Telomere Stress Induced Senescence;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa05222|Small cell lung cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-72202|Transport of Mature Transcript to Cytoplasm;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-69656|Cyclin A:Cdk2-associated events at S phase entry;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa04140|Autophagy - animal;REACT:R-HSA-5689880|Ub-specific processing proteases;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04068|FoxO signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-69481|G2/M Checkpoints;REACT:R-HSA-174143|APC/C-mediated degradation of cell cycle proteins;REACT:R-HSA-453276|Regulation of mitotic cell cycle;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa05224|Breast cancer;REACT:R-HSA-5663220|RHO GTPases Activate Formins;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-73857|RNA Polymerase II Transcription;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-69306|DNA Replication;KEGG:hsa03013|RNA transport
99-97-8	REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-168256|Immune System;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa00480|Glutathione metabolism;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-1643685|Disease;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-69278|Cell Cycle, Mitotic;KEGG:hsa04141|Protein processing in endoplasmic reticulum;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-351202|Metabolism of polyamines;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5389840|Mitochondrial translation elongation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-381119|Unfolded Protein Response (UPR);REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-5368287|Mitochondrial translation;REACT:R-HSA-69202|Cyclin E associated events during G1/S transition;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-5619115|Disorders of transmembrane transporters;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-1483206|Glycerophospholipid biosynthesis;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5628897|TP53 Regulates Metabolic Genes;REACT:R-HSA-5419276|Mitochondrial translation termination;REACT:R-HSA-5368286|Mitochondrial translation initiation;REACT:R-HSA-199991|Membrane Trafficking;REACT:R-HSA-453279|Mitotic G1-G1/S phases;REACT:R-HSA-69275|G2/M Transition;REACT:R-HSA-453274|Mitotic G2-G2/M phases;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-15869|Metabolism of nucleotides;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-5668541|TNFR2 non-canonical NF-kB pathway;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-382556|ABC-family proteins mediated transport;REACT:R-HSA-1483257|Phospholipid metabolism;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5621481|C-type lectin receptors (CLRs);KEGG:hsa01200|Carbon metabolism;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-68886|M Phase;KEGG:hsa04722|Neurotrophin signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-72172|mRNA Splicing;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-69242|S Phase;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-5683057|MAPK family signaling cascades;KEGG:hsa03040|Spliceosome;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN
99011-02-6	REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-168256|Immune System;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04630|Jak-STAT signaling pathway;REACT:R-HSA-6783783|Interleukin-10 signaling;KEGG:hsa05152|Tuberculosis;KEGG:hsa04620|Toll-like receptor signaling pathway;KEGG:hsa05321|Inflammatory bowel disease (IBD);KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa05164|Influenza A;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-73894|DNA Repair;KEGG:hsa05144|Malaria;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa05133|Pertussis;KEGG:hsa05145|Toxoplasmosis;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa05161|Hepatitis B;KEGG:hsa04659|Th17 cell differentiation;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa05146|Amoebiasis;KEGG:hsa05140|Leishmaniasis;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa04621|NOD-like receptor signaling pathway;KEGG:hsa05162|Measles;KEGG:hsa04210|Apoptosis;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-168898|Toll-Like Receptors Cascades;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-212436|Generic Transcription Pathway
99685-96-8	REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1643685|Disease;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-5653656|Vesicle-mediated transport;KEGG:hsa04020|Calcium signaling pathway;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-74160|Gene Expression;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-1433557|Signaling by SCF-KIT;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-8853659|RET signaling;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa04657|IL-17 signaling pathway;KEGG:hsa04080|Neuroactive ligand-receptor interaction;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-193704|p75 NTR receptor-mediated signalling;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-112399|IRS-mediated signalling;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-163685|Integration of energy metabolism;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-416476|G alpha (q) signalling events;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-194840|Rho GTPase cycle;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-416482|G alpha (12/13) signalling events;REACT:R-HSA-2586552|Signaling by Leptin;KEGG:hsa04144|Endocytosis;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa04071|Sphingolipid signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04360|Axon guidance;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-204998|Cell death signalling via NRAGE, NRIF and NADE
99796-69-7	REACT:R-HSA-168256|Immune System
99874-23-4	KEGG:hsa05016|Huntington's disease;KEGG:hsa05014|Amyotrophic lateral sclerosis (ALS);KEGG:hsa05012|Parkinson's disease;REACT:R-HSA-1428517|The citric acid (TCA) cycle and respiratory electron transport;REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways
